WO2021180947A1 - Dispositif, appareil et procédé de détermination de pression de perfusion cutanée - Google Patents

Dispositif, appareil et procédé de détermination de pression de perfusion cutanée Download PDF

Info

Publication number
WO2021180947A1
WO2021180947A1 PCT/EP2021/056380 EP2021056380W WO2021180947A1 WO 2021180947 A1 WO2021180947 A1 WO 2021180947A1 EP 2021056380 W EP2021056380 W EP 2021056380W WO 2021180947 A1 WO2021180947 A1 WO 2021180947A1
Authority
WO
WIPO (PCT)
Prior art keywords
determination device
pressure determination
perfusion pressure
skin perfusion
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2021/056380
Other languages
English (en)
Inventor
Allan Kenneth Frazer Grugeon HUNT
Peter Georg Laitenberger
Lee Ian PARTINGTON
Marcus Damian PHILLIPS
Felix Clarence Quintanar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Publication of WO2021180947A1 publication Critical patent/WO2021180947A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
    • A61B5/0053—Detecting, measuring or recording by applying mechanical forces or stimuli by applying pressure, e.g. compression, indentation, palpation, grasping, gauging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/684—Indicating the position of the sensor on the body
    • A61B5/6842—Indicating the position of the sensor on the body by marking the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
    • A61B2505/09—Rehabilitation or training
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247—Pressure sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683—Means for maintaining contact with the body
    • A61B5/6834—Means for maintaining contact with the body using vacuum

Definitions

  • Embodiments of the present disclosure relate to apparatuses, systems, and methods for the treatment of tissues via sensor-enabled monitoring in communication with various therapy regimes.
  • Embodiments described herein relates to a skin perfusion pressure determination device, apparatus and method of determining skin perfusion pressure.
  • Wound healing is natural process performed by the human body in response to injury.
  • the amount of time taken for a wound to heal is dependent on many different factors which include the human body’s ability to heal itself and any treatments that are applied to the wound to accelerate wound healing. Understanding the healing status of a wound and being able to monitor the healing process helps to inform decisions on further treatment of the wound and can also assist in the development of future wound therapies.
  • SPP Skin Perfusion Pressure
  • Techniques for detecting the restoration of blood flow include radioisotope clearance, laser doppler flow measurement and photoplethysmography. Such techniques are typically performed by clinicians and require instrumentation that is often bulky, complicated and expensive.
  • a wound dressing is typically applied to a wound in order to protect the wound from pathogens, assist healing of the wound and to protect the area of the wound from further injury.
  • the tissue in and around the wound may be inspected periodically. Inspection can be carried out by a clinician using the naked eye, but may also be carried out using optical devices that analyze the appearance of the wounded area to determine the state of the wound. To access the wounded area, the wound dressing must be removed. This is time consuming, inconvenient and often uncomfortable for the patient.
  • the original dressing is usually replaced by a fresh dressing even though the old dressing may not have needed replacing at the time of inspection
  • a probe or other form of inspection device may be used to measure a parameter associated with wound healing at various points about the perimeter of the wound dressing or at various tissue areas.
  • a parameter associated with wound healing is the measurement of the amount of blood perfusion in the tissue surrounding the wound.
  • the amount of blood perfusion will, however, vary about the periphery of the wound dressing.
  • the amount of blood perfusion of tissue at the periphery of a wound to a forearm may be greater in tissue closer to the elbow than in tissue closer to the wrist. Repeated measurements at different locations by clinicians can therefore produce results which are inconsistent and unreliable for determining the status of the healing process.
  • a skin perfusion pressure determination device and a method for using the skin perfusion pressure determination device can comprise a housing including a proximal end and a distal end.
  • the skin perfusion pressure determination device can further comprise a proximal end assembly at the proximal end of the housing configured to contact and exert pressure on a target area, a sensor module provided within the housing and/or the proximal end assembly configured to detect a force exerted on the target area and an amount of blood perfusion at the target area.
  • a skin perfusion pressure determination device comprising a housing including a proximal end and a distal end, and wherein the skin perfusion pressure determination device can further comprise a plunger assembly at the proximal end of the housing configured to contact and exert force on a target area, the plunger assembly comprising a support structure and a sleeve surrounding the support structure, a sensor module provided within the housing and/or the plunger assembly, the sensor module configured to detect a force exerted on the target area and an amount of blood perfusion at the target area, a spring at the distal end of the housing configured to exert a force on the plunger assembly and control the force exerted on the target area, and a PCB or other electronics, wherein the PCB or other electronics are positioned distal to the sensor module.
  • the skin perfusion pressure determination device of any of the preceding paragraphs and/or any of the skin perfusion pressure determination device disclosed herein can include one or more of the following features.
  • the PCB or other electronics can be positioned at the distal end of the housing.
  • the PCB or other electronics can be positioned proximal to the spring.
  • the skin perfusion pressure determination device can further comprise a display to provide feedback of the force exerted on the target area.
  • the display can comprise an indicator portion and an LED, wherein the indicator portion can be configured to display the light emitted from the LED and the indicator portion circumferentially surrounds a portion of the housing.
  • the support structure can support one or more of a sensor, electrical connection for a sensor, a PCB, a battery, battery contacts, and/or an LED.
  • the sensor module can comprise a first sensor for sensing a first parameter associated with a force exerted on the target area by the sensor module and a second sensor for sensing a second parameter associated with an amount of blood perfusion at the target area, wherein the first sensor and the second sensor are arranged such that, when the sensor module is pressed against the target area the first sensor produces an output corresponding to the sensed first parameter and the second sensor produces an output corresponding to the sensed second parameter.
  • the sensor module can comprise a first sensor configured to detect the amount of blood perfusion at the target area and/or a second sensor configured to detect the force exerted on the target area.
  • the first sensor and the second sensor can be positioned at the proximal end of the housing.
  • the first sensor can be positioned at the proximal end of the housing and the second sensor can be positioned at the distal end of the plunger assembly and proximal to the spring.
  • the first sensor can be an optical sensor.
  • the second sensor can be a force sensor.
  • the housing can comprise a grip portion comprising a flared portion.
  • the skin perfusion pressure determination device can further comprise a docking station configured to receive the skin perfusion pressure determination device.
  • the housing can be an elongate housing.
  • a skin perfusion pressure determination device can comprise a housing including a proximal end and a distal end.
  • the skin perfusion pressure determination device can further comprise a plunger assembly at the proximal end of the housing configured to contact and exert force on a target area, a sensor module provided within the housing and/or the plunger assembly, the sensor module configured to detect a force exerted on the target area and an amount of blood perfusion at the target area, and a light source positioned on a portion of an outer surface of the housing configured to emit a light onto or around the target area that provides a guide for positioning of the skin perfusion pressure determination device.
  • a plunger assembly at the proximal end of the housing configured to contact and exert force on a target area
  • a sensor module provided within the housing and/or the plunger assembly, the sensor module configured to detect a force exerted on the target area and an amount of blood perfusion at the target area
  • a light source positioned on a portion of an outer surface of the housing configured to emit a light onto or around the target area that provides a guide for positioning of the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device of any of the preceding paragraphs and/or any of the skin perfusion pressure determination device disclosed herein can include one or more of the following features.
  • the plunger assembly can be configured to be moved from a first position extended from the housing to a second position retracted into the housing.
  • the light source can be positioned on the plunger assembly and is configured to be visible when the plunger assembly is in the first position and not visible when the plunger assembly is in the second position.
  • the light source can be positioned on the housing and can be configured to be visible throughout use of the skin perfusion pressure determination device.
  • the light emitted from the light source can have gradations.
  • the gradations can provide more than one guide for positioning of the skin perfusion pressure determination device.
  • the guide can comprise one or more of a ring, a cone, a spot, a line, a marking, and indicia.
  • a method of using a skin perfusion pressure determination device can comprise providing a skin perfusion pressure determination device at a target area, wherein the skin perfusion pressure determination device can comprise a housing including a proximal end and a distal end, a plunger assembly at the proximal end of the housing, the plunger assembly comprising a support structure and a sleeve surrounding the support structure, a sensor module provided within the housing and/or the plunger assembly, a spring at the distal end of the housing, a PCB or other electronics, wherein the PCB or other electronics are positioned distal to the sensor module, and an indicator portion and an LED, wherein the indicator portion displays the light emitted from the LED and the indicator portion circumferentially surrounds a portion of the housing, exerting a force on a target area with the plunger
  • the skin perfusion pressure determination device and/or method of any preceding paragraph and/or any of the skin perfusion pressure determination device and/or methods disclosed herein may further comprise one or more of the following features.
  • the method can comprise adjusting and/or releasing the force exerted on the target area based on the light emitted from the indicator portion being in the third state.
  • the first state can indicate a state when force is being applied to the target area and the plunger is compressed.
  • the second state can indicate a state when blood flow at the target area has been occluded.
  • the third state can indicate a state when blood flow at the target area has resumed.
  • a method of using or operating the skin perfusion pressure determination device of any of the preceding paragraphs comprising one or more of the features described in the foregoing description.
  • a method of using or operating a skin perfusion pressure determination device comprising one or more features described in the foregoing description.
  • Figure 1 is a schematic representation of a skin perfusion pressure determination device in use
  • FIG. 2 is a schematic representation of components of the skin perfusion pressure determination device shown in Figure 1;
  • Figure 3 is a schematic representation of a sensor for sensing a parameter associated with blood perfusion
  • Figure 4 is a flow chart depicting a method for determining skin perfusion pressure
  • Figure 5 is an example of a display derived from an output of the skin perfusion pressure determination device shown in Figure 1;
  • Figure 6 shows an alternative embodiment of a skin perfusion pressure determination device comprising a probe portion
  • Figure 7A-7B illustrate an embodiment of a skin perfusion pressure determination device
  • Figure 8A-8B illustrate an exploded view of an embodiment of a skin perfusion pressure determination device
  • Figures 8C illustrates an embodiment of the skin perfusion pressure determination device with a flanged portion on a proximal end
  • Figures 8D-8L illustrates embodiments of a skin perfusion pressure determination device with various spring and/or bellows configurations
  • Figures 8M-8P illustrate embodiments of portions of a proximal end assembly with sensors incorporated into the skin perfusion pressure determination device
  • Figures 8Q-8T illustrates embodiments of a skin perfusion pressure determination device with various spring and/or bellows configurations
  • Figures 9A-9F illustrate an embodiment of a skin perfusion pressure determination device utilizing an integrated USB connector
  • Figures 10A-10F illustrate embodiments of a skin perfusion pressure determination device with a palm grip
  • Figures 11A-11J illustrate embodiments of a skin perfusion pressure determination device with a display
  • Figures 12A-12D illustrate embodiments of a skin perfusion pressure determination device with indicators
  • Figures 13A-13K illustrate embodiments of a skin perfusion pressure determination device
  • Figures 14A-14B illustrate an embodiment of a withdrawal mechanism with air bellows
  • Figures 15A-15D illustrate an embodiment of a withdrawal mechanism with a fluid damper device
  • Figures 16A-16D illustrate an embodiment of a withdrawal mechanism with a magnetic brake device
  • Figures 17A-17C illustrate an embodiment of a withdrawal mechanism with a magneto-rheological fluid device
  • Figures 18A-18B illustrate an embodiment of a pump-driven device for use with a skin perfusion pressure determination device
  • Figure 19A-19B illustrates an embodiment of a motor driven device for use with a skin perfusion pressure determination device
  • Figures 20A-20C illustrate embodiments of protective covers for use with a skin perfusion pressure determination device
  • Figure 21 A illustrates the results of sensor readings from a skin perfusion pressure determination device with no protective cover (left side) and with a protective cover made from PLA (right side);
  • Figure 2 IB illustrates the results of sensor readings from a skin perfusion pressure determination device with no protective cover (left side) and with a protective cover made from PP (right side);
  • Figure 22 illustrates an embodiment of a skin perfusion pressure determination device
  • Figures 23A-23C illustrate embodiments of bellows designs for use with the skin perfusion pressure determination device
  • Figures 24A-24B illustrate an embodiment of a proximal end assembly with a bellows design
  • Figures 24C-24D illustrate embodiments of a proximal end assembly with different bellows designs
  • Figures 25A-25G and 26A-26B illustrate an embodiment of a skin perfusion pressure determination device with a plunger assembly
  • Figures 27A-27F and 28A-28E illustrate embodiments of shapes and configurations of the proximal end cap of the skin perfusion pressure determination device
  • Figures 29A-29B illustrate an embodiment of a skin perfusion pressure determination device with a plunger assembly
  • Figures 30A-30E illustrate a skin perfusion pressure determination device with a positioning guide.
  • Figure 31 illustrates an embodiment of a skin perfusion pressure determination with a plunger assembly.
  • Figure 32 illustrates a proximal end cap or tissue contacting portion of a skin perfusion pressure determination device.
  • Figures 33-36 illustrate flow charts of methods of operation and use of a skin perfusion pressure determination device system.
  • Embodiments disclosed herein relate to apparatuses and methods of monitoring and treating biological tissue with sensor-enabled substrates.
  • the embodiments disclosed herein are not limited to treatment or monitoring of a particular type of tissue or injury, instead the sensor-enabled technologies disclosed herein are broadly applicable to any type of therapy that may benefit from sensor-enabled substrates.
  • Some implementations utilize sensors and data collection relied upon by health care providers to make both diagnostic and patient management decisions.
  • Some embodiments disclosed herein relate to the use of sensors mounted on or embedded within substrates configured to be used in the treatment of both intact and damaged human or animal tissue. Such sensors may collect information about the surrounding tissue and transmit such information to a computing device or a caregiver to be utilized in further treatment. In certain embodiments, such sensors may be attached to the skin anywhere on the body, including areas for monitoring arthritis, temperature, or other areas that may be prone to problems and require monitoring. Sensors disclosed herein may also incorporate markers, such as radiopaque markers, to indicate the presence of the device, for example prior to performing an MRI or other technique.
  • markers such as radiopaque markers
  • the sensor embodiments disclosed herein may be used in combination with clothing.
  • clothing for use with embodiments of the sensors disclosed herein include shirts, pants, trousers, dresses, undergarments, outer-garments, gloves, shoes, hats, and other suitable garments.
  • the sensor embodiments disclosed herein may be welded into or laminated into/onto the particular garments.
  • the sensor embodiments may be printed directly onto the garment and/or embedded into the fabric. Breathable and printable materials such as microporous membranes may also be suitable.
  • Sensor embodiments disclosed herein may be incorporated into cushioning or bed padding, such as within a hospital bed, to monitor patient characteristics, such as any characteristic disclosed herein.
  • a disposable film containing such sensors could be placed over the hospital bedding and removed/replaced as needed.
  • the sensor embodiments disclosed herein may incorporate energy harvesting, such that the sensor embodiments are self-sustaining.
  • energy may be harvested from thermal energy sources, kinetic energy sources, chemical gradients, or any suitable energy source.
  • the sensor embodiments disclosed herein may be utilized in rehabilitation devices and treatments, including sports medicine.
  • the sensor embodiments disclosed herein may be used in braces, sleeves, wraps, supports, and other suitable items.
  • the sensor embodiments disclosed herein may be incorporated into sporting equipment, such as helmets, sleeves, and/or pads.
  • such sensor embodiments may be incorporated into a protective helmet to monitor characteristics such as acceleration, which may be useful in concussion diagnosis.
  • the sensor embodiments disclosed herein may be used in coordination with surgical devices, for example, the NAVIO surgical system by Smith & Nephew Inc.
  • the sensor embodiments disclosed herein may be in communication with such surgical devices to guide placement of the surgical devices.
  • the sensor embodiments disclosed herein may monitor blood flow to or away from the potential surgical site or ensure that there is no blood flow to a surgical site. Further surgical data may be collected to aid in the prevention of scarring and monitor areas away from the impacted area.
  • the sensors disclosed herein may be incorporated into a surgical drape to provide information regarding tissue under the drape that may not be immediately visible to the naked eye.
  • a sensor embedded flexible drape may have sensors positioned advantageously to provide improved area-focused data collection.
  • the sensor embodiments disclosed herein may be incorporated into the border or interior of a drape to create fencing to limit/ control the surgical theater.
  • Sensor embodiments as disclosed herein may also be utilized for pre-surgical assessment.
  • such sensor embodiments may be used to collect information about a potential surgical site, such as by monitoring skin and the underlying tissues for a possible incision site.
  • perfusion levels or other suitable characteristics may be monitored at the surface of the skin and deeper in the tissue to assess whether an individual patient may be at risk for surgical complications.
  • Sensor embodiments such as those disclosed herein may be used to evaluate the presence of microbial infection and provide an indication for the use of antimicrobials. Further, sensor embodiments disclosed herein may collect further information in deeper tissue, such as identifying pressure ulcer damage and/or the fatty tissue levels.
  • the sensor embodiments disclosed herein may be utilized in cardiovascular monitoring.
  • such sensor embodiments may be incorporated into a flexible cardiovascular monitor that may be placed against the skin to monitor characteristics of the cardiovascular system and communicate such information to another device and/or a caregiver.
  • a device may monitor pulse rate, oxygenation of the blood, and/or electrical activity of the heart.
  • the sensor embodiments disclosed herein may be utilized for neurophysiological applications, such as monitoring electrical activity of neurons.
  • the sensor embodiments disclosed herein may be incorporated into implantable devices, such as implantable orthopedic implants, including flexible implants. Such sensor embodiments may be configured to collect information regarding the implant site and transmit this information to an external source. In some embodiments, an internal source may also provide power for such an implant.
  • the sensor embodiments disclosed herein may also be utilized for monitoring biochemical activity on the surface of the skin or below the surface of the skin, such as lactose buildup in muscle or sweat production on the surface of the skin.
  • other characteristics may be monitored, such as glucose concentration, urine concentration, tissue pressure, skin temperature, skin surface conductivity, skin surface resistivity, skin hydration, skin maceration, and/or skin ripping.
  • Sensor embodiments as disclosed herein may be incorporated into Ear, Nose, and Throat (ENT) applications. For example, such sensor embodiments may be utilized to monitor recovery from ENT -related surgery, such as wound monitoring within the sinus passage.
  • the sensor embodiments disclosed herein may encompass sensor printing technology with encapsulation, such as encapsulation with a polymer film.
  • encapsulation such as encapsulation with a polymer film.
  • a film may be constructed using any polymer described herein, such as polyurethane.
  • Encapsulation of the sensor embodiments may provide waterproofing of the electronics and protection from local tissue, local fluids, and other sources of potential damage.
  • the sensors disclosed herein may be incorporated into an organ protection layer such as disclosed below.
  • an organ protection layer such as disclosed below.
  • Such a sensor-embedded organ protection layer may both protect the organ of interest and confirm that the organ protection layer is in position and providing protection.
  • a sensor-embedded organ protection layer may be utilized to monitor the underlying organ, such as by monitoring blood flow, oxygenation, and other suitable markers of organ health.
  • a sensor-enabled organ protection layer may be used to monitor a transplanted organ, such as by monitoring the fat and muscle content of the organ.
  • sensor-enabled organ protection layers may be used to monitor an organ during and after transplant, such as during rehabilitation of the organ.
  • the sensor embodiments disclosed herein may be incorporated into treatments for wounds (disclosed in greater detail below) or in a variety of other applications.
  • additional applications for the sensor embodiments disclosed herein include: monitoring and treatment of intact skin, cardiovascular applications such as monitoring blood flow, orthopedic applications such as monitoring limb movement and bone repair, neurophysiological applications such as monitoring electrical impulses, and any other tissue, organ, system, or condition that may benefit from improved sensor-enabled monitoring.
  • any reference to a wound herein can refer to a wound on a human or animal body, and any reference to a body herein can refer to a human or animal body.
  • the disclosed technology embodiments may relate to preventing or minimizing damage to physiological tissue or living tissue, or to the treatment of damaged tissue (for example, a wound as described herein) wound with or without reduced pressure, including for example a source of negative pressure and wound dressing components and apparatuses.
  • the apparatuses and components comprising the wound overlay and packing materials or internal layers, if any, are sometimes collectively referred to herein as dressings.
  • the wound dressing can be provided to be utilized without reduced pressure.
  • any reference to a wound herein can refer to a wound on a human or animal body, and any reference to a body herein can refer to a human or animal body.
  • the disclosed technology embodiments may relate to preventing or minimizing damage to physiological tissue or living tissue, or to the treatment of damaged tissue (for example, a wound as described herein).
  • wound may include an injury to living tissue may be caused by a cut, blow, or other impact, typically one in which the skin is cut or broken.
  • a wound may be a chronic or acute injury. Acute wounds occur as a result of surgery or trauma. They move through the stages of healing within a predicted timeframe. Chronic wounds typically begin as acute wounds. The acute wound can become a chronic wound when it does not follow the healing stages resulting in a lengthened recovery. It is believed that the transition from acute to chronic wound can be due to a patient being immuno compromised.
  • Chronic wounds may include for example: venous ulcers (such as those that occur in the legs), which account for the majority of chronic wounds and mostly affect the elderly, diabetic ulcers (for example, foot or ankle ulcers), peripheral arterial disease, pressure ulcers, or epidermolysis bullosa (EB).
  • venous ulcers such as those that occur in the legs
  • diabetic ulcers for example, foot or ankle ulcers
  • peripheral arterial disease for example, pressure ulcers, or epidermolysis bullosa (EB).
  • EB epidermolysis bullosa
  • wounds include, but are not limited to, abdominal wounds or other large or incisional wounds, either as a result of surgery, trauma, sterniotomies, fasciotomies, or other conditions, dehisced wounds, acute wounds, chronic wounds, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.
  • Wounds may also include a deep tissue injury.
  • Deep tissue injury is a term proposed by the National Pressure Ulcer Advisory Panel (NPUAP) to describe a unique form of pressure ulcers. These ulcers have been described by clinicians for many years with terms such as purple pressure ulcers, ulcers that are likely to deteriorate and bruises on bony prominences.
  • Wound may also include tissue at risk of becoming a wound as discussed herein.
  • tissue at risk may include tissue over a bony protuberance (at risk of deep tissue injury/insult) or pre-surgical tissue (for example, knee tissue) that may has the potential to be cut (for example, for joint replacement/surgical alteration/reconstruction).
  • Some embodiments relate to methods of treating a wound with the technology disclosed herein in conjunction with one or more of the following: advanced footwear, turning a patient, offloading (such as, offloading diabetic foot ulcers), treatment of infection, systemix, antimicrobial, antibiotics, surgery, removal of tissue, affecting blood flow, physiotherapy, exercise, bathing, nutrition, hydration, nerve stimulation, ultrasound, electrostimulation, oxygen therapy, microwave therapy, active agents ozone, antibiotics, antimicrobials, or the like.
  • offloading such as, offloading diabetic foot ulcers
  • treatment of infection systemix
  • antimicrobial antibiotics
  • surgery removal of tissue, affecting blood flow, physiotherapy, exercise, bathing, nutrition, hydration, nerve stimulation, ultrasound, electrostimulation, oxygen therapy, microwave therapy, active agents ozone, antibiotics, antimicrobials, or the like.
  • a wound may be treated using topical negative pressure and/or traditional advanced wound care, which is not aided by the using of applied negative pressure (may also be referred to as non-negative pressure therapy).
  • Advanced wound care may include use of an absorbent dressing, an occlusive dressing, use of an antimicrobial and/or debriding agents in a wound dressing or adjunct, a pad (for example, a cushioning or compressive therapy, such as stockings or bandages), or the like.
  • a pad for example, a cushioning or compressive therapy, such as stockings or bandages
  • treatment of such wounds can be performed using traditional wound care, wherein a dressing can be applied to the wound to facilitate and promote healing of the wound.
  • Some embodiments relate to methods of manufacturing a wound dressing comprising providing a wound dressing as disclosed herein.
  • wound dressings that may be utilized in conjunction with the disclosed technology include any known dressing in the art.
  • the technology is applicable to negative pressure therapy treatment as well as non-negative pressure therapy treatment.
  • a wound dressing comprises one or more absorbent layer(s).
  • the absorbent layer may be a foam or a superabsorbent.
  • wound dressings may comprise a dressing layer including a polysaccharide or modified polysaccharide, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyvinyl ether, a polyurethane, a polyacrylate, a polyacrylamide, collagen, or gelatin or mixtures thereof.
  • Dressing layers comprising the polymers listed are known in the art as being useful for forming a wound dressing layer for either negative pressure therapy or non negative pressure therapy.
  • the polymer matrix may be a polysaccharide or modified polysaccharide.
  • the polymer matrix may be a cellulose.
  • Cellulose material may include hydrophilically modified cellulose such as methyl cellulose, carboxymethyl cellulose (CMC), carboxymethyl cellulose (CEC), ethyl cellulose, propyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxyethyl sulphonate cellulose, cellulose alkyl sulphonate, or mixtures thereof.
  • hydrophilically modified cellulose such as methyl cellulose, carboxymethyl cellulose (CMC), carboxymethyl cellulose (CEC), ethyl cellulose, propyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxyethyl sulphonate cellulose, cellulose alkyl sulphonate, or mixtures thereof.
  • cellulose material may be cellulose alkyl sulphonate.
  • the alkyl moiety of the alkyl sulphonate substituent group may have an alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, or butyl.
  • the alkyl moiety may be branched or unbranched, and hence suitable propyl sulphonate substituents may be 1- or 2-methyl - ethylsulphonate.
  • Butyl sulphonate substituents may be 2-ethyl-ethylsulphonate, 2, 2-dimethyl- ethyl sulphonate, or 1,2-dimethyl-ethylsulphonate.
  • the alkyl sulphonate substituent group may be ethyl sulphonate.
  • the cellulose alkyl sulphonate is described in W010061225, US2016/114074, US2006/0142560, or US 5,703,225, the disclosures of which are hereby incorporated by reference in their entirety.
  • Cellulose alkyl sulfonates may have varying degrees of substitution, the chain length of the cellulose backbone structure, and the structure of the alkyl sulfonate substituent. Solubility and absorbency are largely dependent on the degree of substitution: as the degree of substitution is increased, the cellulose alkyl sulfonate becomes increasingly soluble. It follows that, as solubility increases, absorbency increases.
  • a wound dressing also comprises a top or cover layer.
  • the thickness of the wound dressing disclosed herein may be between 1 to 20, or 2 to 10, or 3 to 7 mm.
  • a non-negative pressure wound dressing suitable for providing protection at a wound site may comprise: an absorbent layer for absorbing wound exudate and an obscuring element for at least partially obscuring a view of wound exudate absorbed by the absorbent layer in use.
  • the obscuring element may be partially translucent.
  • the obscuring element may be a masking layer.
  • the non-negative pressure wound dressing may further comprise a region in or adjacent the obscuring element for allowing viewing of the absorbent layer.
  • the obscuring element layer may be provided over a central region of the absorbent layer and not over a border region of the absorbent layer.
  • the obscuring element is of hydrophilic material or is coated with a hydrophilic material.
  • the obscuring element may comprise a three-dimensional knitted spacer fabric.
  • the spacer fabric is known in the art and may include a knitted spacer fabric layer.
  • the obscuring element may further comprise an indicator for indicating the need to change the dressing.
  • the obscuring element is provided as a layer at least partially over the absorbent layer, further from a wound site than the absorbent layer in use.
  • the non-negative pressure wound dressing may further comprise a plurality of openings in the obscuring element for allowing fluid to move therethrough.
  • the obscuring element may comprise, or may be coated with, a material having size-exclusion properties for selectively permitting or preventing passage of molecules of a predetermined size or weight.
  • the obscuring element may be configured to at least partially mask light radiation having wavelength of 600 nm and less.
  • the obscuring element may be configured to reduce light absorption by 50% or more.
  • the obscuring element may be configured to yield a CIE L* value of 50 or more, and optionally 70 or more. In some embodiments, the obscuring element may be configured to yield a CIE L* value of 70 or more.
  • the non-negative pressure wound dressing may further comprise at least one of a wound contact layer, a foam layer, an odor control element, a pressure-resistant layer and a cover layer.
  • the cover layer is present, and the cover layer is a translucent film.
  • the translucent film has a moisture vapour permeability of 500g/m2/24hours or more.
  • the translucent film may be a bacterial barrier.
  • the non-negative pressure wound dressing as disclosed herein comprises the wound contact layer and the absorbent layer overlies the wound contact layer.
  • the wound contact layer carries an adhesive portion for forming a substantially fluid tight seal over the wound site.
  • the non-negative pressure wound dressing as disclosed herein may comprise the obscuring element and the absorbent layer being provided as a single layer.
  • the non-negative pressure wound dressing disclosed herein comprises the foam layer, and the obscuring element is of a material comprising components that may be displaced or broken by movement of the obscuring element.
  • the non-negative pressure wound dressing comprises an odor control element, and in another embodiment the dressing does not include an odor control element.
  • the odor control element may be dispersed within or adjacent the absorbent layer or the obscuring element.
  • the odor control element may be provided as a layer sandwiched between the foam layer and the absorbent layer.
  • the disclosed technology for a non-negative pressure wound dressing comprises a method of manufacturing a wound dressing, comprising: providing an absorbent layer for absorbing wound exudate; and providing an obscuring element for at least partially obscuring a view of wound exudate absorbed by the absorbent layer in use.
  • the non-negative pressure wound dressing may be suitable for providing protection at a wound site, comprising: an absorbent layer for absorbing wound exudate; and a shielding layer provided over the absorbent layer, and further from a wound facing side of the wound dressing than the absorbent layer.
  • the shielding layer may be provided directly over the absorbent layer.
  • the shielding layer comprises a three-dimensional spacer fabric layer.
  • the shielding layer increases the area over which a pressure applied to the dressing is transferred by 25% or more or the initial area of application.
  • the shielding layer increases the area over which a pressure applied to the dressing is transferred by 50% or more, and optionally by 100% or more, and optionally by 200% or more.
  • the shielding layer may comprise 2 or more sub-layers, wherein a first sub-layer comprises through holes and a further sub-layer comprises through holes and the through holes of the first sub-layer are offset from the through holes of the further sub-layer.
  • the non-negative pressure wound dressing as disclosed herein may further comprise a permeable cover layer for allowing the transmission of gas and vapour therethrough, the cover layer provided over the shielding layer, wherein through holes of the cover layer are offset from through holes of the shielding layer.
  • the non-negative pressure wound dressing may be suitable for treatment of pressure ulcers.
  • a more detailed description of the non-negative pressure dressing disclosed hereinabove is provided in W02013007973, the entirety of which is hereby incorporated by reference.
  • the non-negative pressure wound dressing may be a multi layered wound dressing comprising: a fibrous absorbent layer for absorbing exudate from a wound site; and a support layer configured to reduce shrinkage of at least a portion of the wound dressing.
  • the multi-layered wound dressing disclosed herein further comprises a liquid impermeable film layer, wherein the support layer is located between the absorbent layer and the film layer.
  • the support layer disclosed herein may comprise a net.
  • the net may comprise a geometric structure having a plurality of substantially geometric apertures extending therethrough.
  • the geometric structure may for example comprise a plurality of bosses substantially evenly spaced and joined by polymer strands to form the substantially geometric apertures between the polymer strands.
  • the net may be formed from high density polyethylene.
  • the apertures may have an area from 0.005 to 0.32 mm2.
  • the support layer may have a tensile strength from 0.05 to 0.06 Nm.
  • the support layer may have a thickness of from 50 to 150 pm.
  • the support layer is located directly adjacent the absorbent layer.
  • the support layer is bonded to fibers in a top surface of the absorbent layer.
  • the support layer may further comprise a bonding layer, wherein the support layer is heat laminated to the fibers in the absorbent layer via the bonding layer.
  • the bonding layer may comprise a low melting point adhesive such as ethylene- vinyl acetate adhesive.
  • the multi-layered wound dressing disclosed herein further comprises an adhesive layer attaching the film layer to the support layer.
  • the multi-layered wound dressing disclosed herein further comprises a wound contact layer located adjacent the absorbent layer for positioning adjacent a wound.
  • the multi-layered wound dressing may further comprise a fluid transport layer between the wound contact layer and the absorbent layer for transporting exudate away from a wound into the absorbent layer.
  • the disclosed technology may be incorporated in a wound dressing comprising a vertically lapped material comprising: a first layer of an absorbing layer of material, and a second layer of material, wherein the first layer being constructed from at least one layer of non-woven textile fibers, the non-woven textile fibers being folded into a plurality of folds to form a pleated structure.
  • the wound dressing further comprises a second layer of material that is temporarily or permanently connected to the first layer of material.
  • the vertically lapped material has been slitted.
  • the first layer has a pleated structure having a depth determined by the depth of pleats or by the slitting width.
  • the first layer of material may be a moldable, lightweight, fiber-based material, blend of material or composition layer.
  • the first layer of material may comprise one or more of manufactured fibers from synthetic, natural or inorganic polymers, natural fibers of a cellulosic, proteinaceous or mineral source.
  • the wound dressing may comprise two or more layers of the absorbing layer of material vertically lapped material stacked one on top of the other, wherein the two or more layers have the same or different densities or composition.
  • the wound dressing may in some embodiments comprise only one layer of the absorbing layer of material vertically lapped material.
  • the absorbing layer of material is a blend of natural or synthetic, organic or inorganic fibers, and binder fibers, or bicomponent fibers typically PET with a low melt temperature PET coating to soften at specified temperatures and to act as a bonding agent in the overall blend.
  • the absorbing layer of material may be a blend of 5 to 95 % thermoplastic polymer, and 5 to 95 wt % of a cellulose or derivative thereof.
  • the wound dressing disclosed herein has a second layer comprises a foam or a dressing fixative.
  • the foam may be a polyurethane foam.
  • the polyurethane foam may have an open or closed pore structure.
  • the dressing fixative may include bandages, tape, gauze, or backing layer.
  • the wound dressing as disclosed herein comprises the absorbing layer of material connected directly to a second layer by lamination or by an adhesive, and the second layer is connected to a dressing fixative layer.
  • the adhesive may be an acrylic adhesive, or a silicone adhesive.
  • the wound dressing as disclosed herein further comprises layer of a superabsorbent fiber, or a viscose fiber or a polyester fiber.
  • the wound dressing as disclosed herein further comprises a backing layer.
  • the backing layer may be a transparent or opaque film.
  • the backing layer comprises a polyurethane film (typically a transparent polyurethane film).
  • the non-negative pressure wound dressing may comprise an absorbent component for a wound dressing, the component comprising a wound contacting layer comprising gel forming fibers bound to a foam layer, wherein the foam layer is bound directly to the wound contact layer by an adhesive, polymer based melt layer, by flame lamination or by ultrasound.
  • the absorbent component may be in a sheet form.
  • the wound contacting layer may comprise a layer of woven or non-woven or knitted gel forming fibers.
  • the foam layer may be an open cell foam, or closed cell foam, typically an open cell foam.
  • the foam layer is a hydrophilic foam.
  • the wound dressing may comprise the component that forms an island in direct contact with the wound surrounded by periphery of adhesive that adheres the dressing to the wound.
  • the adhesive may be a silicone or acrylic adhesive, typically a silicone adhesive.
  • the wound dressing may be covered by a film layer on the surface of the dressing furthest from the wound.
  • the non-negative pressure wound dressing may comprise a multi layered wound dressing for use on wounds producing high levels of exudate, characterized in that the dressing comprising: a transmission layer having an MVTR of at least 300 gm2/24 hours, an absorbent core comprising gel forming fibers capable of absorbing and retaining exudate, a wound contacting layer comprising gel forming fibers which transmits exudate to the absorbent core and a keying layer positioned on the absorbent core, the absorbent core and wound contacting layer limiting the lateral spread of exudate in the dressing to the region of the wound.
  • the wound dressing may be capable of handling at least 6g (or 8g and 15g) of fluid per 10cm2 of dressing in 24 hours.
  • the wound dressing may comprise gel forming fibers that are chemically modified cellulosic fibers in the form of a fabric.
  • the fibers may include carboxymethylated cellulose fibers, typically sodium carboxymethylcellulose fiber.
  • the wound dressing may comprise a wound contact layer with a lateral wicking rate from 5mm per minute to 40mm per minute.
  • the wound contact layer may have a fiber density between 25gm2 and 55gm2, such as 35gm2.
  • the absorbent core may have an absorbency of exudate of at least lOg/g, and typically a rate of lateral wicking of less the 20mm per minute.
  • the absorbent core may have a blend in the range of up to 25% cellulosic fibers by weight and 75% to 100% gel forming fibers by weight.
  • the absorbent core may have a blend in the range of up to 50% cellulosic fibers by weight and 50% to 100% gel forming fibers by weight.
  • the blend is in the range of 50% cellulosic fibers by weight and 50% gel forming fibers by weight.
  • the fiber density in the absorbent core may be between 150gm2 and 250gm2, or about 200 gm2.
  • the wound dressing when wet may have shrinkage that is less than 25 % or less than 15 % of its original size/dimension.
  • the wound dressing may comprise a transmission layer and the layer is a foam.
  • the transmission layer may be a polyurethane foam laminated to a polyurethane film.
  • the wound dressing may comprise one or more layers selected from the group comprising a soluble medicated film layer; an odor-absorbing layer; a spreading layer and an additional adhesive layer.
  • the wound dressing may be 2mm and 4mm thick.
  • the wound dressing may be characterized in that the keying layer bonds the absorbent core to a neighboring layer.
  • the keying layer may be positioned on either the wound facing side of the absorbent core or the non-wound facing side of the absorbent core.
  • the keying layer is positioned between the absorbent core and the wound contact layer.
  • the keying layer is a polyamide web.
  • the non-negative pressure wound dressing may be a compression bandage.
  • Compression bandages are known for use in the treatment of oedema and other venous and lymphatic disorders, e.g., of the lower limbs.
  • a compression bandage systems typically employ multiple layers including a padding layer between the skin and the compression layer or layers.
  • the compression bandage may be useful for wounds such as handling venous leg ulcers.
  • the compression bandage in some embodiments may comprise a bandage system comprising an inner skin facing layer and an elastic outer layer, the inner layer comprising a first ply of foam and a second ply of an absorbent nonwoven web, the inner layer and outer layer being sufficiently elongated so as to be capable of being wound about a patient's limb.
  • a compression bandage of this type is disclosed in W099/58090, the entirety of which is hereby incorporated by reference.
  • the compression bandage system comprises: a) an inner skin facing, elongated, elastic bandage comprising: (i) an elongated, elastic substrate, and
  • treatment of such wounds can be performed using negative pressure wound therapy, wherein a reduced or negative pressure can be applied to the wound to facilitate and promote healing of the wound.
  • wound dressing and methods as disclosed herein may be applied to other parts of the body, and are not necessarily limited to treatment of wounds.
  • TNP therapy assists in the closure and healing of many forms of "hard to heal” wounds by reducing tissue oedema; encouraging blood flow and granular tissue formation; removing excess exudate and may reduce bacterial load (and thus infection risk).
  • the therapy allows for less disturbance of a wound leading to more rapid healing.
  • TNP therapy systems may also assist on the healing of surgically closed wounds by removing fluid and by helping to stabilize the tissue in the apposed position of closure.
  • a further beneficial use of TNP therapy can be found in grafts and flaps where removal of excess fluid is important and close proximity of the graft to tissue is required in order to ensure tissue viability.
  • Negative pressure therapy can be used for the treatment of open or chronic wounds that are too large to spontaneously close or otherwise fail to heal by means of applying negative pressure to the site of the wound.
  • Topical negative pressure (TNP) therapy or negative pressure wound therapy (NPWT) involves placing a cover that is impermeable or semi-permeable to fluids over the wound, using various means to seal the cover to the tissue of the patient surrounding the wound, and connecting a source of negative pressure (such as a vacuum pump) to the cover in a manner so that negative pressure is created and maintained under the cover. It is believed that such negative pressures promote wound healing by facilitating the formation of granulation tissue at the wound site and assisting the body’s normal inflammatory process while simultaneously removing excess fluid, which may contain adverse cytokines or bacteria.
  • NPWT can include many different types of materials and layers, for example, gauze, pads, foam pads or multi-layer wound dressings.
  • a multi-layer wound dressing is the PICO dressing, available from Smith & Nephew, includes a wound contact layer and a superabsorbent layer beneath a backing layer to provide a canister-less system for treating a wound with NPWT.
  • the wound dressing may be sealed to a suction port providing connection to a length of tubing, which may be used to pump fluid out of the dressing or to transmit negative pressure from a pump to the wound dressing.
  • RENASYS-F, RENASYS-G, RENASYS-AB, and RENASYS-F/AB available from Smith & Nephew
  • NPWT wound dressings and systems are additional examples of NPWT wound dressings and systems.
  • Another example of a multi-layer wound dressing is the ALLEVYN Life dressing, available from Smith & Nephew, which includes a moist wound environment dressing that is used to treat the wound without the use of negative pressure.
  • reduced or negative pressure levels represent pressure levels relative to normal ambient atmospheric pressure, which can correspond to 760 mmHg (or 1 atm, 29.93 inHg, 101.325 kPa, 14.696 psi, etc.).
  • a negative pressure value of -X mmHg reflects absolute pressure that is X mmHg below 760 mmHg or, in other words, an absolute pressure of (760-X) mmHg.
  • negative pressure that is "less” or "smaller” than X mmHg corresponds to pressure that is closer to atmospheric pressure (such as, -40 mmHg is less than -60 mmHg).
  • Negative pressure that is "more” or “greater” than -X mmHg corresponds to pressure that is further from atmospheric pressure (such as, -80 mmHg is more than -60 mmHg).
  • local ambient atmospheric pressure is used as a reference point, and such local atmospheric pressure may not necessarily be, for example, 760 mmHg.
  • the negative pressure range for some embodiments of the present disclosure can be approximately -80 mmHg, or between about -20 mmHg and -200 mmHg. Note that these pressures are relative to normal ambient atmospheric pressure, which can be 760 mmHg. Thus, -200 mmHg would be about 560 mmHg in practical terms.
  • the pressure range can be between about -40 mmHg and -150 mmHg.
  • a pressure range of up to -75 mmHg, up to -80 mmHg or over -80 mmHg can be used.
  • a pressure range of below -75 mmHg can be used.
  • a pressure range of over approximately -100 mmHg, or even -150 mmHg can be supplied by the negative pressure apparatus.
  • increased wound contraction can lead to increased tissue expansion in the surrounding wound tissue.
  • This effect may be increased by varying the force applied to the tissue, for example by varying the negative pressure applied to the wound over time, possibly in conjunction with increased tensile forces applied to the wound via embodiments of the wound closure devices.
  • negative pressure may be varied over time for example using a sinusoidal wave, square wave, or in synchronization with one or more patient physiological indices (such as, heartbeat). Examples of such applications where additional disclosure relating to the preceding may be found include U.S. Patent No. 8,235,955, titled "Wound treatment apparatus and method," issued on August 7, 2012; and U.S. Patent No. 7,753,894, titled "Wound cleansing apparatus with stress,” issued July 13, 2010. The disclosures of both of these patents are hereby incorporated by reference in their entirety.
  • Embodiments of the wound dressings, wound dressing components, wound treatment apparatuses and methods described herein may also be used in combination or in addition to those described in International Application No. PCT/IB2013/001469, filed May 22, 2013, published as WO 2013/175306 A2 on November 28, 2013, titled “APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY," U.S. Patent Application No. 14/418,908, filed January 30, 2015, published as US 2015/0190286 A1 on July 9, 2015, titled “WOUND DRESSING AND METHOD OF TREATMENT,” the disclosures of which are hereby incorporated by reference in their entireties.
  • Embodiments of the wound dressings, wound dressing components, wound treatment apparatuses and methods described herein may also be used in combination or in addition to those described in U.S. Patent Application No. 13/092,042, filed April 21, 2011, published as US2011/0282309, titled “WOUND DRESSING AND METHOD OF USE,” and U.S. Patent Application No. 14/715,527, filed May 18, 2015, published as US2016/0339158 A1 on November 24, 2016, titled “FLUIDIC CONNECTOR FOR NEGATIVE PRESSURE WOUND THERAPY,” the disclosure of each of which is hereby incorporated by reference in its entirety, including further details relating to embodiments of wound dressings, the wound dressing components and principles, and the materials used for the wound dressings.
  • TNP wound treatment comprising a wound dressing in combination with a pump or associated electronics described herein may also be used in combination or in addition to those described in International Application PCT/EP2016/059329 filed April 26, 2016, published as WO 2016/174048 on November 3, 2016, entitled “REDUCED PRESSURE APPARATUS AND METHODS,” the disclosure of which is hereby incorporated by reference in its entirety.
  • Figure 1 shows an apparatus 2 for determining skin perfusion pressure comprising a skin perfusion pressure determination device 4 secured to a patient’s arm 6 and a monitoring device 8 connected via a lead 10 to the skin perfusion pressure determination device 4.
  • the skin perfusion pressure determination device 4 comprises a wound dressing 12 and a sensor module 14 formed integrally with the wound dressing 12.
  • the wound dressing 12 is in the form of a detachable band that may be secured to the arm 6 of the patient by wrapping it around the arm 6 and securing opposite end portions together using a fastener, such as an adhesive strip or hook and loop fastener or the like.
  • the skin perfusion pressure determination device may be a detachable band that does not comprise a wound dressing but may be secured adjacent a wound if desired.
  • Bands may be secured to other parts of an animal or person’s body including other limbs, such as a leg, or a torso.
  • the lead 10 is connected to the sensor module 14 at one end and to the monitoring device 8 at the other end.
  • the lead 10 provides a means for communication between the sensor module 14 and the monitoring device 8 and also provides a means for supplying power to the sensor module 14.
  • the sensor module 14 can be included in a patch which is attached to the target area, using e.g. an adhesive. In such embodiments, the sensor module 14 does not need to be included in a band which is wrapped around the arm.
  • the monitoring device 8 is configured to receive and process a signal received from the sensor module 14 and display processed information on an integrated display 16.
  • Figure 2 is a system diagram representing components of the apparatus 2 shown in Figure 1.
  • FIG. 2 depicts components of the skin perfusion pressure determination device 4 and the monitoring device 8 which are enclosed, respectively, by broken lines.
  • the sensor module 14 comprises a first sensor in the form of a force sensor 18 for sensing a force transmitted through the sensor module 14 to the patient’s arm 6, and a second sensor in the form of an optical sensor 20 for sensing a parameter which corresponds to the amount of blood perfusion in the skin tissue of the arm 6 underneath the sensor module 14.
  • the optical sensor 20 is a pulse sensor, but other suitable sensors may be used such as a reflective pulse oximeter sensor or the like.
  • the force sensor 18 is a thin-film micro-force sensor with a diameter of 15mm and a force range of 45N.
  • the force sensor 18 also comprises associated read-out electronics.
  • the force sensor 18 is disposed on an upper portion of the optical sensor 20 and the optical sensor 20 is arranged such that it faces away from the force sensor 18 towards the arm 6
  • the sensors 18, 20 are connected via respective electrical wires 10a, 10b, which comprise the lead 10, to an input of the monitoring device 8.
  • FIG. 3 is a schematic representation of the optical sensor 20 in isolation wherein the optical sensor 20 is located against the arm 6.
  • the optical sensor 20 comprises a light emitter in the form of a light emitting diode (LED) 22 which emits light at a predetermined wavelength (or emits light across a predetermined range of wavelengths) and a light detector in the form of a photodiode 24 which is configured to detect light emitted by the LED 22.
  • LED light emitting diode
  • the LED 22 and the photodiode 24 are disposed within a housing 26 and separated by a shield 28 which is opaque to the wavelength or range of wavelengths of light detectable by the photodiode 24.
  • the shield 28 prevents emitted light from the LED being transmitted directly to the photodiode 24.
  • the lower portion of the housing 26 is open or transparent so that light emitted by the LED 22 can pass through the lower portion to the skin tissue of the arm 6 and light reflected or scattered by the skin tissue of the arm 6 can pass back through the lower portion of the housing 26 to the photodiode 24.
  • the shield 28 is spaced slightly from the skin tissue so that it does not contact the skin and so does not prevent light from passing underneath the shield 28. Light received by the photodiode 24 is therefore light which has been emitted by the LED 22 and either reflected, scattered or absorbed and reemitted by the skin tissue of the arm 6.
  • the LED 22 emits light in the green band of the visible spectrum having a wavelength between 495nm and 570nm.
  • Green light is known to be absorbed highly by hemoglobin within blood and so the amount of absorption of green light is correlated with the amount of blood in the skin tissue. Measuring the amount of absorption of green light emitted by the LED 22 can therefore be used to determine the amount of blood, and hence indicate the amount of blood perfusion, in a target area of tissue beneath the sensor module 14.
  • the monitoring device 8 comprises signal processing electronics 30 connected to the leads 10a, 10b and a processor 32 for processing signals received from the force sensor 18 and the optical sensor 20.
  • the processor 32 is configured to display data representing the processed signals on the display 16.
  • the signal processing electronics 30 are further configured to supply power to the sensor module 14.
  • a separate power source may be provided, and that a power source may be integrated into the wound dressing.
  • the skin perfusion pressure determination device may comprise the processor and the processor may be configured to provide a digital output to the monitoring device.
  • the sensor module 14 is placed against the arm 6 of a patient so that the lower portion of the housing 26 of the sensor module 14, which is open or transparent, is adjacent the target area of skin tissue, as shown in Figure 3.
  • the lower portion of the housing 26 may be in contact with the target area.
  • the skin perfusion pressure determination device 4 is then secured to a patient’s arm 6 by wrapping the wound dressing 12 about the arm 6 and securing end portions of the wound dressing 12 together, as shown in Figure 1.
  • the sensor module 14 is connected to the monitoring device 8 by the lead 10 so that the sensor module 14 is in communication with the monitoring device 8.
  • Outputs from the force sensor 18 and the optical sensor 20 are then monitored and displayed on the display 16. Examples of outputs from the force sensor 18 and the optical sensor 20 are shown in the respective lower and upper traces of Figure 5.
  • the upper trace is a photoplethysmogram (PPG) which provides an indication of the amount of light emitted by the LED 22 that is absorbed by the skin tissue at the target area (i.e. the trace is inversely proportional to the amount of light reflected by the skin tissue at the target area and received by the photodiode 24). Therefore, a relatively large amount of blood in the skin tissue, which absorbs a relatively large amount of light emitted by the LED 22, produces a relatively high output trace value, and vice versa. Of course, the trace could be inverted such that the amount of light reflected by the skin tissue is plotted in which case, a large amount of blood within the skin tissue would produce a relatively low output trace value.
  • PPG photoplethysmogram
  • the upper trace will typically have a pulsatile component and a non-pulsatile component.
  • the pulsatile component represents light absorbed by pulsatile arterial blood whereas the non-pulsatile component represents light absorbed by non-pulsatile arterial blood, venous blood and skin tissue.
  • the pulsatile component arises due to the change in blood volume caused by the pressure pulse of the cardiac cycle pushing blood through the blood vessels and capillaries and is therefore associated with blood flow.
  • the pulsatile component can therefore be monitored to obtain an indication of the amount of blood perfusion in the underlying tissue.
  • the amount of light absorbed by the skin tissue initially once the skin perfusion pressure determination device 4 has been secured to the patient’s arm 6 is shown between times ti and h of the upper trace in Figure 5. Each peak represents a pulse of arterial blood through the skin tissue at the target area.
  • Time t2 is the time at which a skin perfusion pressure measurement is commenced and corresponds to initiation of the first step of the method depicted by the flow diagram in Figure 4.
  • a clinician presses the sensor module 14 against the arm 6 to occlude the blood vessels within the tissue below the target area.
  • the amount of force is increased until the pulsatile component of the trace drops below a predetermined level or ceases to be evident, as shown at time t 3.
  • the clinician continues to hold the sensor module 14 against the arm 6 to ensure that the pulsatile arterial blood flow has ceased in the tissue at the target area, as shown between times t 3 and U.
  • there remains a non-zero noise component of the trace which fluctuates at a level below the predetermined level.
  • the clinician begins to reduce the force applied to the sensor module 14 slowly until time ts at which time the pressure module 14 has been released completely and pulsatile arterial blood flow in the tissue at the target area is completely restored.
  • the force exerted by the clinician on the tissue at the target area via the sensor module 14 is recorded by the lower trace. As can be seen from the lower trace, no force is recorded between times ti and h.
  • the force increases relatively rapidly between times h and t 3 as the clinician presses the sensor module 14 against the arm 6 of the patient and then plateaus while the clinician holds the sensor module 14 against the arm 6 between times t 3 andU. As the clinician begins to slowly release the sensor module 14 at time U , the applied force reduces steadily back to zero at time ts and pulsatile arterial blood flow returns to the skin tissue.
  • Pulsatile arterial blood flow returns when the blood pressure is sufficient to overcome the occlusion pressure on the blood vessels within the tissue which is applied by the clinician pressing on the sensor module 14.
  • the return of blood flow is represented by a return of the pulsatile component in the upper trace, as shown at time tspp.
  • Different criteria can be used to determine the return of pulsatile arterial blood flow.
  • return of blood flow could be determined by the return of the value of the upper trace to a predetermined threshold ISPP value such as a value greater than a maximum expected noise value.
  • the threshold value ISPP may be a value that is determined based on the pulse amplitude observed before a force is applied to occlude the blood vessels (i.e. the pulse amplitude between times ti and fz).
  • a threshold value ISPP may be used which is a predetermined percentage of the pulse amplitude observed before a force is applied to occlude the blood vessels.
  • Other algorithms may be used to determine return of the pulsatile component of the trace.
  • the magnitude of the force FSPP of the lower trace at time tspp is then recorded.
  • the recorded force FSPP can subsequently be used to determine a skin perfusion pressure. This may be done by calculation, look-up tables or based on a pre-calibration of the force sensor 18. For example, if the contact area of the portion of the sensor module 14 pressed against the skin tissue is known, the pressure applied to the skin tissue can be calculated. In this instance, the target area corresponds to the contact area of the sensor module 14. In the described embodiment, the contact area of the sensor module 14 is circular and has a diameter of 10mm and therefore a surface area of approximately 80mm 2 . The larger the contact area, the greater the force required to stop blood flow.
  • the device can integrate methods for controlling the force application which can alleviate some of the difficulties described for the small contact areas.
  • a very small contact area can also make it difficult for an accurate reading to be taken by the blood perfusion sensor.
  • the contact area of the sensor module 14 may therefore be between 1mm 2 and 1000mm 2 , for example between 10mm 2 and 400mm 2 .
  • a benefit of the arrangement is that contemporaneous measurements of the pressure exerted by the sensor module 14 on the target area and the amount of blood perfusion are made at the target area. The measurements can be taken and recorded simultaneously to produce an accurate and reliable measurement of blood perfusion pressure at a desired location on a patient’s body.
  • Measurement of skin perfusion pressure may be performed as a single measurement or determined from trends evident from repeated measurements over time.
  • a single measurements can be used to get the perfusion pressure or a measure for the perfusion pressure.
  • repeated measurements over time can be used and the trends can be observe to get the perfusion pressure or a measure for the perfusion pressure. Such measurements may be used to aid the prediction of wound healing.
  • an LED light source in particular a surface-mount LED, provides a compact, widely available, inexpensive, very reliable and a low power consumption light source.
  • an LED which emits light in the green band of the visible spectrum is used.
  • other suitable light sources could be used which emit light having a wavelength that is absorbed or reflected by blood.
  • Light sources which emit light having a wavelength (or range of wavelengths) between 600nm and 1350nm may be used.
  • light sources which emit light in the red band of the visible spectrum having a wavelength of between 600nm and 750nm or which emit light in the near-infrared band of the visible spectrum having a wavelength of between 850nm and lOOOnm may be used.
  • Light sources which emit light in the near-infrared window of biological tissue having a wavelength of between 650nm and 1350nm are beneficial because light has its maximum depth of penetration in tissue at these wavelengths and so a greater proportion of the emitted light will reach the blood vessels within the tissue.
  • CMOS complementary metal-oxide semiconductor
  • sensors for determining a parameter associated with a pressure exerted on the target area may be used.
  • sensors which have a thickness which corresponds to, or is less than, the thickness of a typical wound dressing may be used.
  • Suitable capacitive, resistive thin-film or micromachined sensors or strain gauges or the like may be used. Such sensors are suitable for incorporation onto wound dressings, as described below.
  • sensors may include sensors configured to output a pressure applied by the sensor or the sensor module to the target area.
  • a simple trace showing the outputs from the sensor module 14 is provided to aid the clinician or patient.
  • the processor may, however, be configured to display instructions to a patient/clinician on the display 16 such as instructions to increase the applied force or to reduce the applied force at each stage of the measurement process.
  • An audible signal may be generated to inform a clinician/patient of the pulse strength.
  • the audible signal may be continuous or a series of beeps that vary in frequency or volume depending on the magnitude of the pulsatile component of the trace. For example, an audible beep pattern may become silent when the pulsatile component drops below a threshold value and re-emerges when the pulsatile component returns indicating the return of blood flow in the tissue at the target area.
  • a light or a symbol or a color signal or an audible signal could be used to instruct a user to increase or decrease a force applied.
  • Figure 6 shows an example of an alternative embodiment of part of an apparatus 102 comprising a hand-held skin perfusion pressure determination device 104 comprising a grip portion 106 and a probe portion 108.
  • the probe portion 108 has a pad portion 110 in which a sensor module (not shown) is housed.
  • the sensor module is in accordance with the sensor module 14 shown in Figure 2.
  • the hand-held device 104 is connected to a monitoring device similar to that shown in Figure 1 by a lead 112.
  • the grip portion 106 is held by a clinician and used to press the pad portion 110 against a target area of a patient’s skin. The method shown in Figure 4 and described above is then followed to determine the skin perfusion pressure at the target area.
  • a skin perfusion pressure determination device can be used to measure a blood perfusion or blood perfusion pressure at a target tissue area.
  • the skin perfusion pressure determination device may be used to measure a parameter associated with wound healing at various target tissue areas.
  • the various target tissue area can be various points about the perimeter of the wound dressing.
  • the skin perfusion pressure determination device can provide a measurement of the amount of blood perfusion in the tissue surrounding the wound.
  • the target tissue area can be healthy tissue or tissue not associated with a wound.
  • the skin perfusion pressure determination device can be used in combination with other sensor enabled devices.
  • the skin perfusion pressure determination device can be used in combination with or in coordination with a sensor enabled wound dressing or wound contact layer as described in more detail in International Application No. PCT/IB2017/000693, filed May 12, 2017, published as WO 2017/195038 on November 16, 2017, titled "SENSOR ENABLED WOUND MONITORING AND THERAPY APPARATUS," the disclosure of which is hereby incorporated by reference herein in its entirety.
  • the skin perfusion pressure determination device can be incorporated into various medical devices or apparatuses as described in more detail in International Application No.
  • Figures 7A-8-B illustrate further embodiments of a skin perfusion pressure determination device.
  • Figure 7A illustrates an embodiment of a skin perfusion pressure determination device 804 with a cross sectional view that shows the interior components of the device.
  • the skin perfusion pressure determination device 804 has a proximal end 805 and a distal end 806 and comprises an elongate housing 803.
  • the elongate housing 803 may be made of a single part or multiple parts, which forms or form an elongate body having a proximal end and a distal end.
  • the elongate housing is configured to be hand-held, and in some embodiments has the shape of a pen.
  • a proximal end assembly 807 shown in the enlarged cross-sectional view of Figure 7B, is provided at the proximal end of the elongate housing.
  • the proximal end assembly 807 has a proximal end that defines the proximal end 805 of the device 804 and can be used to contact a target tissue area or skin to obtain a skin perfusion pressure determination.
  • the proximal end assembly 807 in this and other embodiments is described as being connected to or attached to the proximal end of the elongate housing 803, it will be appreciated that components of the proximal end assembly 807 may form part of the elongate housing itself, such that the elongate housing extends to the proximal end 805.
  • the skin perfusion pressure determination device 804 can incorporate a sensor module for obtaining a skin perfusion pressure measurement, as further described herein.
  • the sensor module may be positioned within or on the skin perfusion pressure determination device 804.
  • the sensor module can be associated with and in optical communication with the proximal end 805 of the skin perfusion pressure determination device 804 to obtain a skin perfusion pressure measurement.
  • the sensor module can be provided on the proximal end 805 and/or incorporated into the proximal end 805 of the skin perfusion pressure determination device 804.
  • Figures 8A and 8B illustrate an exploded view of the skin perfusion pressure determination device 804.
  • the skin perfusion pressure determination device 804 can be mechanically or manually actuated.
  • Figure 8A illustrates an embodiment of the proximal end assembly 807.
  • the proximal end assembly 807 includes a proximal end cap 808 enclosing the proximal end 805 of the skin perfusion pressure determination device and a sensor module for obtaining a skin perfusion pressure measurement as described herein.
  • the proximal end 805 of the skin perfusion pressure determination device 804 can include the sensor module as described herein.
  • the proximal end assembly 807 further comprises bellows 809, a plunger 810, a spring 811, and a slider 812 that can move within the device 804 to allow contraction and extension of the proximal end assembly 807.
  • the proximal end cap 808 and bellows 809 can be coupled to an end cap 813 to enclose the plunger 810, spring 811, and slider 812 within.
  • the end cap 813 may be joined to the proximal end of the housing 803.
  • the plunger 810 and spring 811 can be positioned within the slider 812 (shown in Figure 8B).
  • a force is applied to the grip portion of the skin perfusion pressure determination device 804 by the hand of the user or other source.
  • the grip portion By applying a force to the grip portion, the user moves the grip portion towards the skin. This compresses the spring which exerts a force onto the plunger and therefore onto the skin.
  • the bellows changes shape.
  • the force can be released at a controlled rate allowing the proximal end assembly to expand at a controlled rate until the force has been completely removed and the proximal end assembly has returned to a resting (i.e. expanded) state. In other embodiments, the force can be completely removed causing the proximal end assembly to expand to a resting (i.e. expanded) state.
  • the spring 811 can be used to control the force applied to and/or withdrawn from the target area.
  • the bellows can shield the user from the decreasing space between the proximal end cap and the main body or housing of the devices.
  • the bellows prevent the device from pinching the skin or a finger as the proximal end assembly and/or the spring mechanism is compressed. Additionally, the bellows can assist in preventing ingress of foreign material and provide a hygienic material with a smooth surface finish that can be readily cleaned. In some embodiments, the bellows can contribute to the force required by the user to push the sensor down onto the target area. In some embodiments, the bellows can be polymeric bellows.
  • the proximal end cap 808 can include or be in communication with one or more sensors or sensor module to obtain a skin perfusion pressure measurement as described herein.
  • an optical sensor can be provided in the proximal end assembly and can be in communication with the proximal end cap 808 which is configured to be in contact with the target tissue area or skin surface.
  • the sensor module can refer to one or more sensor assemblies and/or one or more sensors used to determine a skin perfusion pressure measurement, including, but not limited to the components described with reference to Figure 2.
  • the one or more sensor assemblies and/or one or more sensors can be positioned within the skin perfusion pressure determination device 804.
  • the one or more sensor assemblies and/or one or more sensors can be positioned within the housing 803 and/or within the proximal end assembly 807. In some embodiments, the one or more sensor assemblies and/or one or more sensors can be incorporated into or provided with proximal end cap 808.
  • the proximal end cap 808 can provide a surface area that will allow for the target area to be blanched or occluded as well as allow for a sensor (i.e. located as a component in the center) to monitor the blood flow synchronously with the application of the pressure over the surface area.
  • the surface area of the proximal end cap 808 can be large enough to distribute the pressure applied to the target tissue area and thereby reduce pain or discomfort to the patient while allowing the target area to be blanched. If the surface area contacting the skin is too small, it can cause pain or discomfort to the patient when pressed against the target area and the small surface area may not form an area of blanched skin.
  • a thumbprint sized area can be suitable for applying pressure and blanching the skin while allowing for appropriate blood flow monitoring.
  • the proximal end cap 808 or the proximal end 805 can be greater than about 30 mm, about 30 mm to about 20mm, about 20mm to about 10mm, about 10mm to about 5mm, or less than about 5mm.
  • the proximal end cap 808 or the proximal end of the skin perfusion pressure determination device that contacts the target area can be flat or substantially flat so that the proximal end cap 808 or the proximal end is stabilized on and rests flat on the target tissue area. This can aid in ensuring that readings are taken such that the axial orientation of the skin perfusion pressure determination device is perpendicular to the plane of the target area.
  • the proximal end of the skin perfusion pressure determination device can be domed to ensure even pressure distribution and contact with skin.
  • the domed surface can be shallow providing slight curvature from the sides of the proximal end.
  • the proximal end or proximal end cap can be domed, curved, and polyhedron surface. The domed surface can allow even pressure distribution and contact with the target area and ensure that readings are taken such that the axial orientation of the skin perfusion pressure determination device is perpendicular to the plane of the target area.
  • a flanged end similar to the pad portion 110 in Figure 6 can be used to provide an increased surface area that is greater than the cross-sectional area of the skin perfusion pressure determination device 804.
  • the flanged end can contact the target tissue area and provide the necessary surface area that will allow for the target area to be blanched or occluded as well as allow for a sensor (i.e. located as a component in the center) to monitor the blood flow synchronously with the application of pressure over the surface area.
  • the proximal end of the skin perfusion pressure determination device can provide a larger surface area to contact the skin by some other means extended outwards in the plane of the skin to stabilize the device on the target area and rest the device flat on the target area.
  • the proximal end of the skin perfusion pressure determination device can be domed to ensure even pressure distribution and contact with the target area.
  • a domed surface (for the purpose of even pressure distribution over the target area where the sensor is located) can be used with an in-plane flange to provide stabilization of the sensor head in the plane of the target area.
  • Figure 8C illustrates an embodiment of the skin perfusion pressure determination device with a proximal end 805 and distal end 806.
  • a flange 870 can be used to stabilize and position the skin perfusion pressure determination device on the target area in the proper orientation for obtaining a reading.
  • the flange 870 can be used to position the spring mechanism 871 (or proximal end assembly including the spring mechanism) running axially up the perfusion pen 804 at a 90-degree angle to the surface of the target area 872.
  • the flange can be positioned around the proximal end 805 of the skin perfusion pressure determination device.
  • Figure 8C illustrates a cross sectional view through the flange as a disc 873 at the target area interface 872 and a tube 874 which the skin perfusion pressure determination device 804 can run through.
  • the skin perfusion pressure determination device 804 with the sensor module can be positioned axially through the tube 874 of the flange 870 at a 90 degree angle to the plane of the surface of the target area 872.
  • the proximal end cap can be transparent or open. In some embodiments, if the proximal end cap is open, then a surface area can be provided that allows the target area to be blanched or occluded. In some embodiments, the surface area of the optical sensor or sensor module can allow for the target area to be blanched or occluded and the optical sensor or sensor module can be in direct contact with the skin. In such embodiments, the proximal end cap can be open or can be optional. In some embodiments, the proximal end cap is an optional feature of the proximal end assembly.
  • the sensor module and/or the proximal end of the proximal end assembly can be in contact with the target area and can provide a surface area sufficient to allow for the target area to be blanched or occluded as well as allow for a sensor (i.e. located as a component in the center) to monitor the blood flow synchronously with the application of the pressure over the surface area.
  • the sensor and/or sensor module may be positioned in the center of the proximal end of the device. In some embodiments, the sensor and/or sensor module may be positioned off-center or in any portion at the proximal end of the device.
  • the proximal end cap 808 can be formed from glass materials, for example, high strength glass materials such as coming or gorilla glass.
  • the material of the proximal end cap 808 can be any material that allows for an optically clear, biocompatible and scratch resistant contact design option for the optical sensor.
  • the scratch resistant contact surface of the proximal end cap 808 and/or the proximal end can maintain an optical pathway over repeated use of the device.
  • the glass can be made into the various shapes described for the target area contacting end or proximal end of the device.
  • the glass material can also allow for cleaning and sterilization of the device for re-use to reduce waste and consumables.
  • the proximal end cap can be used to apply a force on the skin and to carry out the optical measurements.
  • Figures 8M-8P illustrate embodiments of a portions of a proximal end assembly with force sensor 876 and optical sensor 877 incorporated into the device.
  • an optical sensor 877 can be used to provide the optical measurements as described herein.
  • the optical sensor 877 can be incorporated into or can be the sensor module within or in communication with the proximal end cap and the proximal end.
  • the optical sensor 877 can work over small ranges.
  • the optical sensor 877 can be located in or on the proximal side of the proximal end cap 808 as illustrated in Figure 8M.
  • the optical sensors 877 can shine red and infra-red light on the target tissue area and monitor the response.
  • the optical sensor 877 can have its own window that allows light to pass through.
  • the optical sensor and proximal end cap 808 can have an open proximal end or can utilize a transparent window 878 on the proximal side to allow optical communication with the target tissue area.
  • an optically transparent window can be provided in the region of the sensor within the proximal end cap 808 in order to protect the sensor and the sensor electronics and also to provide a skin-compatible interface as illustrated in Figure 8N.
  • the sensor can be manufactured with a transparent window and the sensor with the integrated transparent window can be located in a recess in the proximal end cap 808.
  • the sensor can sit flush with the proximal end of the proximal end cap 808 and be part of the target area interface of the device. In such embodiments, a separate transparent window is not needed in the proximal end cap 808. In some embodiments, a separate transparent window can be used with the proximal end cap 808 whether or not the optical sensor 877 has an integrated transparent window. In some embodiments the separate transparent window can be beneficial, for example for cleaning or skin-compatibility.
  • the whole proximal end cap 808 could be made from a transparent material 879 as illustrated in Figure 80.
  • Figure 8P illustrates the use of a disposable skin-interfacing part 880 such as a disposable cover as described in more detail herein.
  • the disposable skin-interfacing part 880 can be positioned at the proximal end of the skin perfusion pressure determination device on a proximal side of the proximal end cap 808.
  • the disposable skin-interfacing part 880 could serve as the transparent window as well as providing a disposable cover.
  • the optical sensor 877 can be housed in the proximal end cap 808 in a recess or hole.
  • the additional disposable component can then provide a transparent cover.
  • the proximal end cap in addition to allowing for an optical measurement, can also be used to apply the force to the target tissue area.
  • the proximal end of the proximal end cap 808 can be shaped to provide a more uniform application of the skin pressure, for example, it can be domed rather than be flat.
  • the material of the proximal end of the proximal end cap can be compliant so that the proximal end can deform as the pressure is applied.
  • the proximal end cap can be formed from any plastics and/or metals.
  • the material of the proximal end cap can be a composite or complex structure.
  • the proximal end cap 808 can be useful for protecting the sensors, routing the connections to the force sensor and optical sensors, and can allow for cleanability of the device. In some embodiments, the proximal end cap 808 is optional.
  • the proximal portion of the plunger 810 can be designed to fulfil many of the functions of the proximal end cap 808.
  • Figures 8Q-8T illustrate embodiments of the skin perfusion pressure determination device 804 with various embodiments of the proximal end assembly components.
  • the proximal end 805 of the skin perfusion pressure determination device 804 can be connected to the distal portion of the skin perfusion pressure determination device 804 by a spring 811.
  • the space between the proximal end 805 and the distal portion of the device can be open and the spring 811 would be accessible.
  • the proximal end cap 881 can have distally extending arms that overlap the sides of the portion of the skin perfusion pressure determination device 804 connected to the distal end of the spring 811.
  • the overlapping proximal end cap 881 to create a telescopic-type of arrangement and the portion of the skin perfusion pressure determination device 804 connected to the distal end of the spring 811 can move distally to proximally or proximally to distally within the extended arms of the overlapping proximal end cap 881.
  • the overlapping proximal end cap 881 can have a sliding seal 882 between the two parts.
  • the portion of the skin perfusion pressure determination device 804 connected to the distal end of the spring 811 is shown inside of the arms of the overlapping proximal end cap 881, in some embodiments, the overlapping proximal end cap 881 can be positioned inside the walls of the portion of the skin perfusion pressure determination device 804 connected to the distal end of the spring 811.
  • a rolling diaphragm structure 883 can be used between the proximal end 805 and the portion of the skin perfusion pressure determination device 804 connected to the distal end of the spring 811 as shown in Figure 8T.
  • Figure 8B illustrates an exploded view of the skin perfusion pressure determination device 804.
  • the skin perfusion pressure determination device 804 includes a sensor assembly 814 and a control unit 815.
  • the control unit 815 can comprise one or more printed circuit boards (PCBs) 816.
  • the sensor assembly 814 can be a force sensor.
  • the sensor assembly 814 and a control unit 815 can be surrounded by a casing 817 which forms part of the elongate housing.
  • the casing can be formed from one or more casing portions coupled together to form the casing or elongate housing and surround the electronic components including but not limited to the sensor assembly 814 and the control unit 815.
  • the casing 817 can be formed from two casing portions coupled together as illustrated in Figure 8B.
  • the casing can be formed as a single integrated casing.
  • the end cap 813, casing 817, and a distal end cap 818 can be coupled to enclose the sensor assembly 814 and control unit 815.
  • the user can apply a force to the skin of the patient using the skin perfusion pressure determination device 804 in order to reduce and temporarily stop the blood flow in the skin. Then the user can release this force slowly until blood flow is re established.
  • the user can apply this force directly as in some of the examples described herein. However, if, for example, the user applies this force directly by hand, then any small motion of the hand can lead to a significant change of force. Also, any jittering of the hand could also lead to a change in the force. In order to allow the user to have better control over the force applied, some compliance can be added to the skin perfusion pressure determination device.
  • the spring 811 can provided this compliance.
  • the spring 811 can link the distal end of the housing 803 of the skin perfusion pressure determination device 804 which the user grips with the proximal part (including the proximal end 805) which applies the force to the proximal end of the skin perfusion pressure determination device.
  • the proximal end 805 then in turn applies the force to the target area.
  • the spring will generate a force on the target area as it is compressed. It can require a certain displacement to generate a certain force. With this spring in the path, the user will need to move the grip portion of the skin perfusion pressure determination device by a certain distance towards the target area, thereby compressing the spring 811 which in turn then applies a certain force to the target area. The softer the spring, the larger the displacement needs to be to generate a certain force on the target area. This compliance in the system can make it easier for the user to apply and release the force in a more controllable manner. In addition, small relative motions of the user’s hand relative to the target area can have a smaller effect.
  • Figure 8E illustrates embodiments of a skin perfusion pressure determination device with different spring types.
  • a softer spring can generate a smaller amount of force applied to the target area (illustrated with the device on the left side of Figure 8E) and a tighter spring can cause a larger force to be applied to the skin (illustrated with the device on the right side of Figure 8E).
  • the spring when a small force is applied to the skin or target area, the spring can be compressed less (illustrated with the device on the left side of Figure 8E) than if a larger amount of force is applied to the skin or target area (illustrated with the device on the right side of Figure 8E).
  • a number of different grip options can be used for the skin perfusion pressure determination device.
  • the user can apply and control the force applied to the skin perfusion pressure determination device in a different way.
  • the spring can provide a mechanism for making the force control easier. Both the different grip options and the different spring options can help in giving the user better control of the force application.
  • the distal end of the housing of the skin perfusion pressure determination device and the proximal end need to be able to move relative to each other.
  • the skin perfusion pressure determination device is used to measure the force applied to the skin, and therefore, the additional components in the system which links the distal end of the housing and the proximal end of the skin perfusion pressure determination device should be limited to avoid the additional components providing or taking up a significant amount for force.
  • the distal end of the housing and the proximal end can stay in alignment and move linearly relative to each other. This can require some guidance system, for example, the plunger 810 and slider 812.
  • Figures 8F-8J provides various options.
  • an open gap as shown in Figure 8F.
  • the proximal end 805 and distal end of the housing 803 can have an open gap in between them (i.e. a design without the bellows 809).
  • there would then be an opening in the skin perfusion pressure determination device which exposes the interior of the skin perfusion pressure determination device to the outside world. Dirt and fluids could get inside and damage the electronics and/or the interior of the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device is intended to be reusable, the ability to clean the skin perfusion pressure determination device can be useful. With the open gap, this can be difficult to achieve.
  • various features can be used to cover the space or break in the distal end of the housing created by positioning the spring between the distal end of the housing and proximal end. Covering the space can have a number of advantages, including, but not limited to, it is more aesthetically pleasing, provides a continuous outer shape of the skin perfusion pressure determination device, protects the interior components of the skin perfusion pressure determination device, and provides a cleaner interface and makes the device cleanable.
  • the structures used to close the gap provides a component which links the distal end of the housing to the proximal end and it can therefore have an influence on the force measurement.
  • Figures 8G to 8J illustrate embodiments of structures that can be used to close the space or gap between the distal end of the housing and the proximal end.
  • other components of the proximal end assembly or housing are not shown in Figures 8C-8J, however, any of the components describe herein for the skin perfusion pressure determination device can be used in combination with components described with reference to Figures 8C-8J.
  • the space can be closed with a tube made from an elastic material or any other flexible material.
  • the material of the tube would then compress and/or stretch as the skin perfusion pressure determination device is operated.
  • Figure 8H illustrates the use of a bellows as described herein.
  • the advantage of a bellows can be that the bellows structure can be engineered to deform with a lower force.
  • the structure of the bellows can be designed to let it compress easily. For example, certain sections of the bellows can be thin out to help it compress with even lower forces as described in more detail herein.
  • Figure 81 illustrates the use of a bag-like structure where there is some excessive material.
  • the bag-like structure deforms (as opposed to the material stretching) as the distal end of the housing and the proximal end move relative to each other. While this bag-like structure can change shape with very low force, it can be harder to clean than a bellows or tube structure.
  • Figure 8J illustrates the use of a bag-like structure which encompasses the proximal end of the device.
  • the bag material could be skin-compatible or biocompatible and not interfere with the operation of the optical sensor.
  • the bag can be replaceable and it can be changed between uses in order to provide a sterile interface to the target area (i.e. in this example, the bag is a one-use disposable component).
  • the structure linking the distal end of the device and the proximal end and covering up the gap could be used as the spring.
  • the internal spring 811 is not required and the structure linking the distal end of the device and the proximal end and covering up the gap is used as a spring 811 is used in the skin perfusion pressure determination device 804.
  • a metal spring can allow the spring constants to be varied depending on the type of metal spring used.
  • the bellows 809, 909, 1109, 1209, and 1309 in Figures 7A-13K can be the gap closing structures described herein implemented in the form of bellows.
  • the bellows can be connected to the proximal end cap 808 and the proximal end of case 817.
  • the force sensor which measures the force on the skin can be located between the proximal end cap 808 and the plunger 810. In such embodiments, there can be the possibility that some part of the force applied to the skin is taken up in the bellows and does not pass through the force sensor. If this is not taken account of, this can lead to measurement errors. In order to take account of this, several steps can be taken.
  • the bellows can be designed to compress very easily, i.e. with a very low force. This can be achieved by using soft materials and using the hinged structure in the bellows design.
  • the force required to compress the bellows can be small in comparison to the forces that are applied to the target area and which would be measured.
  • the force sensor can be calibrated with the bellows in place. This can take account of the force taken up/exerted by the bellows in the force sensor calculation and force calculation.
  • the material properties are not only relied on to enable the compression of the structure, but structural features can be designed in, such as hinges or thinned out wall sections which aid in the compression.
  • the bellows 809 does not couple to the proximal end cap 808 but instead couple to an intermediate plate 875 as shown in Figure 8K.
  • a force sensor 876 can be used between the proximal end cap 808 and the intermediate plate 875. This would remove the influence of the bellows on the force measurement.
  • the optical sensor would still be located in the proximal end cap 808.
  • the force sensor 876 can be used instead of or in addition to force sensor described herein with the sensor assembly 814.
  • an end feature of the plunger 810 can be shaped to provide the function of this intermediate plate, as illustrated in Figure 8L.
  • the skin perfusion pressure determination device can determine the skin perfusion pressure or a measurement or index of skin perfusion pressure by positioning a proximal end of a skin perfusion pressure determination device on a target area of patient, the skin perfusion pressure determination device comprising a bellows portion. A force is then applied to the skin perfusion pressure determination device against the target area, causing the bellows portion to contract. The force and/or pressure applied to the target area by the skin perfusion pressure determination device can be measured using a first sensor within the device. The blood perfusion in the target area beneath the proximal end can be measured using a second sensor within the device.
  • the force applied to the target area at a controlled rate can be released at a controlled rate by expanding the spring and the bellows portion as described herein.
  • obtaining or determining a skin perfusion pressure or taking a skin perfusion pressure measurement can refer to obtaining or determining an index or measurement which is based on a perfusion pressure and does not require that the perfusion pressure itself be measured.
  • the one or more sensors used to sense or detect a parameter associated with an amount of blood perfusion at the target area can be detecting the onset of the pulse waveform (i.e. the onset of blood flow into the tissue) and/or the amount of perfusion.
  • the one or more sensors used to sense or detect a parameter associated with an amount of blood perfusion at the target area can detect that perfusion occurring and not necessarily how much or the amount of blood perfusion.
  • the one or more sensors used to sense or detect a parameter associated with an amount of blood perfusion at the target area can determine a measure for when perfusion starts or exists in a tissue area.
  • the skin perfusion pressure determination device can utilize various designs such as described above and as further described herein incorporating the sensors and signal processing elements into an elongate housing.
  • the skin perfusion pressure determination device described herein can be incorporate various features of the skin perfusion pressure determination device described in International Application No. PCT/EP2018/055940, filed March 9, 2018, titled “DEVICE, APPARATUS AND METHOD OF DETERMINING SKIN PERFUSION PRESSURE,” the disclosure of which is incorporated by reference herein.
  • the skin perfusion pressure determination device can incorporate features of International Application No. PCT/EP2018/055940, including, but not limited to, the displays, indicators, LEDs, symbols, methods of use, and any other features described in more details therein.
  • the skin perfusion pressure determination device can include an elongate housing having a proximal end and a distal end.
  • the elongate housing can include a sensor module provided within the elongate housing and the sensor module can be used to detect a pressure exerted on a target area and/or an amount of blood perfusion at the target area.
  • the sensor module can be used to detect a pressure exerted on a target area and/or an amount of blood perfusion at the target area with methods or devices similar to those described herein, specifically with reference to the sensor module and signal processing elements described with reference to Figure 2.
  • a proximal end assembly at the proximal end of the housing can include a proximal end cap at the proximal end of the proximal end assembly.
  • the proximal end cap and/or the proximal end assembly can contact and exert a pressure on the target area.
  • the elongate housing can include a display to provide feedback of the pressure exerted on a target area and/or the amount of blood perfusion at the target area.
  • a communication device can be used for providing data transfer from the skin perfusion pressure determination device to a control unit, remote computer, and/or data storage device.
  • Figures 9A-9F illustrate an embodiment of a skin perfusion pressure determination device utilizing an integrated USB connector 923.
  • the skin perfusion pressure determination device of Figures 9A-9F can be similar to and can include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A- 8B.
  • the skin perfusion pressure determination device 904 can be a hand-held device with an elongate housing 903 including a grip portion 921 and a display 922.
  • the grip portion 921 can be indented as illustrated in Figures 9A-9C to allow for the user to have a more comfortable and controlled grip on the device.
  • the grip portion 921 can provide a surface which may include a flat surface for holding and controlling the skin perfusion pressure determination device.
  • the grip portion 921 can include contoured sides of the elongate housing 903. In some cases, the grip portion 921 can have axial symmetry and as used herein, the contoured side can refer to a contour on the external face of a cylinder or the curved or contoured surface of the grip portion.
  • the display 922 as illustrated in Figure 9A-9C can be an LED circumferential display that wraps around the body of the device 904. The LED display can provide an indication of pressure or feedback of the pressure. As illustrated in Figure 9A-9C, the LED display can be provided proximal to the grip portion and distal to the proximal end 905 of the elongate housing 903.
  • the LED display can be provided anywhere on the device 904, including but not limited to, at the proximal or distal end of the device.
  • the grip portion 921 of the device 904 can allow for the user to hold the device and provide control when the proximal end 905 of the skin perfusion pressure determination device 904 is placed on the target tissue area or skin surface.
  • the elongate housing 903 can include a proximal end assembly and bellows portion as described with reference to Figures 7A and 8T.
  • the bellows portion 909 can contract when the proximal end cap is in contact with the target tissue area and force is applied from the skin perfusion pressure determination device to the target area.
  • the spring within the proximal end assembly contracts which can cause the bellows portion 909 to contract.
  • the bellows portion can have a waisted shape and can contract inward when the force is applied.
  • the bellows portion can have a diamond, bulb, toroidal, or kicked out shape and can contract and extend outward or kick out when the force is applied.
  • the device 904 can include a USB connector 923 at the distal end 906 of the device for providing communication between the skin perfusion pressure determination device 904 and a computer.
  • the USB connector 923 can be used for charging the skin perfusion pressure determination device 904.
  • the USB connector 923 portion of the skin perfusion pressure determination device 904 can be plugged into a computer 924.
  • the device can incorporate any type of connector on the distal end 906. The device can use a USB connector or any other computer or device connectors that allows communication of data between computers or between a computer and computer peripherals.
  • the devices described herein can communicate with an external device in several ways.
  • a cable can be attached permanently to the pen, a cable can be detached from the pen and connected via a connector when used, via a cradle, i.e. by placing the pen into a cradle after it has been used and the cradle is connected to the pc or external display, and/or wireless.
  • FIG 9C illustrates a removable end cap 925 that can be positioned over the USB connector 923 portion of the skin perfusion pressure determination device 904 when the USB connector 923 is not in use.
  • Figure 9C illustrates a skin perfusion pressure determination device 904 with the end cap 925 covering the USB connector 923 and a skin perfusion pressure determination device 904 with the end cap 925 removed from the USB connector 923.
  • Figures 9D-9F illustrate embodiments of the skin perfusion pressure determination device 904 with the USB connector with the end cap 925 completely removed ( Figure 9D), positioned just above the USB connector 923 ( Figure 9E), and completely covering the USB connector 923 ( Figure 9F).
  • the USB can be on any portion of the device not just the proximal end of the device.
  • the USB end cap does not have to be removable and instead can be hinged or can slide to expose the USB.
  • the USB end is not capped but covered with a piece of material that does not necessarily touch or cap the USB.
  • the shape of the skin perfusion pressure determination device 904 can lead the user to instinctively hold the device in different ways.
  • the gripping portion of the skin perfusion pressure determination device 904 can be designed to encourage or require a certain orientation of the device in the user’s hand.
  • the skin perfusion pressure determination device can require careful and steady (non-shaking) control of the pressure and/or the direction of pressure application at a 90-degree angle to the target tissue area.
  • the grip portion of the device can drive hand orientation.
  • the hand orientation can drive arm alignment.
  • the skin perfusion pressure determination device 904 can be held in any orientation described herein, including the orientations suggested by the grip portions and shapes of the device described in later embodiments.
  • the palm grip shown in Figure IOC the pen grip shown in Figure 10E, 12C, 131, 25A-25G, 26A-26B, 27A-27F, and 28A-28E, the barrel grip shown in Figures 11F-11G and 13H, and/or any other grip that allows the user to control the device can be used.
  • the shape and size of the devices can require or encourage a different grip and arm alignment.
  • the different grip and/or arm alignment can change the degree of control over the steady application and/or removal of pressure on the target area.
  • the grip portion 921 can guide and/or aid the user to correctly orient and hold the pen at the correct angle.
  • the display can be circumferential light guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and use of the device.
  • the light guide can be any LED or arrangement of LEDs, not necessarily circumferential, to guide the user through the procedure.
  • Figures 10A-10F illustrate embodiments of a skin perfusion pressure determination device with a palm grip.
  • the skin perfusion pressure determination device of Figures 10A- 10F can be similar to and include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A-8B.
  • Figure 10A illustrates a skin perfusion pressure determination device 1004 with an elongate housing 1003 comprising a proximal end 1005 and a distal end 1006.
  • the elongate housing 1003 can be shaped and sized to be gripped with the palm of a user’s hand.
  • the skin perfusion pressure determination device 1004 can include a display 1022.
  • the display 1022 as illustrated in Figure 10A-10B can be a LED circumferential display that wraps around the body of the device 1004.
  • the LED display can provide an indication of pressure or feedback of the pressure.
  • the LED display can be provided anywhere on the device 1004, including but not limited to, the proximal or distal end of the device.
  • the skin perfusion pressure determination device 1004 can include a contoured or waisted grip portion 1021 and a rounded distal end 1006 that provides a palm grip portion 1023.
  • the waisted grip portion 1021 can provide a surface for holding and controlling the skin perfusion pressure determination device.
  • the grip portion 1021 can include a waisted contour of the elongate housing.
  • the palm grip portion 1023 can have a bulb-like shape that allows for the skin perfusion pressure determination device 1004 to rest comfortably in the palm of a user’s hand as illustrated in Figures 10C-10F.
  • the waisted grip portion 1021 and the palm grip portion can allow for the user to hold the device in the palm of their hand and provide control when the proximal end 1005 of the skin perfusion pressure determination device 1004 is placed on the skin surface.
  • the grip portion can be made of a grip material.
  • the grip material can be a non-slip material that improves the users grip on the device and provides stability.
  • the grip material can have protrusions or bumps to provide an improved gripping surface.
  • the grip material can be a rubber, foam, and/or fabric material.
  • the LED display can be provided proximal to the waisted grip portion 1021 and distal to the proximal end 1005 of the elongate housing 1003.
  • the LED display can be provided anywhere on the device 1004, including but not limited to, at the proximal or distal end of the device.
  • FIG 10B illustrates an embodiment of the skin perfusion pressure determination device 1004 docked to a docking station.
  • the skin perfusion pressure determination device 1004 can be docked on the docking station 1024.
  • the docking station can allow for data transfer and/or charging of the skin perfusion pressure determination device 1004.
  • the data transfer and/or charging can be conducted through a wireless contact connection (shown in Figure 10B) or the device can be electrically connected through an electrical connector.
  • the docking station can be a computer or other control unit. Data collected by the skin perfusion pressure determination device 1004 can be transferred to the computer or other electronic device for storage and/or processing.
  • the docking station 1024 can include a display that can be used to display information or data collected by the skin perfusion pressure determination device 1004 and/or provide controls or settings for the skin perfusion pressure determination device 1004. In some embodiments, the docking station can be used to calibrate the skin perfusion pressure determination device 1004. In some embodiments, the docking station provides a housing for storing the skin perfusion pressure determination device 1004. The skin perfusion pressure determination device 1004 can be docked into the docking station 1024 with the palm grip portion 1023 resting in the docking station as shown in Figure 10B. In other embodiments, the skin perfusion pressure determination device 1004 can be docked into the docking station 1024 with the proximal or skin contacting end resting in the docking station or in any other configuration.
  • Figures lOC-lOF illustrate various embodiments of a skin perfusion pressure determination device 1004 similar to the device described with reference to Figures 10A- 10B.
  • Figures IOC and 10E illustrate embodiments of the skin perfusion pressure determination device 1004 being gripped by a user.
  • the shape of the device can lead the user to instinctively hold the devices in different ways.
  • the skin perfusion pressure determination device is held by the user at the distal end and the users palm covers the distal end.
  • the skin perfusion pressure determination device can be held by the user like a pen, for example, between a thumb and index finger of the user.
  • a grip where the device is positioned between the thumb and index finger of the user can be referred to herein as the pen grip or the external precision grip where the device is pinched between the thumb and index finger and the grip has two extra components of support for the device in the cleft of the thumb and support for the whole hand along its medial edge.
  • the skin perfusion pressure determination device can require careful and steady (non shaking) control of the pressure and/or the direction of pressure application at a 90-degree angle to the target tissue area.
  • the grip portion of the device can drive hand orientation.
  • the hand orientation can drive arm alignment. For example, with the palm over a bulb or rounded surface similar to the palm grip portion 1023, a user is likely to naturally push down on the device.
  • the user’s hand and arm can be at right angles to the direction of force.
  • the skin perfusion pressure determination device can be a tube-shaped device as illustrated in Figures 11 A-l 1 J (described later) and the user’s hand can grip or wrap around the tube-shaped device with the user’s hand and arm at right angles to the direction of force as illustrated in Figures 11F-11G.
  • a grip where the hand can grip or wrap around the tube-shaped or elongate device can be referred to herein as a barrel grip or power grip where the user’s fingers are bunched firmly around an object and in some instances overlapped by the thumb.
  • the thumb can be positioned out straight along the handle.
  • the shape and size of the devices can require or encourage a different grip and arm alignment.
  • the different grip and/or arm alignment can change the degree of control over the steady application and/or removal of pressure on the target area.
  • the grip portion 1021 can guide and/or aid the user to correctly orient and hold the pen at the correct angle.
  • the skin perfusion pressure determination device 1004 can be held in any orientation described herein, including the orientations suggested by the grip portions and shapes of the device described in other embodiments.
  • the palm grip shown in Figure IOC the pen grip shown in Figure 10E, 12C, and 131
  • the barrel grip shown in Figures 11F-11G and 13H and/or any other grip that allows the user to control the device can be used.
  • the display can be circumferential light guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and use of the device.
  • the light guide can be any LED or arrangement of LEDs, not necessarily circumferential, to guide the user through the procedure.
  • the elongate housing 1003 can include a proximal end assembly and bellows portion as described with reference to Figures 7A-7B and 8A-8B.
  • the bellows portion can contract when the proximal end cap is in contact with the target tissue area and force is applied from the skin perfusion pressure determination device to the target area.
  • the bellows portion can have a waisted shape and can contract inward when the force is applied.
  • the bellows portion can have a diamond, bulb, toroidal, or kicked out shape and can contract and extend outward or kick out when the force is applied.
  • Figures 11A-11K illustrate embodiments of a skin perfusion pressure determination device with a display.
  • the skin perfusion pressure determination device of Figures 11A-11K can be similar to and include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A-8B.
  • Figure 11A illustrates a skin perfusion pressure determination device 1104 with an elongate housing 1103 that includes a display screen 1122.
  • the elongate housing 1103 can have a proximal end 1105 and a distal end 1106.
  • the skin perfusion pressure determination device 1104 can include a front facing display screen 1122 to aid in orientation and provide information and feedback to the user during use. In some embodiments, the front facing display screen 1122 can guide the user to hold the device in a certain orientation.
  • the display screen 1122 as illustrated in Figure 11A- 1 IE can be positioned at the distal end 1106 of the device. This positioning can allow for the display to be readable as the proximal or skin contacting end 1105 of the skin perfusion pressure determination device 1104 is contacting the skin.
  • the screen display 1122 can provide an indication of skin perfusion pressure, pressure applied to the skin, and/or feedback to the user.
  • the screen display 1122 can be provided anywhere on the device 1104.
  • the skin perfusion pressure determination device 1104 can incorporate a communication device for providing data transfer from the skin perfusion pressure determination device to a computer or control unit. In some embodiments, the skin perfusion pressure determination device 1104 can incorporate wireless communication to communicate with a computer or control unit.
  • the skin perfusion pressure determination device 1104 can include a grip to provide a surface for holding and controlling the skin perfusion pressure determination device.
  • the grip can include a grip portion 1121 and a palm grip portion 1123.
  • the palm grip portion 1123 can have a cylindrical shape and can allow the skin perfusion pressure determination device 1104 to rest comfortably in the palm of a user’s hand as illustrated in Figures 11F-11G and can allow for the user to hold the device in the palm of their hand and provide control when the proximal end 1105 of the skin perfusion pressure determination device 1104 is placed on the skin surface.
  • the grip portion 1121 can include a grip material positioned on the proximal end of the housing proximal to the screen.
  • the palm grip portion 1123 can include a grip material (not shown).
  • the grip material can be a non-slip material that improves the users grip on the device and provides stability.
  • the grip material can have protrusions or bumps to provide an improved gripping surface.
  • the grip material can be a rubber, foam, and/or fabric material.
  • the grip portion 1121 and/or the palm grip portion 1123 can be a grooved, centrally thickened, or hilted design to prevent or reduce the user’s hand and/or finger from sliding down the housing. These can prevent the user’s hand from slipping down onto the target area, for example, the patient skin or wound.
  • the grooved, centrally thickened, or hilted design can be useful for use with gloves or wet conditions where the grip on the device may be compromised.
  • Figures 1 lF-11G illustrate an embodiment of the skin perfusion pressure determination device 1104 being gripped by a user.
  • the shape of the device can lead the user to instinctively hold the devices in different ways.
  • the skin perfusion pressure determination device can require careful and steady (non shaking) control of the pressure and/or the direction of pressure application at a 90-degree angle to the target tissue area.
  • the grip portion of the device can drive hand orientation.
  • the hand orientation can drive arm alignment.
  • the skin perfusion pressure determination device 1104 can be held in any orientation described herein, including the orientations suggested by the grip portions and shapes of the device described in other embodiments.
  • the palm grip shown in Figure IOC the pen grip shown in Figure 10E, 12C, and 131, the barrel grip shown in Figures 11F-11G and 13H, and/or any other grip that allows the user to control the device can be used.
  • the shape and size of the devices can require or encourage a different grip and arm alignment.
  • the different grip and/or arm alignment can change the degree of control over the steady application and/or removal of pressure on the target area.
  • the grip portion 1121 can guide and/or aid the user to correctly orient and hold the pen at the correct angle.
  • the display can be a light guide illuminated by a LED or a screen.
  • a color or multiple colors can be used to guide the user through the procedure and use of the device.
  • the skin perfusion pressure determination device 1104 can include a power button or switch 1125.
  • the power button or switch 1125 can be located on any portion of the skin perfusion pressure determination device 1104. The switch can be used to turn the skin perfusion pressure determination device on and/or off.
  • the display screen 1122 can include a touch screen.
  • the touch screen display screen can include the power button or switch 1125.
  • the elongate housing 1103 can include a proximal end assembly and bellows portion 1109 as described with reference to Figures 7A-7B and 8A-8B.
  • the bellows portion 1109 can contract when the proximal end cap is in contact with the target tissue area and force is applied from the skin perfusion pressure determination device to the target area.
  • the spring within the proximal end assembly contracts which can cause the bellows portion 909 to contract.
  • the bellows portion 1109 can have a waisted shape and can contract inward when the force is applied.
  • the bellows portion 1109 can have a diamond, bulb, toroidal, or kicked out shape and can contract and extend outward or kick out when the force is applied.
  • Figure 11H illustrates a back side of an embodiment of the skin perfusion pressure determination device 1104.
  • Figure 111 illustrates a side view of an embodiment of the skin perfusion pressure determination device 1104.
  • Figure 11J illustrates a front view of an embodiment of the skin perfusion pressure determination device 1104.
  • Figures 12A-12E illustrate embodiments of a skin perfusion pressure determination device with indicators.
  • the skin perfusion pressure determination device of Figures 12A-12F can be similar to and include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A-8B.
  • the skin perfusion pressure determination device 1204 can comprise an elongate housing 1203.
  • the elongate housing 1203 can have a proximal end 1205 and a distal end 1206.
  • Figure 12A illustrates a skin perfusion pressure determination device 1204 that includes a display 1222.
  • the skin perfusion pressure determination device 1204 can include a display 1222 with one or more LEDs as illustrated in Figure 12B.
  • the LED display can provide an indication of the pressure applied to the skin and/or feedback to the user.
  • the LED display can provide feedback of the pressure exerted on a target area and/or the amount of blood perfusion at the target area.
  • the LED display can be provided anywhere on the elongate housing 1203 of the device 1204. This positioning can allow for the display to be readable as the proximal or skin contacting end 1205 of the skin perfusion pressure determination device 1204 is contacting the skin.
  • the skin perfusion pressure determination device 1204 can include a grip portion 1221 and a tapered distal end 1226.
  • the grip portion can provide a surface for holding and controlling the skin perfusion pressure determination device.
  • the grip portion 1221 comprises a grip material positioned on the proximal end of the elongate housing.
  • the grip portion 1221 can have a cylindrical shape and can allow the skin perfusion pressure determination device 1204 to rest comfortably in a user’s hand as illustrated in Figures 12C- 12D and can allow for the user to hold the device in a controlled position when the proximal or skin contacting end 1205 of the skin perfusion pressure determination device 1204 is placed on the skin surface.
  • the grip material can be a non-slip material that improves the users grip on the device and provides stability. In some embodiments, the grip material can have protrusions or bumps to provide an improved gripping surface.
  • the grip material can be a rubber, foam, and/or fabric material.
  • the LED display can be positioned on the elongate housing
  • the skin perfusion pressure determination device 1204 can be connected to a control unit, remote computer, electrical or charging assembly, or any other device.
  • the skin perfusion pressure determination device can include a communication device for providing data transfer from the skin perfusion pressure determination device to a computer or control unit.
  • the communication device can include an electrical wiring connecting the skin perfusion pressure determination device 1204 to a control unit.
  • the communication device can include a connector which can be coupled to a cable or electrical wiring which links the device to a control unit.
  • the tapered distal end 1226 of the skin perfusion pressure determination device 1204 can include a cable assembly (not shown) that connects the distal end of the skin perfusion pressure determination device
  • the communication device comprises a device for wireless communication.
  • Connecting the skin perfusion pressure determination device 1204 to a control unit or device can allow for data transfer and/or charging of the skin perfusion pressure determination device 1204.
  • the data transfer and/or charging can be conducted through an electrical connector extending from the tapered distal end 1226.
  • the electrical connector extending from the tapered distal end 1226 can be connected to a computer or other control unit. Data collected by the skin perfusion pressure determination device 1204 can be transferred to the computer or other electronic device for storage and/or processing.
  • the electrical connector extending from the tapered distal end 1226 can be used to transfer data collected by the skin perfusion pressure determination device 1204 and/or provide controls or settings for the skin perfusion pressure determination device 1204.
  • the skin perfusion pressure determination device 1204 can be thin and have a minimal footprint. In some embodiments, the slim design of the skin perfusion pressure determination device 1204 can ease handling of the device and improve accuracy.
  • the elongate housing 1203 can include a proximal end assembly and bellows portion 1209 as described with reference to Figures 7A-7B and 8A-8B.
  • the bellows portion 1209 can contract when the proximal end cap is in contact with the target tissue area and force is applied from the skin perfusion pressure determination device to the target area.
  • the bellows portion 1209 can have a diamond, bulb, toroidal, or kicked out shape and can contract and extend outward or kick out when the force is applied.
  • the bellows portion 1209 can have a waisted shape and can contract inward when the force is applied.
  • Figure 12C illustrates an embodiment of the skin perfusion pressure determination device 1204 being gripped by a user.
  • the shape of the device can lead the user to instinctively hold the devices in different ways.
  • the skin perfusion pressure determination device can require careful and steady (non-shaking) control of the pressure and/or the direction of pressure application at a 90-degree angle to the target tissue area.
  • the grip portion of the device can drive hand orientation.
  • the hand orientation can drive arm alignment.
  • the skin perfusion pressure determination device 1204 can be held in any orientation described herein, including the orientations suggested by the grip portions and shapes of the device described in other embodiments.
  • the palm grip shown in Figure IOC the pen grip shown in Figure 10E, 12C, and 131, the barrel grip shown in Figures 11F-11G and 13H, and/or any other grip that allows the user to control the device can be used.
  • the shape and size of the devices can require or encourage a different grip and arm alignment.
  • the different grip and/or arm alignment can change the degree of control over the steady application and/or removal of pressure on the target area.
  • the grip portion 1221 can guide and/or aid the user to correctly orient and hold the pen at the correct angle.
  • the display can be circumferential light guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and use of the device.
  • the light guide can be any LED or arrangement of LEDs, not necessarily circumferential, to guide the user through the procedure.
  • Figures 13A-13L illustrate embodiments of a skin perfusion pressure determination device.
  • the skin perfusion pressure determination device of Figures 13A-13L can be similar to and include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A-8B.
  • the skin perfusion pressure determination device 1304 can comprise an elongate housing 1303.
  • the elongate housing 1303 can have a proximal end 1305 and a distal end 1306.
  • Figure 13A illustrates a skin perfusion pressure determination device 1304 that includes a display to provide feedback of the pressure exerted on a target area and/or the amount of blood perfusion at the target area.
  • the display can include a plurality of LED displays.
  • the skin perfusion pressure determination device 1304 includes a first display 1322 and a second display 1327.
  • the first display 1322 can include an LED positioned on the top or distal most end 1306 of the skin perfusion pressure determination device 1304 as illustrated in Figure 13F-13G.
  • the second display 1327 can be positioned on the side of the skin perfusion pressure determination device 1304.
  • the first LED display 1322 can include a top display on the distal most end of the elongate housing and a second LED display 1327 can include a side display on a side of the proximal end of the elongate housing.
  • the second display can include a row of indicators as illustrated in Figures 13A-13B and 13E-13F.
  • the row of indicators can include number, color, symbol, and/or any other indicators.
  • the first and/or second display 1322 and 1327 can provide an indication of the pressure applied to the skin and/or feedback to the user.
  • the first display 1322 can provide an indication of pressure feedback and the second display 1327 can provide a location indicator and/or reading or measurement. This positioning of the first and second displays 1322 and 1327 can allow for the display to be readable as the proximal or skin contacting end 1305 of the skin perfusion pressure determination device 1304 is contacting the skin.
  • the skin perfusion pressure determination device 1304 can include a grip portion 1321.
  • the grip portion 1321 can provide a surface for holding and controlling the skin perfusion pressure determination device 1304.
  • the grip portion 1321 can include a grip material positioned on the proximal end of the elongate housing as illustrated in Figure 13B.
  • the grip portion 1321 can have a cylindrical shape and can allow the skin perfusion pressure determination device 1304 to rest comfortably in a user’s hand as illustrated in Figures 13H- 131 and can allow for the user to hold the device in a controlled position when the proximal or skin contacting end 1305 of the skin perfusion pressure determination device 1304 is placed on the skin surface.
  • the grip material can be a non-slip material that improves the users grip on the device and provides stability. In some embodiments, the grip material can have protrusions or bumps to provide an improved gripping surface.
  • the grip material can be a rubber, foam, and/or fabric material.
  • the skin perfusion pressure determination device 1304 can include a communication device for providing data transfer from the skin perfusion pressure determination device to a computer or control unit.
  • the skin perfusion pressure determination device 1304 can be connected to a control unit, remote computer, electrical or charging assembly, or any other device.
  • the distal end 1306 of the skin perfusion pressure determination device 1304 can include an electrical wire or cable 1328 that connects the distal end of the skin perfusion pressure determination device 1304 to a computer 1329 as illustrated in Figure 13B.
  • Connecting the skin perfusion pressure determination device 1304 to a computer, control unit, or other device can allow for data transfer and/or charging of the skin perfusion pressure determination device 1304.
  • the data transfer and/or charging can be conducted through an electrical wire or cable 1328 extending from the distal end 1306.
  • the electrical wire or cable 1328 extending from the distal end 1306 can be connected to a computer, control unit, or other device.
  • Data collected by the skin perfusion pressure determination device 1304 can be transferred to the computer or other electronic device for storage and/or processing.
  • the electrical wire or cable 1328 extending from the distal end 1306 can be used to transfer data collected by the skin perfusion pressure determination device 1304 and/or provide controls or settings for the skin perfusion pressure determination device 1304.
  • Figure 13C illustrates a zoomed in view of the proximal end assembly 1307 of an embodiment of a skin perfusion pressure determination device 1304 shown in Figure 13D.
  • Figure 13D illustrates two different grip portions 1321 of an embodiment of the skin perfusion pressure determination device 1304.
  • the grip portion 1321 can be provided as a strip of material on the side of the skin perfusion pressure determination device 1304.
  • the grip portion 1321 can be provided as a piece of material wrapped around the barrel of the proximal end assembly as shown in one of the embodiment on the left side of Figure 13D and the embodiment in Figure 13C.
  • the grip portion can be formed integrally as part of the housing, as part of the moulding process, via in-mould decoration or two-shot moulding.
  • the elongate housing 1303 can include a proximal end assembly and bellows portion 1309 as described with reference to Figures 7A-7B and 8A-8B.
  • the bellows portion 1309 can contract when the proximal end cap is in contact with the target tissue area and force is applied from the skin perfusion pressure determination device to the target area.
  • the bellows portion 1309 can have a diamond, bulb, toroidal, or kicked out shape and can contract and extend outward or kick out when the force is applied.
  • the bellows portion 1309 can have a waisted shape and can contract inward when the force is applied.
  • Figure 13E illustrates the several examples of the first and second display 1322 and 1327 on the skin perfusion pressure determination device 1304.
  • Figure 13F illustrates embodiments of the skin perfusion pressure determination device 1304 with a first display 1322 and a second display 1327.
  • Figure 13G illustrates the skin perfusion pressure determination device 1304 similar to the skin perfusion pressure determination device 1304 described with reference to Figures 13A and 13B except the skin perfusion pressure determination device 1304 shown in Figure 13G is wireless.
  • the wireless skin perfusion pressure determination device 1304 can be docked on a docking station 1324.
  • the docking station 1324 can allow for data transfer and/or charging of the skin perfusion pressure determination device 1304.
  • the data transfer and/or charging can be conducted through a wireless contact connection or the device can be electrically connected through an electrical connector on the docking station 1324.
  • the docking station 1324 can be a computer or other control unit. Data collected by the skin perfusion pressure determination device 1304 can be transferred to the computer or other electronic device for storage and/or processing.
  • the docking station 1324 can include a display 1329 that can be used to display information or data collected by the skin perfusion pressure determination device 1304 and/or provide controls or settings for the skin perfusion pressure determination device 1304. In some embodiments, the docking station 1324 can be used to calibrate the skin perfusion pressure determination device 1304. In some embodiments, the docking station 1324 provides a housing for storing the skin perfusion pressure determination device 1304. The skin perfusion pressure determination device 1304 can be docked into the docking station 1324 with the proximal or skin contacting end resting in the docking station as illustrated in Figure 13G. In other embodiments, the skin perfusion pressure determination device 1304 can be docked into the docking station 1324 with the distal end resting in the docking station or in any other configuration.
  • Figures 13H and 131 illustrate an embodiment of the skin perfusion pressure determination device 1304 held by a user to apply pressure to the skin to obtain a skin perfusion measurement 1304.
  • Figures 13H-13I illustrate an embodiment of the skin perfusion pressure determination device 1304 being gripped by a user.
  • the shape of the device can lead the user to instinctively hold the devices in different ways.
  • the skin perfusion pressure determination device can require careful and steady (non-shaking) control of the pressure and/or the direction of pressure application at a 90-degree angle to the target tissue area.
  • the grip portion of the device can drive hand orientation.
  • the hand orientation can drive arm alignment.
  • the skin perfusion pressure determination device 1304 can be held in any orientation described herein, including the orientations suggested by the grip portions and shapes of the device described in other embodiments.
  • the palm grip shown in Figure IOC, the pen grip shown in Figure 10E, 12C, and 131, the barrel grip shown in Figures 11F-11G and 13H, and/or any other grip that allows the user to control the device can be used.
  • the shape and size of the devices can require or encourage a different grip and arm alignment.
  • the different grip and/or arm alignment can change the degree of control over the steady application and/or removal of pressure on the target area.
  • the grip portion 1321 can guide and/or aid the user to correctly orient and hold the pen at the correct angle.
  • Figure 13 J illustrates a side view of an embodiment of the skin perfusion pressure determination device 1304.
  • Figure 13K illustrates a front view of an embodiment of a skin perfusion pressure determination device 1304.
  • the display can include a circumferential light guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and use of the device.
  • the light guide can be any LED, arrangement of LEDs or screens, not necessarily circumferential, to guide the user through the procedure.
  • the skin perfusion pressure determination devices described herein can be powered by one or more power options.
  • the skin perfusion pressure determination device can be powered by metal contact points. Metal contact points can use contact points to transmit power to a battery within the device. Metal contact points can allow the skin perfusion pressure determination device to be flush with the charging device. Additionally, by removing openings or recess for charging, the metal contact point charging can maintain cleanliness of the device.
  • metal contact points can have the potential for conductivity to be affected by cleaning chemicals and the construction of the device can require more complicated molding.
  • the device can be powered during its operation by an internal battery and the battery can then be recharged and data can be transferred in/out using the metal connector points.
  • the battery can be removable and/or replaceable and can be changed instead of being recharged.
  • the skin perfusion pressure determination devices described herein can be powered by USB charging.
  • the battery of the skin perfusion pressure determination device can be charged using a USB cable connection.
  • the device can be powered during its operation by an internal battery and the battery can then be recharged and data can be transferred in/out using the USB connector.
  • the USB connection can create a space for bacteria, volatile organic compounds (VOCs), or other harmful components to be harbored at the connection point.
  • a fixed USB connector can be used to power the skin perfusion pressure determination device.
  • the fixed USB can connect the skin perfusion pressure determination device to a power source.
  • the fixed USB could be used without a battery to delivery power to the device.
  • the fixed USB connector can be used to attach a cable in order to connect the skin perfusion pressure determination device to a power source. Therefore, the skin perfusion pressure determination device can only be used within the limited distance of the power source allowed by the cable.
  • the design with the fixed USB connector and without an internal battery can require a power source or computer to always be connected while the skin perfusion pressure determination device is in use. In some embodiments, any design which does not use an internal battery, can require a power source or computer to always be connected while the skin perfusion pressure determination device is in use
  • wireless or induction charging can be used to charge the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device can be charged on a charging station or docking station similar to the docking stations discussed herein.
  • the wireless or induction charging can provide a seamless housing for the skin perfusion pressure determination device since the housing does not have to include a recess or cord for charging.
  • the skin perfusion pressure determination device can have a removable battery. The removable battery could be switched out with a new battery when the old battery runs down.
  • the opening in the device for receiving the battery can allow for bacteria, VOCs, or other harmful components to be harbored at the attachment point. In such cases, the opening that allows for the battery to be changed can be closed or sealed to prevent bacterial, VOCs, or other harmful components from entering the device.
  • the skin perfusion pressure determination devices can transfer data collected by the sensors to a computer, control unit, or other device through various methods.
  • data can be transferred through metal contact points similar to the metal contact points used to power the device.
  • data can be wirelessly transferred from the skin perfusion pressure determination device to a computer, control unit, or other device.
  • the data can be transferred over Bluetooth, zigbee, or other wireless technology.
  • the wireless communication device can be embedded in the skin perfusion pressure determination device.
  • data can be transferred from the skin perfusion pressure determination device to computer, control unit, or other device by using a USB cable. The USB cable would limit the distance between the skin perfusion pressure determination device to computer, control unit, or other device.
  • a contactless data transfer can be used.
  • the data can be transferred from the skin perfusion pressure determination device to computer, control unit, or other device via a RF/NFC link.
  • the contactless data transfer can have a limited distance. In some embodiments, a smaller amount of data can be transferred than with other methods.
  • data can be transferred from the skin perfusion pressure determination device to computer, control unit, or other device using infrared. Infrared data transfer can require line of sight between the two devices.
  • a cable jacket can be formed from PVC or TPE (Thermoplastic Elastomer).
  • the cable can be shielded with aluminium foil or braided SPC with aluminium foil underneath.
  • the connection moulding of the cable can include overmoulded nylon, overmoulded TPE with an injection moulded cover, overmoulded PP, overmoulded nylon with injection moulded cover, or overmoulded nylon with injection moulded PP cover.
  • the connection strain relief of the cable can be nylon, TPE, or PP.
  • the skin perfusion pressure determination devices described herein can be used to determine a skin perfusion pressure measurement. Such measurements may be used to aid the prediction of wound healing.
  • a clinician or the patient themselves presses the sensor module and/or the proximal end of the skin perfusion pressure determination device against the target area of a patient’s body to occlude the blood vessels within the tissue below the target area. The amount of force is increased until the pulsatile component of the trace drops below a predetermined level or ceases to be evident.
  • the clinician continues to hold the sensor module in the skin perfusion pressure determination device against the target area to ensure that the pulsatile arterial blood flow has ceased in the tissue at the target area.
  • the clinician begins to reduce the force applied to the sensor module in the skin perfusion pressure determination device slowly until the pressure module in the skin perfusion pressure determination device has been released completely and pulsatile arterial blood flow in the tissue at the target area is completely restored.
  • an automatic or controlled force application or force withdrawal mechanism can assist the user in obtaining a measurement of skin perfusion pressure by controlling the amount of force applied to occlude the blood vessels within the tissue below the target area.
  • an automatic or controlled withdrawal of force can allow for a slow and measured release of pressure over the target area until the blood flow in the tissue at the target area is completely restored.
  • a user can still be required to keep their hand reasonably still and/or withdraw it slightly.
  • the control or withdrawal mechanism described herein can be used to assist the user and allow the force to be reduced in a more controlled way.
  • control or withdrawal mechanism can be used to help the user to apply and/or withdraw the applied force slowly.
  • the automatic or controlled withdrawal of force can allow for more accurate and repeatable measurements provided by the skin perfusion pressure determination device.
  • Various mechanisms can be utilized to automate or control the force application of the skin perfusion pressure determination device.
  • Figures 14A-17C illustrate embodiments of withdrawal mechanisms for use with a skin perfusion pressure determination device.
  • the user applies a force and, when the device detects that the pulse has stopped (i.e. the blood flow has been occluded), the device slowly releases the force applied to the skin. This release can be controlled using, for example, one or more of the withdrawal mechanisms described in Figures 14A-17C.
  • the user can control the force applied to the skin using a control mechanism. This force can be controlled using, for example, one or more of the control mechanisms described in Figures 18A-19B.
  • the user when using a withdrawal or control mechanism the user’s hands provides as a minimum an end stop that the device presses against.
  • hand movements of the user if they interfere with the operation of the device, can be (partially) compensated for.
  • the withdrawal or control mechanisms described herein can also be used with the integrated approaches shown in Figure 1, where the band provides the end stop the device presses again to generate the force.
  • the skin perfusion pressure determination device can utilize various designs incorporating the sensors and signal processing elements into an elongate housing.
  • the skin perfusion pressure determination device can include an elongate housing having a proximal end and a distal end similar to and include features of the elongate housing and skin perfusion pressure determination device described with reference to Figures 7A-13K.
  • the elongate housing can include a sensor module provided within the elongate housing and/or the proximal end assembly configured to detect a pressure exerted on a target area and an amount of blood perfusion at the target area.
  • the elongate housing can include a proximal end assembly configured to exert a pressure on the target area.
  • the proximal end assembly can include a withdrawal mechanism to automatically control the pressure exerted on the target area by the proximal end assembly.
  • a skin perfusion pressure can be determined by positioning a proximal end of a skin perfusion pressure determination device on a target area of patient.
  • a force can be applied to the skin perfusion pressure determination device against the target area.
  • the force or a pressure applied to the target area by the skin perfusion pressure determination device can be measured using a first sensor within the device.
  • Blood perfusion in the target area beneath the proximal end can be measured using a second sensor within the device. After the device detects that blood flow has been occluded in the target area, the device can automatically withdraw the force applied to the target area at a controlled rate.
  • Figures 14A-14B illustrate an embodiment of a withdrawal mechanism with air bellows.
  • the air bellows device 1410 can be used with the elongate housing of the skin perfusion pressure determination device described herein.
  • the air bellows device 1410 can be provided within the elongate housing.
  • air bellows device 1410 can be integrated into the housing of the elongate housing, for example, in some embodiments, the air bellows device 1410 can be integrated with the components of the proximal end assembly described herein.
  • the air bellows device 1410 can be provided within the proximal end assembly of the skin perfusion pressure determination device described herein.
  • the air bellows device 1410 can utilize the release of (trapped) air from a reservoir using a pulsed valve to reduce/control the force applied to the skin.
  • the air bellows device 1410 can include bellows, a flexible air container, or air spring 1411 that can include a proximal end 1405 for contacting the target tissue area.
  • the air bellows device can use a valve or control mechanism 1412.
  • the valve or control mechanism 1412 can be positioned within a housing 1413 when in use.
  • the bellows 1411 can be connected to a proximal end of the housing 1415.
  • the valve or control mechanism 1412 can be used to release air from the bellows 1411 in a controlled manner.
  • the withdrawal mechanism includes the bellows device 1411 in fluid communication with the control valve 1412.
  • the bellows device 1411 can contract when the proximal end assembly is in contact with the target area and force is applied from the proximal end assembly to the target area.
  • the bellows are configured to expand when the control valve is opened allowing air to fill the bellows.
  • the expansion of the bellows can be due to the bellows itself or via a mechanism, for example, a spring can be included which expands the bellows when the valve is open.
  • the valve or control mechanism can include an on/off valve, an on/off valve with flow restrictor, a proportional/analog valve, and/or other known valve control mechanisms.
  • the on/off valve can be manually or electrically operated.
  • An electrically operated on/off valve can utilize a control system to control the time the valve is opened.
  • the electrically operated on/off valve can allow for pulse-width modulated control (length of on- time is varied) with frequency fixed.
  • the frequency can be varied with a fixed opening time.
  • the frequency and duty cycle can be varied.
  • the on/off valve with flow restrictor can utilize the same control systems as the on/off valve.
  • the on/off valve with flow restrictor can additionally manually or electronically control the flow resistance of flow restrictor.
  • the proportional/analog valve can be manually controlled and/or electronically controlled.
  • the air bellows device 1410 can be a self-resetting mechanism. When the valve or control mechanism has released all pressure, the air bellows device 1410 has been reset. In some embodiments, the valve or control mechanism can be run with a preprogramed algorithm to open or pulse at a predetermined rate until the desired pressure is achieved. In some embodiments, the user can use the measured force and/or the measured pressure detected by the sensors in the skin perfusion pressure determination device to adjust the bellows or application of force from the bellows.
  • the bellows can reduce the force in a more controlled way by letting air out after the perfusion has stopped or the blood flow in the target area is occluded. In some embodiments, the bellows can reduce the force applied to the target tissue area in the initial force application phase as the user presses the device into the target tissue area. If too large a force is detected, the valve could open up, release air and therefore reduce the force applied to the target tissue area, therefore reducing the risk of damage to the target tissue area.
  • Figures 15A-15D illustrate an embodiment of a withdrawal mechanism with a fluid damper device 1510.
  • the fluid damper device 1510 can be provided within the elongate housing of the skin perfusion pressure determination device described herein.
  • the fluid damper device 1510 can be provided within the proximal end assembly of the skin perfusion pressure determination device described herein.
  • the fluid damper device 1510 can include a spring 1517 that can include a proximal end 1505 for contacting the target tissue area.
  • the fluid damper device 1510 can use a liquid filled piston 1516.
  • the passage of the fluid out of one chamber of the piston 1516 can be controlled using a pulsed valve or control mechanism 1512. This allows for a controlled rate of release of the force from the skin.
  • the fluid damper device 1510 includes a spring portion 1517 and a housing 1513 as illustrated in Figure 15B.
  • the control system can control the fluid flow from one chamber of the piston 1516 to the other.
  • the compressed spring 1517 exerts a force on the intermediate platform 1520 and therefore the piston 1518. This causes fluid to flow from one end of the cylinder to the other, allowing the piston to move vertically upward or toward the distal end 1506 of the device and allowing the spring 1517 to expand and therefore reduces the force on the skin.
  • the piston In the initial state the piston is extended and the valve is closed. As the valve is closed, the piston is locked in this position. The user exerts a force onto the skin via the skin perfusion pressure determination device and compresses the spring 1517.
  • the valve starts to allow passage of fluid form one chamber to the other.
  • the spring via the piston pressurizes the fluid in one chamber which forces fluid to flow when the valve is open. This fluid flow in turn then allows the piston to move which expands the spring and reduces the force.
  • the liquid filled piston 1516 can include the proximal end and the distal end.
  • the liquid filled piston comprises a first chamber at the distal end and a second chamber at the proximal end with the seal of the piston separating the two chambers.
  • the liquid filled piston 1516 can be in fluid communication with a control valve 1512.
  • the spring 1517 can include a proximal end and a distal end.
  • the spring 1517 can be positioned proximal to the liquid filled piston 1516 and the intermediate platform 1520 positioned at the proximal end of the liquid filled piston 1516 and at the distal end of the spring 1517. In a first position, the piston is extended and the valve is closed and the piston is locked in this position because the valve is closed.
  • the spring 1517 can be compressed by a force applied to the skin perfusion pressure determination device.
  • the control valve can be opened to allow fluid to move from the first chamber to the second chamber of the fluid filled piston 1516 allowing the piston to move which expands the spring and reduces the force.
  • the valve 1512 can be used to control the movement of the fluid (and piston) within the cylinder 1519.
  • the piston 1516 When the piston 1516 is in the extended position the base platform 1521 at the proximal end 1505 is applying a maximum pressure to the target tissue area.
  • the valve 1512 can be opened and fluid can be allowed to move from the distal compartment to the proximal compartment (not shown) of the cylinder 1519. This will allow the piston and intermediate platform 1520 to move toward a distal end 1506 of the device, allowing the spring 1517 to expand and reducing the force applied to the skin.
  • the spring portion 1517 can include one or more springs connected to a base platform 1521 and an intermediate platform 1520. This spring portion 1517 can allow for better control and more even application of the force to the tissue area. For example, small vibrations of the hand are less likely to cause a large change in force applied to the tissue area.
  • the valve 1512 can be used to control the movement of fluid in the system in a controlled manner.
  • the valve or control mechanism can include an on/off valve, an on/off valve with flow restrictor, a proportional/analog valve, and/or other known valve control mechanisms.
  • the on/off valve can be manually or electrically operated.
  • An electrically operated on/off valve can utilize a control system to control the time the valve is opened.
  • the electrically operated on/off valve can allow for pulse-width modulated control (length of on-time is varied) with frequency fixed.
  • the frequency can be varied with a fixed opening time.
  • the frequency and duty cycle can be varied.
  • the on/off valve with flow restrictor can utilize the same control systems as the on/off valve.
  • the on/off valve with flow restrictor can additionally manually or electronically control the flow resistance of flow restrictor.
  • the proportional/analog valve can be manually controlled and/or electronically controlled.
  • Figures 16A-16D illustrate an embodiment of a withdrawal mechanism with a magnetic brake device 1610.
  • the magnetic brake device can be an electromagnetic clutch or electromagnetic brake.
  • the magnetic brake device 1610 can be provided within the elongate housing of the skin perfusion pressure determination device described herein.
  • the magnetic brake device 1610 can be provided within the proximal end assembly of the skin perfusion pressure determination device described herein.
  • the magnetic brake device 1610 can include a spring 1617 that can include a proximal end 1605 for contacting the target tissue area.
  • the magnetic brake device 1610 can use a magnetic clutch 1641 and a ratchet arm 1643 to hold the proximal end 1605 in place and apply the force to the target tissue area.
  • the magnetic clutch 1641 can include a wheel with teeth 1642 that interacts with teeth 1644 of the arm 1643. Then, when required, the magnetic clutch 1641 can slowly release the force applied to the skin by gradually allowing two parts of the mechanism to slip relative to each other. As the magnetic clutch 1641 slips, the gear wheel 1642 can rotate which in turn allows the arm 1643 to move. The movement of the arm 1643 can allow the spring 1617 to expand, thereby reducing the force applied to the tissue. In some embodiments, the proximal end 1605 is not moved but the spring is expanded which reduces the force which the spring exerts on the proximal end and therefore also the force which the proximal end exerts on the spring.
  • the arm 1642 can move through a channel or guide 1645 as shown in Figure 16B-16D to provide stability and guide the movement of the arm.
  • the withdrawal mechanism can include the magnetic brake device 1610 including the magnetic clutch 1641 with a gear with teeth.
  • the spring 1617 can be positioned at a proximal end of the device.
  • the ratchet arm 1643 with teeth can be positioned distal to the spring 1617 and can exert a pressure on the spring 1617 in a first position.
  • the teeth of the ratchet arm can be in communication with the teeth of the gear on the magnetic clutch 1641.
  • the magnetic brake device 1610 can allow for the gear to turn in response to a magnetic field.
  • the ratchet arm When the gear is allowed to turn, the ratchet arm can apply a torque to turn the gear and the gear can move the ratchet arm 1643 toward the distal end of the elongate housing releasing the pressure on the spring 1617.
  • Figures 16A-16D illustrate a rectangular shaped housing
  • the magnetic brake device 1610 can be any shape or size necessary to fit in the skin perfusion pressure determination device systems similar to the devices described herein.
  • a magnetic field can be applied to control the magnetic brake.
  • a current can be applied through the magnetic brake with different voltages or different currents across the brake.
  • a wide range power supply and control systems can be used to apply the current.
  • the magnetic brake device can have an on/off control that can be manually or electrically operated.
  • the electrically operated on/off control can deactivate the magnetic brake for brief periods of time by electronic signals (pulses).
  • the electrically operated on/off control can use a pulse-width modulated control (length of on-time is varied) with a frequency fixed.
  • the electrically operated on/off control can vary the frequency with a fixed opening time.
  • the electrically operated on/off control can vary frequency and duty cycle.
  • the magnetic brake can have a proportional/analog control that can be manually released and/or electronically controlled.
  • the proportional/analog control that can be electronically controlled where friction is changed in an analogue manner by applying different voltage levels or passing different current levels through the coil in the magnetic brake.
  • Figures 17A-17C illustrate an embodiment of a withdrawal mechanism with a magneto-rheological fluid device 1710.
  • the magneto-rheological fluid device 1710 can be provided within the elongate housing of the skin perfusion pressure determination device described herein.
  • the magneto-rheological fluid device 1710 can be provided within the proximal end assembly of the skin perfusion pressure determination device described herein.
  • the magneto-rheological fluid device 1710 uses an adjustment of the viscosity of a magnetorheological fluid to reduce the force applied to the skin.
  • the magneto-rheological fluid device 1710 illustrated in Figures 17A-17C uses two syringes or housings or reservoir 1748 with plungers 1747 with magneto-rheological fluid inside the syringe housing.
  • a magnet (e.g., electromagnet) 1746 can be used to apply a magnetic field to the magneto-rheological fluid which in turn adjusts the viscosity of the fluid. By controlling the viscosity of the fluid, a user can control how the fluid flows from one syringe to the other.
  • the magneto-rheological fluid device system controls the flow of a magneto- rheological fluid within the syringe system.
  • the reservoir can include two syringes or housings 1748 connected by an orifice. Each chamber of the syringes or housings 1748 can receive a plunger which can move within the chamber.
  • the magneto- rheological fluid device system controls the flow of a magneto-rheological fluid within the reservoir by controlling the viscosity of the fluid as it flows through an orifice in the housings and thereby allowing the plungers to move within the reservoir.
  • the spring can be allowed to expand and exert a force on the plungers to move the plungers and fluid within the housings.
  • the viscosity of the fluid is adjusted by changing the magnetic field in the region of the orifice.
  • the magnetic field can be created using and controlled by one or more permanent magnets and/or a coil wound around the reservoir and/or orifice.
  • the movement of the one or more permanent magnets can be controlled manually including, but not limited to, changing the distance between the magnet and container/orifice, changing orientation, bringing in additional magnet(s) to increase the field, and/or bringing in additional magnet(s) to decrease/cancel field.
  • a system can be used which is analogous to the fluid filled cylinder described herein with reference to Figures 15A-15D.
  • the cylinder can be filled with the magneto-rheological fluid.
  • a magnet or electromagnet in place of the valve used in the embodiments described with reference to Figures 15A-15D, can be used to apply a magnetic field over a section of the tube linking the two cylinder chambers.
  • the mode of operation is exactly the same as described above, except that the magnetic fried instead of pulsing the valve is used to control the movement of fluid in the cylinder.
  • the withdrawal mechanism 1710 can include a magneto-rheological fluid device with a magneto-rheological fluid that can change viscosity in response to a change in a magnetic field applied to the magneto-rheological fluid.
  • the reservoir 1748 can include a first plunger 1747 on the proximal end of the reservoir 1748, a second plunger 1747 on the distal end of the reservoir 1738.
  • the first plunger 1748 and the second plunger 1748 can move within the reservoir in a proximal to distal direction and/or a distal to proximal direction.
  • the reservoir can consist of two chambers which are linked by pipe or orifice, for example, with the magnetic field being applied to the pipe or orifice.
  • the magneto- rheological fluid can be contained in the reservoir between the first plunger and the second plunger.
  • the spring 1717 can be in communication with a proximal end of the first plunger.
  • Figure 17B illustrates the spring 1717 in a compressed position.
  • Figure 17C illustrate the spring 1717 in an extended position.
  • the magnet and/or a coil wrapped around the reservoir and/or orifice containing the magneto-rheological fluid 1746 can generate a magnetic field.
  • the first and second plunger 1747 can have a first proximal position including the first plunger extended from the proximal end of the reservoir and the second plunger inserted into the reservoir.
  • the viscosity of the magneto-rheological fluid can prevent movement of the plungers within the reservoir.
  • the magnetic field can change the viscosity of the magneto-rheological fluid and can allow the magneto-rheological fluid to move within the reservoir.
  • the spring can then expand and move the first plunger to a second distal position which can move the fluid from the proximal chamber to the distal chamber.
  • the second distal position can include the first plunger inserted within the reservoir and the second plunger extending from the distal end of the reservoir.
  • the movement of the one or more permanent magnets can be electrically operated.
  • Electronically controlled mechanisms can be used such as, but not limited to, an electromechanical actuator (e.g. motor, solenoid or other actuators) to change distance between magnet and container/orifice, change orientation, bring in additional magnet(s) to increase field, and/or bring in additional magnet(s) to decrease/cancel field.
  • the coil wound around the reservoir and/or orifice containing the magneto-rheological fluid can be electronically controlled by passing a current through the coil to generate the magnetic field.
  • An on/off control can be used to apply the field for certain periods of time.
  • the on/off control can utilize a pulse-width modulated control (current on-time is varied) with frequency fixed, varied frequency with a fixed current on- time, and/or frequency and duty cycle can be varied.
  • Electronic proportional control can also be used.
  • the electronic proportional control can change the magnitude of current in an analogue manner by applying different voltage levels or passing different current levels through the coil.
  • FIGs 18A-19B illustrate embodiments of control mechanisms for use with a skin perfusion pressure determination device.
  • the control mechanisms can be used for the application and/or withdrawal of force on the tissue at the target area.
  • the control mechanism can control the force applied to the skin by using a pump driven device (shown in Figure 18A-18B) or a motor driven device (shown in Figures 19A-19B).
  • the skin perfusion pressure determination device can utilize various designs incorporating the sensors and signal processing elements into an elongate housing.
  • the skin perfusion pressure determination device can include an elongate housing having a proximal end and a distal end similar to and including features of the elongate housing and skin perfusion pressure determination device described with reference to Figures 7A-13K.
  • the elongate housing can include a proximal end and a distal end.
  • the elongate housing can include a sensor module provided within the housing and/or the proximal end assembly.
  • the sensor module can detect a pressure exerted on a target area and an amount of blood perfusion at the target area.
  • the elongate housing can include a proximal end assembly similar to the proximal end assembly described with reference to Figures 7-8.
  • the proximal end assembly can include a control mechanism configured to automatically control the pressure exerted on the target area by the sensor module.
  • a method of determining skin perfusion pressure can be used as described herein.
  • the skin perfusion pressure can be determined by positioning a proximal end of a skin perfusion pressure determination device on a target area of patient.
  • a force can be applied to the skin perfusion pressure determination device against the target area.
  • the force or a pressure applied to the target area by the skin perfusion pressure determination device can be measured using a first sensor within the device.
  • the blood perfusion in the target area beneath the proximal end can be measured using a second sensor within the device.
  • the device can control the application and/or withdrawal of force by the skin perfusion pressure determination device against the target area.
  • FIGS 18A-18B illustrate an embodiment of a pump-driven device 1810 for use with a skin perfusion pressure determination device.
  • the pump-driven device 1810 can use a pump 1851 and a valve 1852 to pump air into a reservoir 1853 and release air from the reservoir 1853, respectively.
  • the pressure in the reservoir can be adjusted which in turn adjusts the force applied to the target tissue area by the skin perfusion pressure determination device.
  • the pump-driven device 1810 controls the force applied to the target tissue area by controlling the pressure in the reservoir 1853.
  • the pressure can be controlled by the interplay of the pump 1851 which pumps air into the system and the valve 1852 which lets air out of the system.
  • the pump driven device can include the reservoir 1853 and the pump 1851 in fluid communication with the control valve 1852.
  • the pump 1851 can pump air into the reservoir 1853 or allow air to escape from the reservoir 1853.
  • the control valve 1852 can control the amount of air that fills or escapes the reservoir 1853.
  • a rod (not shown) can move within the reservoir 1853 and extend from the proximal end of the reservoir 1853.
  • the pump driven device 1810 can include a first position wherein the reservoir is filled with air thereby causing the rod to extend proximally from the reservoir to allow the skin perfusion pressure determination device to exert pressure on the target area.
  • the pump driven device 1810 can include a second position wherein the rod is contained within the reservoir as illustrated in Figure 18A-18B.
  • the pump and the valve can work with any working fluid.
  • the use of air can be convenient, as the atmosphere can be used as an unlimited reservoir.
  • a tank of the working fluid can be used to pump the working fluid out of and then release it back into. Any other gases or liquids can be used.
  • an additional spring can be used between the piston and the component which applies the force to the target area as the extension/position of the piston would be controlled rather than the pressure inside it.
  • the pump 1851 can incorporate several features that can control the force applied to the target tissue area.
  • the pump speed can be electronically controlled.
  • Analogue/proportional control can be used by controlling the magnitude of voltage applied to pump and/or the frequency of the control signal applied to pump.
  • An on/off valve can be used to control the pump speed electronically.
  • the on/off valve can control the pump speed by controlling open time with a control system, using pulse-width modulated control (length of on-time is varied) with frequency fixed, varying frequency with a fixed opening time, varying frequency and duty cycle.
  • the valve 1852 can incorporate several features that can control the force applied to the target tissue area.
  • the valve 1852 can use an on/off valve that is manually or electrically operated.
  • the on/off valve can be electrically operated by controlling open time with a control system, using pulse-width modulated control (length of on-time is varied) with frequency fixed, varying frequency with a fixed opening time, varying frequency and duty cycle.
  • An on/off valve with a flow restrictor can be used and the on/off valve with a flow restrictor can utilize the same control systems as the on/off valve described above.
  • the on/off valve with flow restrictor can additionally manually or electronically control the flow resistance of flow restrictor.
  • a proportional/analog valve can be used that can be manually controlled and/or electronically controlled.
  • Figure 19A-19B illustrate an embodiment of a motor driven device 1910 for use with a skin perfusion pressure determination device.
  • the motor driven device 1910 can use a motor 1960 coupled to lead- screw 1961 and a spring 1917 to adjust the force applied to the target tissue area by the proximal end 1905 of the skin perfusion pressure determination device.
  • the motor driven device 1910 can control the force applied to the target tissue area by compressing or extending a spring 1917 using a motor 1960.
  • a wide range of motors could be used including, for example, DC motors, AC motors, piezo motors, or other motors.
  • electromechanical actuators can be used in place of a motor, for example, a solenoid, an electric linear actuator/cylinder, or other electromechanical actuators.
  • the motor driven device 1910 can include a motor 1916 and a lead screw 1961 coupled to the motor 1916.
  • the lead screw 1961 can within the proximal end assembly in a proximal to distal and/or distal to proximal direction.
  • the spring 1917 can be coupled to the lead screw 1916.
  • the spring 1917 can move within the proximal end assembly in a proximal to distal and/or distal to proximal direction and can adjust the force applied to the target tissue area by the proximal end of the proximal end assembly.
  • the lead-screw is configured to extend or move in a proximal direction exerting a force on the spring which exerts a force on the target tissue area.
  • the lead-screw can retract or move in a distal direction releasing the force exerted on the spring.
  • Figures 20A-20C illustrate protective cover 2035 that can be placed over the proximal tissue contacting end 2005 of a skin perfusion pressure determination device 2004, which can be any of the devices described herein.
  • the protective cover 2035 can be a thin film or material for covering the tissue contacting end 2005 of the device 2004.
  • the protective cover 2035 can be helpful for sterilizing or cleaning the device between uses.
  • the skin perfusion pressure determination device 2004 with a first protective cover can be applied to a first tissue area for a first measurement. Then the skin perfusion pressure determination device 2004 can be removed from the first tissue area and the protective cover 2035 can be removed and discarded.
  • a second protective cover can be applied to the skin perfusion pressure determination device 2004. Then the skin perfusion pressure determination device 2004 with the second protective cover can be applied to a second tissue area for a second measurement.
  • Figures 20A-20C illustrate embodiments of protective covers with a central portion 2037.
  • Figure 20A illustrates a protective cover 2035 with extended pieces of material 2038 extending from the central portion 2037. The extended pieces of material 2038 can wrap around the proximal end 2005 of the skin perfusion pressure determination device 2004.
  • Figure 20B illustrates a protective cover 2035 with a lip 2039 extending from the central portion 2037. The lip 2039 can wrap around the proximal end 2005 of the skin perfusion pressure determination device 2004.
  • Figure 20C illustrates a protective cover 2035 with a tab 2040 extending from the central portion 2037.
  • the tab 2040 can wrap around the proximal end 2005 of the skin perfusion pressure determination device 2004 and can be used to place or remove the protective cover 2035 from the proximal end 2005.
  • the protective cover can be a clip-on cup and/or adhesive patch.
  • the protective cover 2035 can be formed from a material that is biocompatible or capable of contacting the skin and that does not interfere with the measurement.
  • the protective cover 2035 can be optically transparent so as not to interfere with the sensor readings.
  • the protective cover 2035 does not need to be completely transparent as long as the sensors in the skin perfusion pressure determination device can detect the required wavelengths.
  • the protective cover can be formed from a thermoplastic polymers such as polylactic acid (PLA) or polypropylene (PP).
  • the protective cover can be made of glass materials, for example, a high strength glass material such corning or gorilla glass.
  • the protective cover can be made of any material including the materials described herein with reference to the proximal end of the skin perfusion pressure determination device.
  • Figure 21 A illustrates the results of sensor readings from a skin perfusion pressure determination device with no protective cover (left side) and with a protective cover made from PLA (right side). As illustrated in Figure 21 A the protective cover made from PLA does not interfere with the sensors or measurement ability of the skin perfusion pressure determination device.
  • Figure 2 IB illustrates the results of sensor readings from a skin perfusion pressure determination device with no protective cover (left side) and with a protective cover made from PP (right side). As illustrated in Figure 2 IB the protective cover made from PP does not interfere with the sensors or measurement ability of the skin perfusion pressure determination device.
  • Figure 22 illustrates a skin perfusion pressure determination device 2204 with a proximal tissue contacting end 2205.
  • a cover 2236 can be used to cover the tissue contacting end 2205 of the skin perfusion pressure determination device 2204 when the skin perfusion pressure determination device 2204 is stored.
  • the cover 2236 can protect the tissue contacting end 2205 of the skin perfusion pressure determination device 2204 and help maintain the cleanliness of the device.
  • Figures 23A-23C illustrate embodiments of bellows designs for use with any of the skin perfusion pressure determination devices described herein.
  • the bellows design can be part of the proximal end assembly (as described with reference to Figures 8A-8D) that applies force to a target area.
  • the bellows can be designed so that the bellows do not apply a force and instead will compress or crumble easily when the user applies force to the skin perfusion pressure determination device at a target area.
  • the cross-sectional views of the bellows designs are illustrated on the right most image in Figures 23A-23C.
  • the bellows designs of Figure 23A-23C can include sections where the walls are thinned down to enable the bellows to collapse.
  • the thinned wall sections are illustrated in the cross-section shown in Figure 23A-23C.
  • the thinned walls can allow for a controlled way of bending and collapsing and a controlled compression and extension of the bellows.
  • the controlled bending of the bellows can protect the components positioned within the bellows.
  • the skin perfusion pressure determination device includes an interior chamber with one or more PCB, electronic components, and/or electrical wiring.
  • the contraction of the bellows during the application of force to the target area can reduce breakage of the one or more PCB, electronic components, and/or electrical wiring.
  • the minimum kick out of the bellows can provide greater protection for not trapping the PCB or wires and preventing the pinch of the edges of the bellows during contraction.
  • Figure 23 A illustrates a bellows design with an abrupt material cut-outs that provide a shallow kick out.
  • the bellows design illustrated in Figure 23A can also have a softer outer radius.
  • Figure 23B illustrates a bellows design with a gradual varied material thickness and a softer inner radius.
  • the bellows design illustrated in Figure 23B provides a pronounced kick out when the bellows are contracted.
  • Figure 23C illustrates a bellows design with sharp inner cut-outs and a controlled and minimized kick out of the bellows when contracted.
  • Figures 24A-24B illustrate an embodiment of a proximal end assembly with a bellows design.
  • Figure 24A illustrates the bellows in an expanded configuration and
  • Figure 24B illustrates the bellows in a contracted configuration.
  • Figures 24C-24D illustrate embodiments of a proximal end assembly with different bellows designs.
  • Figures 25A-25G illustrate an embodiment of a skin perfusion pressure determination device.
  • the skin perfusion pressure determination device of Figures 25A-25G can be similar to and can include similar components as the skin perfusion pressure determination device described with reference to Figures 7A-7B and 8A-8B.
  • the skin perfusion pressure determination device 2504 can be a hand-held device with an elongate housing 2503 including a grip portion 2521 and a casing 2531.
  • the grip portion 2521 and casing 2531 can be cylindrical tube like housings.
  • the grip portion 2521 and the casing 2531 can act as a housing or casing enclosing the interior of the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device 2504 can include a proximal end 2507 and a distal end 2506.
  • the skin perfusion pressure determination device 2504 can have a tissue contacting portion 2505 at the proximal most end of the device.
  • the skin perfusion pressure determination device 2504 can include a plunger assembly 2570 that can move relative to the grip portion 2521 and the casing 2531 of the housing.
  • the plunger assembly 2570 can include a sleeve 2532.
  • the skin perfusion pressure determination device 2504 can include an indicator portion 2522.
  • the indicator portion can be a part of the elongate housing that is formed from a translucent or transparent material as illustrated in Figure 25A and 25B.
  • the skin perfusion pressure determination device 2504 can be provided with a removable and/or replaceable cover 2536 which can be used to cover the tissue contacting end 2505.
  • the cover 2536 can be similar to the cover described herein with reference to other skin perfusion pressure determination device embodiments.
  • the skin perfusion pressure determination device 2504 can be used without a cover and instead the proximal end cap of the skin perfusion pressure determination device 2504 can be cleaned between use or application.
  • the skin perfusion pressure determination device can be sterilized or cleaned in various ways between use.
  • the tip can be sterile.
  • the tip or proximal end cap (described in more detail below) could be disposable.
  • the tip or proximal end cap can be cleaned and not sterile.
  • the skin perfusion pressure determination device can have the ability to be cleaned between uses and/or patients.
  • the proximal end of the skin perfusion pressure determination device can be cleaned with isopropyl alcohol (IPA) or ethanol wipes.
  • IPA isopropyl alcohol
  • the skin perfusion pressure determination device can be cleaned with an autoclave.
  • the skin perfusion pressure determination device can be cleaned or sanitized using some other disinfectant.
  • the skin perfusion pressure determination device can be cleaned or sanitized by placing the device in a container or receptacle of cleaning fluid, for example, alcohol or disinfectant.
  • the skin perfusion pressure determination device can have a seal between the grip portion 2521/ casing 2531 and the plunger assembly 2570 with the intent of preventing ingress of contaminated liquid or other foreign material from getting into a location that would be difficult to clean.
  • the plunger assembly 2570 can be designed to be removable from the grip portion 2521 and the casing 2531 and both the plunger assembly 2570 and the grip portion 2521 and the casing 2531 can be designed to allow for easy cleaning, sanitation, and/or sterilization prior to or between use.
  • Figures 25A-25B illustrate an embodiment of a skin perfusion pressure determination device 2504 with a grip portion 2521 that can encourage appropriate use of the skin perfusion pressure determination device 2504 by the user.
  • the grip portion 2521 can be designed to require the user to hold the skin perfusion pressure determination device 2504 in a certain configuration as described herein.
  • the skin perfusion pressure determination device 2504 illustrated in Figures 25A-25B can be held by the user like a pen, for example, between a thumb and index finger of the user.
  • the grip portion 2521 can include a flared portion 2571.
  • the flared portion 2571 can provide for slip protection.
  • the skin perfusion pressure determination device 2504 can be sized (with an appropriate diameter) to be held comfortably within the hand of a user in a pen grip. This hold and configuration can enable a controlled force application onto the tissue area.
  • the flared portion 2571 can assist in keeping the user’s hands or fingers away from the plunger assembly.
  • the body of the grip portion 2521 can be between 10mm to 40mm (about 10mm to 40mm) and the flared portion 2571 can be between 1mm to 10mm (about 1mm to 10mm) wider than the body of the grip portion 2521. Therefore, the total diameter of the flared portion 2571 (body of grip portion including the flared portion) can be between 11mm - 50mm (about 11mm - 50mm).
  • the body of the grip portion 2521 can be 8mm to 16mm (about 8mm to about 16mm).
  • the body of the grip portion 2521 can be 16mm (about 16mm).
  • the surface contour of the flared portion 2571 can be 2mm to 3mm (about 2mm to about 3mm).
  • Figure 25C illustrates an embodiment of the skin perfusion pressure determination device 2504 illustrating the transparent or translucent nature of the sleeve 2532.
  • Figure 25D illustrates a cross sectional perspective view of an embodiment of the skin perfusion pressure determination device 2504.
  • FIG. 25E illustrates a cross sectional view of an embodiment of the skin perfusion pressure determination device 2504.
  • the skin perfusion pressure determination device 2504 can include an elongate housing 2503 that includes the casing 2531, the grip portion 2521, and the sleeve 2532 that enclose the components of the device.
  • the elongate housing 2503 can also include a collar 2546 at the proximal end of the grip portion 2521.
  • at least a portion of the collar 2546 can be transparent or translucent and can incorporate the indicator portion 2522.
  • the flared portion 2571 of the grip portion 2521 can assist in keeping the user’s hands or fingers away from the indicator portion 2522.
  • the sleeve 2532 can move relative to the collar 2546 and move in and out of the collar 2546 as the skin perfusion pressure determination device 2504 is pressed against the skin of the patient.
  • the sleeve 2532 can move along an axis that runs from the proximal end 2507 to the distal end 2506 of the skin perfusion pressure determination device 2504 and the sleeve 2532 is retracted into and extended from the reminder of the housing 2503.
  • a stop feature 2544 can be incorporated into the housing to stop the sleeve 2532 when the sleeve 2532 is retracted into the housing 2503.
  • the interior of the housing 2503 can include a spring 2541 at the distal end of the device as illustrated in Figure 25E.
  • the proximal end of the spring 2541 can be in contact with a battery cap 2542 that encloses a battery 2543 within a battery compartment 2553.
  • the battery compartment 2553 can include one or more battery contacts for providing electrical communication with the battery and/or other components.
  • a PCB and/or other electronics 2545 can be positioned on and/or within a chassis or support structure 2547.
  • the proximal end 2507 of the device can incorporate an optical sensor 2551 as illustrated in Figure 25E and 25F.
  • the optical sensor can be positioned on and/or within a proximal end cap 2549 with an optical sensor window.
  • the end cap 2549 can be sealed to the sleeve 2532 with a gasket 2554.
  • the gasket 2554 can be a silicone bead gasket.
  • the skin perfusion pressure determination device 2504 can also include a force sensor 2552 positioned on the proximal end of the skin perfusion pressure determination device 2504.
  • the force sensor 2552 can be distal to the optical sensor 2551 and proximal to the PCB and/or other electronics 2545.
  • Figure 25F illustrates a zoomed in view of the proximal end of the skin perfusion pressure determination device 2504 embodiment shown in Figure 25E.
  • the positioning of the optical sensor 2551 and an optical sensor ribbon cable 2556 at the proximal most end of the device is illustrated in Figure 25F.
  • the force sensor 2552 can be positioned distal to the optical sensor 2551.
  • a force sensor ribbon cable 2555 can extend from the force sensor 2552 as illustrated in Figure 25F.
  • the optical sensor ribbon cable 2556 and the force sensor ribbon cable 2555 can allow for the optical sensor 2551 and the force sensor 2552 to communicate with the PCB and/or other electronic components 2545 (shown in Figure 25E).
  • Figure 25F illustrates a cover 2536 that can cover the proximal most end of the skin perfusion pressure determination device 2504.
  • the cover can be a single use cover that clips directly onto the proximal most end cap 2549 with the optical sensor window.
  • the cover can be molded in a clear, transparent, or translucent material as described herein with reference to other cover embodiments. The material of the cover can be selected so as not to interfere with the use and measurement conducted with the optical sensor.
  • Figure 25G illustrates an exploded view of the interior components of the skin perfusion pressure determination device 2504.
  • the spring 2541 can have a spring constant of between 0.1 N/mm to 2 N/mm.
  • Figure 25G illustrates the removeable battery cap 2542.
  • the battery cap 2542 can be sealed to the battery compartment with a sealing mechanism (for example, an o-ring sealing mechanism).
  • the removeable battery cap 2542 can be threaded and can align with complementary threading within the battery compartment.
  • the chassis or support structure 2547 can act as a battery compartment, PCB support, light pipe, ribbon cable support, and/or force sensor platform.
  • the support structure 2547 can be molded in clear plastic or some translucent or transparent material.
  • the support structure 2547 can support the PCB 2561 and an LED (not shown).
  • the LED can be incorporated onto the PCB 2561.
  • the LED can be positioned on the proximal edge of the PCB and can provide lighting into the sleeve and/or collar portion of the housing.
  • the features of the chassis or support structure 2547 can act as a light pipe to disperse the light from the LED uniformly. This can allow the at least partially transparent or translucent portion of the collar 2546 (shown in Figure 25E) to act as an indicator portion 2522 (shown in Figures 25A, 25B, and 25E) and display the light emitted from the LED.
  • more than one LED can be used to increase the intensity of the LED or to provide different colors of LED to emit different colors.
  • the sleeve is at least partially translucent or transparent, the light emitted from the LED can also be seen in at least part of the sleeve 2532.
  • the indicator portion 2522 can allow for a circumferential visual guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and application of force during use of the device.
  • the visual guide can use any LED or arrangement of LEDs, not necessarily circumferential, to guide the user through the procedure.
  • the indicator portion 2522 can be positioned at a portion of the skin perfusion pressure determination device 2504 that is in close proximity of the grip portion. This can allow the user to receive information and/or feedback from the visual indicator as they hold the device and use it.
  • the sleeve 2532 can be a frosted or partially obscuring material that allows for transmission of light and the light emitted by the LEDs to be visible through the material but can obscure the interior components of the skin perfusion pressure determination device so the interior components are not visible from the outer surface of the device.
  • the sleeve 2532 can be positioned around at least a portion of the chassis or support structure 2547 to cover and/or seal the PCB and/or other electronic components.
  • the light emitted from the LED can be visible at the proximal end of the collar 2546 forming the indicator portion 2522. In some cases, the light emitted from the LED can be visible at the proximal end of the collar 2546 and/or from the external surface of the sleeve and either or both of these areas can form the indicator portion 2522.
  • the LED can be located on the PCB. In other cases, the LED can be attached to the PCB via a flexible PCB or wire. This can allow the LED to be local to the area being illuminated. In some cases, the LED can be positioned within the interior of the housing but remote form the PCB. In some cases, the indicator portion 2522 can allow for uniform circumferential illumination around the device.
  • the light emitted by the LED can illuminate the proximal end of the collar, a portion of the sleeve, and/or the grip portion.
  • the light emitted by the LED can act as a dual visual feedback system for the user.
  • the LED can change intensity, blink, change color, or use a sequence of flashes to indicate different states to the user.
  • feedback can also be displayed on a display that is incorporated into the skin perfusion pressure determination device 2504 or a remote display.
  • the display can be a PC/Tablet GUI.
  • the display can provide an indication or feedback to the user that mirrors the indication or feedback provided by the light emitted by the LED on the skin perfusion pressure determination device 2504.
  • the user can then choose to use whichever (or combination of) feedback system they want to take the reading and use the device. For example, if the pen is removed too fast the LED/GUI will display a visual indicator (e.g. LED flashing yellow/audible feedback from GUI) to indicate this state.
  • a visual indicator e.g. LED flashing yellow/audible feedback from GUI
  • the reading can be taken with the skin perfusion pressure determination device without a display.
  • the skin perfusion pressure determination device can use acoustic feedback and/or haptic feedback.
  • Figure 25G illustrates the skin perfusion pressure determination device 2504 in a first configuration with a plunger assembly 2570.
  • the plunger assembly 2570 can include the chassis or support structure 2547 and sleeve 2532 and their associated components. At least a portion of the plunger assembly can be positioned within the portion of the housing comprising the grip portion and/or the casing of the housing.
  • the grip portion and/or casing can be a housing or casing enclosing and/or surrounding at least some of the components of the skin perfusion pressure determination device 2504. In some cases, the grip portion and/or casing can be a hollow cylindrical housing or casing.
  • a portion of the exterior surface of the plunger assembly 2570 can extend from the grip portion of the housing 2503.
  • the proximal end 2507 of the skin perfusion pressure determination device 2504 can be applied to the tissue area.
  • the support structure 2547 and sleeve 2532 of the plunger assembly 2570 can retract within the grip portion and/or casing of the housing and can exert a force on the spring 2541 causing the spring to compress.
  • the plunger assembly 2570 formed from the support structure 2547 and sleeve 2532 can move along the axis of the skin perfusion pressure determination device 2504 that extends from the proximal end to the distal end of the skin perfusion pressure determination device 2504.
  • the plunger assembly 2570 can be in a second configuration where it is retracted into the grip portion 2521 and casing 2531 of the housing 2503 as illustrated in Figure 25B.
  • the spring can expand and push the plunger assembly 2570 out of the housing 2503 back to the first configuration illustrated in Figure 25A.
  • the movement of the plunger assembly 2570 into and out of the grip portion 2521 and casing 2531 of the housing 2503 can be controlled by the amount the spring 2541 is compressed or expanded.
  • the spring constant can range from 0.1 N/mm (about 0.1 N/mm) to 2 N/mm (about 2 N/mm). In some cases, the spring constant can be less than 0.1 N/mm, 0.1 N/mm to 2 N/mm, or greater than 2 N/mm.
  • Positioning the force sensor 2552 at a proximal end of the device can allow for a force measurement to be taken without being affected by the friction forces in the barrel as the force reading is taken directly at or almost directly at the surface instead of indirectly further inwards or distally in the assembly where friction may alter the measurement since the force sensor is subject to additional forces.
  • Figures 26A-26B illustrate an embodiment of the skin perfusion pressure determination device 2604.
  • the skin perfusion pressure determination device 2604 illustrated in Figures 26A-26B is similar to the skin perfusion pressure determination device 2504 illustrated in Figure 25A-25G and the skin perfusion pressure determination device 2604 can incorporate the same components and features as the skin perfusion pressure determination device 2504.
  • Figure 26A illustrates a cross section of the skin perfusion pressure determination device 2604, however, not all the interior components are shown for simplicity.
  • the interior components of the skin perfusion pressure determination device 2604 can be the same as interior components of the skin perfusion pressure determination device 2504 except the force sensor 2652 can be positioned in a portion of the housing 2603 that is at the distal end of the plunger assembly 2570 formed from the sleeve 2532 and battery compartment 2653 and proximal to the spring 2641 as illustrated in Figure 26A.
  • the force sensor 2652 can include a force sensor ribbon cable 2566 that extends distally.
  • the force sensor ribbon cable 2566 can connect to the internal PCB.
  • Figure 26B illustrates a cross-sectional view of the skin perfusion pressure determination device 2604 with some of the forces that can impact the force measurement due to the movement of the sleeve and chassis or support structure within the housing 2603.
  • the sleeve 2632 can move within a portion of the housing 2603.
  • the sleeve 2632 can contact the housing 2603 at a first contact point 2661 and a second contact point 2662. Each of these contact points can create friction or other forces that may impact the force measurement of the device.
  • lateral forces on the proximal end cap or sleeve such as forces applied to the side for the sleeve or proximal end cap can also impact the force reading.
  • the force sensor measurement can account for these varied forces or friction that can impact an accurate force reading of the force applied to the tissue area.
  • Figures 27A-27F and 28A-28E illustrate various embodiments of shapes and configurations of the proximal end cap of the skin perfusion pressure determination device.
  • Figures 27A-27F illustrate different proximal end cap shapes that can be used.
  • the proximal end cap 2705 can have a flat proximal portion and a diameter that is the same as (or substantially the same as) the diameter of the sleeve 2732 and the circumference of the proximal end cap is flush with the circumference of the sleeve.
  • the proximal end cap 2705a, 2705b, and 2705e can have a diameter that is greater than the diameter of the sleeve 2732. This can allow for a greater surface area to contact the tissue area than the surface area of 2705. This increased surface area can more evenly distribute the force applied to the tissue area.
  • the proximal end cap 2705a can include curved edges along the circumference of the proximal most end of the end cap as shown in Figure 27B.
  • the proximal end cap 2705b can include tapered edges along the circumference of the proximal end of the end cap as shown in Figure 27C.
  • the proximal end cap 2705e can have a domed shape at the proximal end of the end cap as shown in Figure 27F.
  • the proximal end cap can have a flanged end similar to the proximal end cap 2705c and 2705d illustrated in Figures 27D and 27E.
  • the flanged end can provide an increased surface area that is greater than the cross-sectional area of the sleeve 2732 of the skin perfusion pressure determination device 2704.
  • the proximal end cap 2705d can include a flanged end as well as a proximal nipple portion as illustrated in Figure 27E.
  • the flanged area of the proximal end cap 2705d can reduce point pressure as it spreads pressure out across the application area.
  • the nipple section of the proximal end cap 2705d can help to create the occlusion of blood local to the sensor at the measurement location as it can be the first part to touch the tissue, and then the remainder of blood peripheral to the measurement location can be spread outwards from the sensor as pressure is applied with the flanged section.
  • the nipple portion can concentrate the force in the center of the pen and therefore the total force which needs to be applied by the user can be less than it is in the case of the proximal end cap 2750 in Figure 27A. Having to apply less force can be beneficial to the user and enables better force control. This configuration can also enable force sensors with a lower range and therefore potentially less noise to be used. The same benefits can be seen with the other embodiments that allow for the less force to be applied.
  • the proximal end caps illustrated in Figures 27A-27F can contact the target tissue area and provide the necessary surface area that will allow for the target area to be blanched or occluded as well as allow for a sensor (i.e. located as a component in the interior of the device) to monitor the blood flow synchronously with the application of pressure over the surface area.
  • the proximal end cap of the skin perfusion pressure determination device can provide a larger surface area to contact the skin by use of the flanged end or some other means extended outwards in the plane of the skin to stabilize the device on the target area and rest the device flat on the target area.
  • the proximal end cap of the skin perfusion pressure determination device can be domed to ensure even pressure distribution and contact with the target area.
  • a domed surface (for the purpose of even pressure distribution over the target area where the sensor is located) can be used with an in-plane flange to provide stabilization of the sensor head in the plane of the target area.
  • Figures 28A-28E illustrate the proximal end caps shown in Figures 27B-27F with a corresponding cross sectional view of the proximal end cap.
  • the gap in the middle of the proximal end caps shown in Figures 28A-28E correspond to the area that holds the optical sensor or a window that allows transmission of light to and from the optical sensor.
  • the surface of the proximal end cap that contacts the tissue area can have a diameter that ranges from 4 mm (about 4 mm) to 30 mm (about 30 mm). In some cases, the surface of the proximal end cap that contacts the tissue area can have a diameter that is less than 4mm, between 4 mm (about 4 mm) and 30 mm (about 30 mm), or greater than 30 mm. In some cases, only a portion of the proximal end cap needs to contact the tissue area to take the measurement necessary. In such cases, only a portion of the diameter would be in contact with the tissue area.
  • a cover can be used with any of the proximal end cap shapes described in Figures 27A-27F and 28A-28E.
  • the cover can mirror the shape of the proximal end cap.
  • the proximal end cap can be flat similar to the proximal end cap 2705 illustrated in Figure 27A and a shaped cover can be used.
  • the shaped cover can be domed, have a flanged end, or can be any other shape to provide pressure distribution.
  • the proximal end cap or proximal end of the device can have some beveling and/or doming of the tip to allow the pressure to be distributed across the soft tissue it is pushing onto.
  • an increasingly homogenous occlusion of capillaries under the tip can be accomplished with the shape of the proximal end cap or the proximal end of the skin perfusion pressure determination device.
  • the proximal end cap or the proximal end of the skin perfusion pressure determination device can be beveled, tapered, and/or a dome shape.
  • Figures 29A-29B illustrate an embodiment of a skin perfusion pressure determination device.
  • the skin perfusion pressure determination device of Figures 29A-29B can be similar to and can include similar components to the skin perfusion pressure determination device described with reference to Figures 7A-7B, 8A-8B, 25A-25G, and 26A-26B.
  • Figure 29A illustrates a skin perfusion pressure determination device 2904.
  • Figure 29B illustrates the skin perfusion pressure determination device 2904, however, all the interior components may not be shown for simplicity.
  • the interior components of the skin perfusion pressure determination device 2904 can be the same as the interior components of the skin perfusion pressure determination device described herein except the positioning of some of the components can be different.
  • the PCB and/or other electronics 2945 can be positioned in a portion of the housing 2903 that is at the distal end of the plunger assembly 2970 formed from the sleeve 2932 and proximal to the spring 2941 as illustrated in Figure 29B.
  • the optical sensor 2951 and force sensor 2952 can include an optical sensor ribbon cable and/or a force sensor ribbon cable that extends distally to connect to the internal PCB 2945.
  • the skin perfusion pressure determination device 2904 can be a hand-held device with an elongate housing 2903 including a grip portion 2921 and a casing 2931.
  • the grip portion 2921 and casing 2931 can be cylindrical tube-like housings.
  • the grip portion 2921 and the casing 2931 can act as a housing or casing enclosing the interior of the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device 2904 can include a proximal end 2907 and a distal end 2906.
  • the skin perfusion pressure determination device 2904 can have a tissue contacting portion 2905 at the proximal most end of the device.
  • the skin perfusion pressure determination device 2904 can include a plunger assembly 2970 that can move relative to the grip portion 2921 and the casing 2931 of the housing.
  • the plunger assembly 2970 can include a sleeve 2932.
  • the skin perfusion pressure determination device 2904 can include an indicator portion (not shown).
  • the indicator portion can be a part of the elongate housing that is formed from a translucent or transparent material as illustrated in Figures 25A and 25B.
  • the skin perfusion pressure determination device 2904 can be provided with a removable and/or replaceable cover which can be used to cover the tissue contacting end 2905.
  • the cover can be similar to the cover described herein with reference to other skin perfusion pressure determination device embodiments.
  • the skin perfusion pressure determination device can be used without a cover and instead the proximal end cap of the skin perfusion pressure determination device can be cleaned between use or application.
  • the skin perfusion pressure determination device can be sterilized or cleaned in various ways between uses.
  • the tip can be sterile.
  • the tip or proximal end cap could be disposable.
  • the tip or proximal end cap can be cleaned and not sterile.
  • the skin perfusion pressure determination device can have the ability to be cleaned between uses and/or patients.
  • the proximal end of the skin perfusion pressure determination device can be cleaned with isopropyl alcohol (IP A) or ethanol wipes.
  • IP A isopropyl alcohol
  • the skin perfusion pressure determination device can be cleaned with an autoclave.
  • the skin perfusion pressure determination device can be cleaned or sanitized using some other disinfectant.
  • the skin perfusion pressure determination device can be cleaned or sanitized by placing the device in a container or receptacle of cleaning fluid, for example, alcohol or disinfectant.
  • the skin perfusion pressure determination device can have a seal between the grip portion 2921/ casing 2931 and the plunger assembly 2970 with the intent of preventing ingress of contaminated liquid or other foreign material into a location that would be difficult to clean.
  • the plunger assembly 2970 can be designed to be removable from the grip portion 2921 and the casing 2931 and both the plunger assembly 2970 and the grip portion 2921 and the casing 2931 can be designed to allow for easy cleaning, sanitation, and/or sterilization prior to or between use.
  • Figures 29A-29B illustrate an embodiment of a skin perfusion pressure determination device 2904 with a grip portion 2921 that can encourage appropriate use of the skin perfusion pressure determination device 2904 by the user.
  • the grip portion 2921 can be designed to require the user to hold the skin perfusion pressure determination device 2904 in a certain configuration as described herein with reference to Figures 25A-25B or any other embodiment described herein.
  • the skin perfusion pressure determination device 2904 illustrated in Figures 29A-29B can be held by the user like a pen, for example, between a thumb and index finger of the user.
  • a grip where the device is positioned between the thumb and index finger of the user can be referred to herein as the pen grip or the external precision grip where the device is pinched between the thumb and index finger and the grip has extra components of support for the device in the cleft of the thumb and support for the whole hand along its medial edge.
  • the grip portion 2921 can include a flared portion 2971. The flared portion 2971 can provide for slip protection.
  • the skin perfusion pressure determination device 2904 can be sized (with an appropriate diameter) to be held comfortably within the hand of a user in a pen grip. This hold and configuration can enable a controlled force application onto the tissue area.
  • the flared portion can be sized (with an appropriate diameter) to be held comfortably within the hand of a user in a pen grip. This hold and configuration can enable a controlled force application onto the tissue area.
  • the flared portion can be sized (with an appropriate diameter) to be held comfortably within the hand of a user in a pen grip. This hold and configuration can enable a controlled force application onto the tissue area.
  • the body of the grip portion 2921 can be between 10mm to 40mm (about 10mm to 40mm) and the flared portion 2971 can be between 1mm to 10mm (about 1mm to 10mm) wider than the body of the grip portion 2921. Therefore, the total diameter of the flared portion 2971 (body of grip portion including the flared portion) can be between 11mm - 50mm (about 11mm - 50mm). In some cases, the body of the grip portion 2921 can be 8mm to 16mm (about 8mm to about 16mm). In some cases, the body of the grip portion 2921 can be 16mm (about 16mm). In some cases, the surface contour of the flared portion 2971 can be 2mm to 3mm (about 2mm to about 3mm).
  • FIG. 29B illustrates an exploded view of the skin perfusion pressure determination device 2904.
  • the skin perfusion pressure determination device 2904 can include an elongate housing 2903 that includes the casing 2931, the grip portion 2921, and the sleeve 2932 that enclose the components of the device.
  • the elongate housing 2903 can also include a collar 2946 at the proximal end of the grip portion 2921. In some cases, at least a portion of the collar can be transparent or translucent and can incorporate the indicator portion. In some cases, the flared portion 2971 of the grip portion 2921 can assist in keeping the user’s hands or fingers away from the indicator portion.
  • the sleeve 2932 can move relative to the collar 2946 and move in and out of the collar 2946 as the skin perfusion pressure determination device 2904 is pressed against the skin of the patient.
  • the sleeve 2932 can move along an axis that runs from the proximal end 2907 to the distal end 2906 of the skin perfusion pressure determination device 2904 and the sleeve 2932 is retracted into and extended from the reminder of the housing 2903.
  • a stop feature (not shown) can be incorporated into the housing to stop the sleeve 2932 when the sleeve 2932 is retracted into the housing 2903.
  • the interior of the housing 2903 can include a spring 2941 at the distal end of the device as illustrated in Figure 29B.
  • the proximal end of the spring 2941 can be in contact with a battery 2943 and/or a battery compartment 2953 that holds the battery 2943.
  • the battery compartment 2953 can include one or more battery contacts for providing electrical communication with the battery and/or other components.
  • a PCB and/or other electronics 2945 can be positioned on and/or within the elongate housing 2903.
  • the proximal end 2907 of the device can incorporate an optical sensor 2951 as illustrated in Figure 29B.
  • the optical sensor can be positioned on and/or within a proximal end cap at the proximal end of the device.
  • the proximal end cap can have an optical sensor window to allow the optical sensor 2951 to detect characteristics of the tissue on the opposite side of the proximal end cap.
  • the end cap or tissue contacting portion 2905 can be sealed to the sleeve 2932 with a gasket 2954.
  • the gasket 2954 can be a silicone bead gasket.
  • the skin perfusion pressure determination device 2904 can also include a force sensor 2952 positioned on the proximal end of the skin perfusion pressure determination device 2904.
  • optical sensor 2951 and/or force sensor 2952 assembly The positioning of the optical sensor 2951 and/or force sensor 2952 assembly at the proximal-most end of the device is illustrated in Figure 29B.
  • the optical sensor 2951 and/or force sensor 2952 assembly can be positioned proximal to the PCB and/or other electrical components 2945.
  • An optical sensor ribbon cable and/or force sensor ribbon cable can extend from the optical sensor and force sensor respectively and can allow for the optical sensor 2951 and the force sensor 2952 to communicate with the PCB and/or other electronic components 2945.
  • the PCB and/or other electronic components 2945 can be supported by a support structure 2947.
  • a cover can be used that can cover the proximal most end of the skin perfusion pressure determination device 2904.
  • the cover can be a single use cover that clips directly onto the proximal most end cap with the optical sensor window.
  • the cover can be molded in a clear, transparent, or translucent material as described herein with reference to other cover embodiments. The material of the cover can be selected so as not to interfere with the use and measurement conducted with the optical sensor.
  • Figure 29B illustrates an exploded view of the interior components of the skin perfusion pressure determination device 2904.
  • the spring 2941 can have a spring constant of between 0.1 N/mm to 2 N/mm.
  • the support structure 2947 can support the PCB 2945 and an LED (not shown).
  • the LED can be incorporated onto the PCB 2945.
  • the LED can be positioned on the proximal edge of the PCB and can provide lighting into the sleeve and/or collar portion of the housing.
  • the support structure 2947 can be molded in clear plastic or some translucent or transparent material. The features of the chassis or support structure 2947 can act as a light pipe to disperse the light from the LED uniformly.
  • the at least partially transparent or translucent portion of the collar 2946 can act as an indicator portion and display the light emitted from the LED.
  • more than one LED can be used to increase the intensity of the LED or to provide different colors of LED to emit different colors.
  • the sleeve is at least partially translucent or transparent, the light emitted from the LED can also be seen in at least part of the sleeve 2932.
  • the indicator portion can allow for a circumferential visual guide illuminated by a LED.
  • a color or multiple colors can be used to guide the user through the procedure and application of force during use of the device.
  • the visual guide can use any LED or arrangement of LEDs, not necessarily circumferential, to guide the user through the procedure.
  • the indicator portion can be positioned at a portion of the skin perfusion pressure determination device 2904 that is in close proximity of the grip portion. This can allow the user to receive information and/or feedback from the visual indicator as they hold the device and use it.
  • the sleeve 2932 can be a frosted or a partially obscuring material that allows for transmission of light and the light emitted by the LEDs to be visible through the material but can obscure the interior components of the skin perfusion pressure determination device so the interior components are not visible from the outer surface of the device.
  • the sleeve 2932 can be positioned around at least a portion of the chassis or support structure 2947 to cover and/or seal the PCB and/or other electronic components.
  • the light emitted from the LED can be visible at the proximal end of the collar 2946 forming the indicator portion 2922. In some cases, the light emitted from the LED can be visible at the proximal end of the collar 2946 and/or from the external surface of the sleeve and either or both of these areas can form the indicator portion 2922.
  • the LED can be located on the PCB. In other cases, the LED can be attached to the PCB via a flexible PCB cable or wire. This can allow the LED to be local to the area being illuminated. In some cases, the LED can be positioned within the interior of the housing but remote from the PCB. In some cases, the indicator portion 2922 can allow for uniform circumferential illumination around the device.
  • the light emitted by the LED can illuminate the proximal end of the collar, a portion of the sleeve, and/or the grip portion.
  • the light emitted by the LED can act as a dual visual feedback system for the user.
  • the LED can change intensity, blink, change color, or use a sequence of flashes to indicate different states to the user.
  • feedback can also be displayed on a display that is incorporated into the skin perfusion pressure determination device 2904 or a remote display.
  • the display can be a PC/Tablet GUI.
  • the display can provide an indication or feedback to the user that mirrors the indication or feedback provided by the light emitted by the LED on the skin perfusion pressure determination device 2904.
  • the user can then choose to use whichever (or combination of) feedback system they want to take the reading and use the device. For example, if the pen is removed too fast the LED/GUI will display a visual indicator (e.g. LED flashing yellow/audible feedback from GUI) to indicate this state.
  • a visual indicator e.g. LED flashing yellow/audible feedback from GUI
  • the reading can be taken with the skin perfusion pressure determination device without a display.
  • the skin perfusion pressure determination device can use acoustic feedback and/or haptic feedback.
  • a portion of the exterior surface of the plunger assembly 2970 (for example, the sleeve) can extend from the grip portion of the housing 2903.
  • the proximal end 2907 of the skin perfusion pressure determination device 2904 can be applied to the target area.
  • the support structure 2947 and sleeve 2932 of the plunger assembly 2970 can retract within the grip portion and/or casing of the housing and can exert a force on the spring 2941 causing the spring to compress.
  • the plunger assembly 2970 formed from the support structure 2947 and sleeve 2932 can move along the axis of the skin perfusion pressure determination device 2904 that extends from the proximal end to the distal end of the skin perfusion pressure determination device 2904.
  • the plunger assembly 2970 can be in a second configuration where it is retracted into the grip portion 2921 and casing 2931 of the housing 2903.
  • the spring can expand and push the plunger assembly 2970 out of the housing 2903 back to the first configuration.
  • the movement of the plunger assembly 2970 into and out of the grip portion 2921 and casing 2931 of the housing 2903 can be controlled by the amount the spring 2941 is compressed or expanded.
  • the spring constant can range from 0.1 N/mm (about 0.1 N/mm) to 2 N/mm (about 2 N/mm). In some cases, the spring constant can be less than 0.1 N/mm, 0.1 N/mm to 2 N/mm, or greater than 2 N/mm.
  • Positioning the force sensor 2952 at a proximal end of the device can allow for a force measurement to be taken without being affected by the friction forces in the barrel as the force reading is taken directly at or almost directly at the surface instead of indirectly further inwards or distally in the assembly where friction may alter the measurement since the force sensor is subject to additional forces.
  • Positioning the PCB and/or other electronic components 2945 at a more distal end of the device can prevent cracking of PCB and/or other electronic components 2945 as a force is exerted on the target area by the skin perfusion pressure determination device 2904.
  • the placement of the PCB and/or other electronic components 2945 at a more distal end 2906 of the device can protect the PCB and/or other electronic components 2945 from the forces exerted by the user to depress the plunger and the forces from the spring within the device.
  • the PCB and/or other electronic components 2945 can be positioned at a more distal end 2906 of the device or at a location distal to the optical sensor and force sensor.
  • the skin perfusion pressure determination device 2904 can include the force sensor and/or PCB in the central immobile core or support structure and the spring and outer barrel can move behind and around the central immobile core or support structure of the device.
  • the PCB and/or other electronic components 2945 can still be flexible or allow for some movement within the device but the movement can be minimal compared to the distance travelled by the spring or other moving components in the device.
  • the positioning, placement, or location of the skin perfusion pressure determination device for measurements or readings taken with the device on the target area can be important. It may be necessary to control the location of measurement for repeated measurements or for obtaining data from different areas or sides of a wound or target area. It may also be necessary to take measurements at various distances from the wound or target area. It may be necessary to provide for a method or device that can provide a consistent location for the reading of the skin perfusion pressure determination device relative to a target area or a wound and/or wound edge. In some cases, the wound can be changing shape throughout healing and therefore, in some cases, the location of measurement can be taken from a wound edge. In other cases, the location of measurement can be relative to a fixed position on the skin or target area.
  • the fixed position can be a location that is set on the first reading and defined from the wound edge.
  • This fixed position can provide for a measurement at an absolute position on the skin, independent of the wound edge since the wound edge can be a changing shape. This can be important for the proper measurement of a healing wound or target area. It can provide for repeated measurements at the same location over a period of time that can provide the user with more accurate or complete data relating to the condition or characteristics of the target tissue region and/or the wound.
  • the perfusion measurement When the user assesses perfusion, the perfusion measurement would be taken from a location at a distance relative to the wound edge and/or target area.
  • the location can be changed from one measurement to the next depending on the change of shape or size of the wound edge and/or target area.
  • the location can be set to a first location based on the distance of that first location from the wound edge and/or target area when the first measurement is taken. A subsequent measurement can then be taken from that same location regardless of the distance from the wound edge and/or target tissue area at the time of the subsequent measurements.
  • the distance could be measured using a separate measurement device, for example, a ruler.
  • the distance can also be measured by providing a measurement device or positioning guide within the skin perfusion pressure determination device itself.
  • the skin perfusion pressure determination device can incorporate a light source to emit a cone of light emanating from the skin perfusion pressure determination device.
  • the cone of light can allow for the skin perfusion pressure determination device to be consistently positioned a fixed distance from the wound and/or target tissue area.
  • a light source can be mounted a fixed distance up the skin perfusion pressure determination device at an angle outwards creating the cone of light.
  • Figure 30A illustrates a skin perfusion pressure determination device 3004 with a light source 3081 mounted a fixed distance up the skin perfusion pressure determination device 3004.
  • the light source 3081 can create a cone of light 3082 emanating from the skin perfusion pressure determination device 3004 to provide a guide for positioning of the skin perfusion pressure determination device.
  • Figures 30B and 30D illustrate a skin perfusion pressure determination device 3004 with a light source 3081 emitting a light 3082, 3083 (shown in Figure 30E) (for example, cone of light) onto the skin surface or surface of the target area.
  • Figures 30C and 30E illustrate a top view of a skin perfusion pressure determination device 3004 emitting a light 3082, 3083 (shown in Figure 30E) forming a cone of light onto the skin surface or surface of the target area.
  • the light emanating from the skin perfusion pressure determination device can have gradations as shown in Figures 30D and 30E.
  • the gradations of the light emanating from the skin perfusion pressure determination device can be one or more distances, for example, less than 2cm, 2cm, 3cm, 4cm, 5cm, and/or more than 5 cm, measured from the wound edge and/or the target area to the outer circumference of the proximal end of the skin perfusion pressure determination device.
  • the light emanating from the skin perfusion pressure determination device can have one distance as shown in Figures 30B and 30C.
  • the single distance can be less than 2cm, 2cm, 3cm, 4cm, 5cm, more than 5 cm measured from the wound edge and/or the target area to the outer circumference of the proximal end of the skin perfusion pressure determination device.
  • the single distance can be 5cm or 2 inches measured from the wound edge and/or the target area to the outer circumference of the proximal end of the skin perfusion pressure determination device.
  • the distance of the light emanating from the skin perfusion pressure determination device can be any distance measured from the wound edge and/or the target area to the outer circumference of the proximal end of the skin perfusion pressure determination device that could be used for taking a measurement and/or analyzing the characteristics related to the wound and/or target area.
  • the light emanating from the skin perfusion pressure determination device can be a ring, a cone, a spot, a line, and/or any other marking or indicia that provides a guide that allows the user to place the tip of the skin perfusion pressure determination device gently on the skin surface or the surface of the target area, a light marker or guide would then confirm the skin perfusion pressure determination device was a certain distance from the wound edge and/or the target area.
  • the light source and light emitting from the skin perfusion pressure determination device can also be used to create a cone of light to indicate proper orientation of the skin perfusion pressure determination device.
  • a cone of light can be projected onto the surface to confirm the perpendicular alignment of the skin perfusion pressure determination device.
  • the cone of light can be used to confirm the perpendicular alignment of the skin perfusion pressure determination device as well as the appropriate distance of the skin perfusion pressure determination device from the wound edge and/or the target tissue area.
  • the inclusion of the light source can still allow the skin perfusion pressure determination device to have an exterior surface that can be easy to clean and allowed smooth movement of the casing over the plunger assembly.
  • the light source can be on an outer surface of the plunger assembly or on an outer surface of the casing of the elongate housing. When the light source is on the plunger assembly, the light source would no longer be visible when the plunger assembly is retracted into the casing. In such cases, the light source may no longer be useful once the measurement is under way.
  • the light source can be immediately or almost immediately occluded as the measurement is started and the plunger assembly is transitioning to the retracted position moving within the casing of the elongate housing.
  • the light source can be on a more proximal portion of the outer surface of plunger assembly or can be on the outer surface of the casing. In such cases, the light source can remain visible and can continue emitting light onto the surface of the target area while the measurement is taken. This can help with keeping the skin perfusion pressure determination device upright or at the proper perpendicular alignment during the measurement or reading taken by the skin perfusion pressure determination device.
  • Figure 31 illustrates an exploded view of the skin perfusion pressure determination device 3104.
  • the skin perfusion pressure determination device 3104 of Figure 31 can be similar to the skin perfusion pressure determination device 2904 described with reference to Figure 29B.
  • the skin perfusion pressure determination device 3104 can include an elongate housing 3103 that includes the casing 3131, the grip portion 3121, and the sleeve 3132 that encloses the components of the device.
  • the elongate housing 3103 can also include a collar 3146 at the proximal end of the grip portion 3121. In some cases, at least a portion of the collar can be transparent or translucent and can incorporate the indicator portion.
  • the sleeve 3132 can move relative to the collar 3146 and move in and out of the collar 3146 as the skin perfusion pressure determination device 3104 is pressed against the skin of the patient.
  • the sleeve 3132 can move along an axis that runs from the proximal end 3107 to the distal end 3106 of the skin perfusion pressure determination device 3104 and the sleeve 3132 is retracted into and extended from the reminder of the housing 3103.
  • a stop feature (not shown) can be incorporated into the housing to stop the sleeve 3132 when the sleeve 3132 is retracted into the housing 3103.
  • the skin perfusion pressure determination device can include a spring 3141, battery cap 3115, battery compartment 3153, and battery 3143 similar to the devices described with reference to Figure 29B.
  • the skin perfusion pressure determination device comprises a chassis or support structure 3147 and a PCB and other components 3145, force sensor support disk 3113, optical sensor 3151, and an optical sensor support disk 3112.
  • the force sensor can be positioned near the proximal end 3107 similar to and near the optical sensor 3151.
  • the skin perfusion pressure determination device can include a proximal end cap or tissue contacting portion 3105 at the proximal end of the device and a distal end cap or casing plug 3116 at the distal end of the device.
  • the proximal end cap or tissue contacting portion 3105 can be adhered to the sleeve 3132 using an adhesive between the two parts.
  • the adhesive can be a soft silicone adhesive between the sleeve 3132 and the end cap or tissue contacting portion 3105.
  • the adhesive can be soft so as not to interfere with the force measurement of the device but also provide the structural integrity required.
  • An end cap o-ring 3117 can be positioned between the proximal end cap or tissue contacting portion 3105 and the sleeve 3132 and can prevent adhesive from entering the space where the sensors and/or sensor module is located.
  • Figure 32 illustrates a proximal end cap or tissue contacting portion 3205 of the skin perfusion pressure determination device.
  • the proximal end cap or tissue contacting portion 3205 can be transparent or translucent to allow a light to pass through the proximal end cap or tissue contacting portion 3205 to communicate with a sensor and/or sensor module.
  • the transparent or translucent portion of the proximal end cap or tissue contacting portion 3205 can be a capture window or central portion 3218 of the proximal end cap or tissue contacting portion 3205.
  • a portion of the proximal end cap or tissue contacting portion 3205 can be obscured to minimize the light interference from entering the proximal end cap through the areas around the intended light capture window or central portion 3218.
  • the obscured portion can also help to reduce light interference from the internal LEDs, for example, the LEDs used with the indicator portion that light up the indicator portion as a visual aid during use.
  • the skin perfusion pressure determination device system can include a base station to communicate with the skin perfusion pressure determination device.
  • the base station can be a control unit, remote computer, and/or data storage device computer as described herein.
  • the base station can be a laptop or tablet.
  • the base station can run a data acquisition and display software.
  • the base station can be in wireless communication with the skin perfusion pressure determination device or with any other device.
  • Figure 33 illustrates a flow chart of an initialization procedure for a skin perfusion pressure determination device.
  • the skin perfusion pressure determination device can be assembled at the point of use and prepared for a measurement.
  • the user can take all components out of their packaging or case.
  • the user can then boot up a base station.
  • the user can launch the skin perfusion pressure determination device application software subsystem.
  • the skin perfusion pressure determination device application software subsystem can attempt to connect to the skin perfusion pressure determination device.
  • Figure 33 illustrates the initialization procedure of the device.
  • the force sensor measurement period can be set 3301.
  • the indicator portion of the skin perfusion pressure determination device can provide an indication to a user 3302.
  • the indicator portion can flash in a color or illuminate in a pattern.
  • the indicator portion of the skin perfusion pressure determination device can flash in a blue color.
  • the system can confirm the pairing request is received 3303. If the request is not received it will try to notify again until the system times out.
  • the skin perfusion pressure determination device application software subsystem can send a command to notify the user that a pairing request is received 3304.
  • the skin perfusion pressure determination device application software subsystem can indicate this request by illuminating or flashing the indicator portion on the skin perfusion pressure determination device.
  • the skin perfusion pressure determination device can have an indicator portion that displays the LEDs flashing three times in a white color.
  • the skin perfusion pressure determination device application software subsystem can show the measurement screen.
  • the indicator portion of the skin perfusion pressure determination device can illuminate to notify successful pairing 3305.
  • the skin perfusion pressure determination device indicator portion can illuminate a solid white color.
  • the skin perfusion pressure determination device can enter an error state.
  • the skin perfusion pressure determination device application software subsystem can indicate a pairing error. Once the device is initialized the device can then be in an active state and the system is ready for measurement.
  • Figure 34 is a flow chart of a method of using the system in an active state.
  • the skin perfusion pressure determination device can be used to take a measurement of the perfusion pressure at a number of locations around the periphery of the wound.
  • the force sensor measurement period and the optical sensor measurement period can be set to active.
  • the user can initiate a measurement by selecting the measurement option in the application software subsystem.
  • the application software subsystem can create a measurement data file for data storage.
  • the application software subsystem can indicate to the user the measurement location by displaying information of the relative position of the first measurement location with respect to the wound. When the connection is established and no force is applied the indicator portion of the skin perfusion pressure determination device is in a first state.
  • the first state can be a first color and/or pattern of illumination, for example, a white color.
  • the skin perfusion pressure determination device can be positioned at the measurement site and the indicator portion can be in a second state.
  • the second state can be a second color and/or second pattern of illumination (for example, a solid green color).
  • the indicator portion indicates if the force is excessive or appropriate. For example, if the force is appropriate the indicator portion remains in the second state (for example, a green color). If the force is excessive, the indicator portion can turn to a third state.
  • the third state can be a third color and/or pattern of illumination (for example, an orange or yellow can alert the user of the excessive force).
  • the indicator portion can change to another state to further alert the user (for example, a red color can alert the user of an extreme condition that may damage the skin).
  • the user can move the pen to the indicated measurement location and presses the pen slowly with increasing force against the patient skin. During this movement the indicator portion can be maintained in the second state when the force is appropriate.
  • the indicator portion can transition to a fourth state.
  • the fourth state can be a fourth color and/or pattern of illumination (for example, a flashing pattern of illumination).
  • the skin perfusion pressure determination device can take a measurement.
  • the indicator portion can transition to another state between each measurement or when measurements are completed.
  • the application software subsystem can record the force and optical sensor measurement provided by the skin perfusion pressure determination device and save this data to the measurement data file.
  • the states of the indicator portion above are described with relation to certain conditions, the states of the indicator portion can vary based on the predetermined conditions of the skin perfusion pressure determination device system.
  • the indicator portion of the skin perfusion pressure determination device can display guidance and information to guide the user through the measurement and the indicator portion states can vary depending on the requirements of the system.
  • the application software subsystem can guide the user sequentially through measurements at further locations by displaying the respective measurement location and guiding the user through the measurement at this location by repeating the process described for the first location and measurement.
  • the application software subsystem can display a measurement summary to the user.
  • the skin perfusion pressure determination device can be provided at the target area. A force can be exerted on a target area with the plunger assembly of the skin perfusion pressure determination device when the indicator portion is in a first state. The spring of the skin perfusion pressure determination device can exert a force on the plunger assembly to control the force exerted on the target area as the plunger is depressed.
  • a first force measurement of the force can be exerted on the target area and a first measurement of the amount of blood perfusion at the target area with the sensor module can be taken when the light emitted from the indicator portion is in a second state.
  • the force exerted on the target are can be adjusted and/or released based on the light emitted from the indicator portion being in the second state.
  • a second force exerted on the target area and a second amount of blood perfusion at the target area can be detected with the sensor module when the light emitted from the indicator portion is in a third state.
  • the force exerted on the target area can be adjusted and/or released based on the light emitted from the indicator portion being in the third state.
  • the first state can indicate a state when force is being applied to the target area and the plunger is compressed.
  • the second state can indicate a state when blood flow at the target area has been occluded.
  • the third state can indicate a state when blood flow at the target area has resumed.
  • Figure 35 is a flow chart of the operation of the skin perfusion pressure determination device in a sleep state.
  • the force sensor measurement period is set to a sleep state and the optical sensor measurement is set to inactive.
  • the skin perfusion pressure determination system determines if a force is applied that is greater than a threshold force measurement. If a force is applied that is greater than the threshold force, the device can also check that the duration of the force applied exceeds a threshold duration. If the force applied and/or the duration of the force applied exceeds the respective thresholds, the device can go into an initialization and/or active state as described above. If the force applied does not exceed a threshold, the device will remain inactive. The device will continue to check the force applied in regular increments until the threshold force and/or threshold duration is applied.
  • Figure 36 is a flow chart of the operation of the skin perfusion pressure determination device in an error state.
  • the device can display an appropriate error sequence to the user.
  • the error sequence can be displayed by the indicator portion on the skin perfusion pressure determination device and/or on a base station display screen.
  • the device can check if the length of time of inactivity has been reached where the device will enter the sleep state. If that length of time has passed, the device will enter the sleep state. If the length of inactivity has not passed, the device can keep checking until the length of time has passed or the error is addressed by the user.
  • the skin perfusion pressure determination device can be used to capture various measurements. First, a force can be applied to a target area with the proximal end of the skin perfusion pressure determination device and blood flow is occluded. The force at which blood flow is occluded can be the data point captured. The measurement can end and a pressure can be calculated if desired.
  • a force can be applied to a target area with the proximal end of the skin perfusion pressure determination device and blood flow is occluded. Then the force applied can be reduced and blood flow can be restored. The force at which blood flow is restored can be the data point captured. The measurement can end and a pressure can be calculated if desired.
  • a force can be applied to a target area with the proximal end of the skin perfusion pressure determination device and blood flow is occluded. Then the force applied can be reduced and blood flow can be restored. The force at which blood flow is occluded and blood flow is restored can be the data captured. The measurement can end and pressure can be calculated for these two data points if desired.
  • the blood perfusion sensor may comprise other types of optical sensors or may be a non-optical sensor
  • the skin perfusion pressure determination device could comprise other types of data storage devices. It will also be appreciated that, where applicable, each embodiment described previously could be modified so that recorded data is processed and/or stored locally on a skin perfusion pressure determination device or transmitted for remote processing and/or storage and vice versa.
  • the embodiments described above comprise a sensor module which is configured such that an optical sensor can be positioned adjacent the skin and a force sensor is located above the optical sensor.
  • Other possible arrangements include a sensor module in which a force sensor and an optical sensor are arranged such that, in use, the force sensor is placed next to a target region of skin tissue and the optical sensor is positioned above the force sensor.
  • the force sensor may comprise through-holes or transparent portions through which light can be transmitted.
  • an accelerometer, magnetometer, gyroscope, any other sensor, a comparison to an external feature, and/or tilt sensor can be used which can be used to determine the angle of application of force. Knowing the angle of application of force can allow for numerical compensation for this angle and/or warning of the user if this angle gets too large as this can impact the reading. In some cases, reaching certain angular points can prevent a reading from being taken, or the data from being reliable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

Des modes de réalisation de l'invention concernent des appareils et des procédés pour un dispositif de détermination de la pression d'une perfusion cutanée. Dans certains cas, un dispositif de détermination de pression de perfusion cutanée peut comprendre un module de capteur comprenant un premier capteur permettant de détecter un premier paramètre associé à une pression exercée sur une zone cible par le module de capteur et un second capteur permettant de détecter un second paramètre associé à une quantité de perfusion sanguine au niveau de la zone cible, le premier capteur et le second capteur étant agencés de telle sorte que, lorsque le module de capteur est pressé contre la zone cible, le premier capteur produit une sortie correspondant au premier paramètre détecté et le second capteur produit une sortie correspondant au second paramètre détecté, un ensemble d'extrémité proximale conçu pour entrer en contact avec la zone cible. Dans certains cas, un dispositif de détermination de pression de perfusion cutanée peut avoir un guide de positionnement pour positionner le dispositif de détermination de pression de perfusion cutanée au niveau de la zone cible.
PCT/EP2021/056380 2020-03-12 2021-03-12 Dispositif, appareil et procédé de détermination de pression de perfusion cutanée Ceased WO2021180947A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2003586.1A GB202003586D0 (en) 2020-03-12 2020-03-12 Device, apparatus and method of determining skin perfusion pressure
GB2003586.1 2020-03-12

Publications (1)

Publication Number Publication Date
WO2021180947A1 true WO2021180947A1 (fr) 2021-09-16

Family

ID=70453616

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/056380 Ceased WO2021180947A1 (fr) 2020-03-12 2021-03-12 Dispositif, appareil et procédé de détermination de pression de perfusion cutanée

Country Status (2)

Country Link
GB (1) GB202003586D0 (fr)
WO (1) WO2021180947A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025044554A1 (fr) * 2023-08-31 2025-03-06 北京他山科技有限公司 Module de mesure de paramètres cutanés séparable

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015531A1 (fr) * 1993-01-18 1994-07-21 The State Of Israel Systeme d'angiographie vasculaire a infrarouge
US5703225A (en) 1995-12-13 1997-12-30 Kimberly-Clark Worldwide, Inc. Sulfonated cellulose having improved absorbent properties
WO1999058090A1 (fr) 1998-05-14 1999-11-18 Ethicon, Inc. Bande de contention multicouche
US6759566B1 (en) 1995-11-18 2004-07-06 Bristol-Myers Squibb Company Bandaging system
US20060142560A1 (en) 2004-12-29 2006-06-29 Glasser Wolfgang G Sulfoalkylated cellulose
WO2006110527A2 (fr) 2005-04-08 2006-10-19 3M Innovative Properties Company Systeme de bande de contention
EP1718257A1 (fr) 2004-02-13 2006-11-08 Bristol-Myers Squibb Company Pansement pour plaies a couches multiples
US20090234206A1 (en) * 2007-11-27 2009-09-17 Sanna Gaspard Medical device for diagnosing pressure ulcers
WO2010061225A2 (fr) 2008-11-27 2010-06-03 Speciality Fibres And Materials Limited Matériaux absorbants
US7753894B2 (en) 2004-04-27 2010-07-13 Smith & Nephew Plc Wound cleansing apparatus with stress
US20110282309A1 (en) 2010-04-27 2011-11-17 Smith & Nephew Plc Wound dressing and method of use
US8235955B2 (en) 2005-04-27 2012-08-07 Smith & Nephew Plc Wound treatment apparatus and method
EP2498829A1 (fr) 2009-11-10 2012-09-19 ConvaTec Technologies Inc. Composant pour pansement des plaies
WO2013007973A2 (fr) 2011-07-14 2013-01-17 Smith & Nephew Plc Pansement et méthode de traitement
WO2013175306A2 (fr) 2012-05-23 2013-11-28 Smith & Nephew Plc Appareils et procédés pour une thérapie de plaie par pression négative
WO2015085240A1 (fr) * 2013-12-05 2015-06-11 Veriskin Llc Dispositif de surveillance d'une perfusion cutanée
US20150190286A1 (en) 2012-08-01 2015-07-09 Smith & Nephew Plc Wound dressing and method of treatment
WO2016174048A1 (fr) 2015-04-27 2016-11-03 Smith & Nephew Plc Appareils à pression réduite
US20160339158A1 (en) 2015-05-18 2016-11-24 Smith & Nephew Plc Fluidic connector for negative pressure wound therapy
WO2017195038A1 (fr) 2016-05-13 2017-11-16 Smith & Nephew Plc Appareil de surveillance et de thérapie de plaie activé par un capteur
WO2018162728A2 (fr) * 2017-03-09 2018-09-13 Smith & Nephew Plc Dispositif, appareil et procédé de détermination de pression de perfusion cutanée
EP3424417A1 (fr) * 2016-03-04 2019-01-09 NS Materials Inc. Capteur de débit sanguin et dispositif de mesure de débit sanguin
US20190350470A1 (en) * 2018-05-21 2019-11-21 ARC Devices Ltd. Apparatus in Electronic Medical Records Systems that Determine and Communicate Multi-Vital-Signs from Electromagnetic Radiation of a Subject

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015531A1 (fr) * 1993-01-18 1994-07-21 The State Of Israel Systeme d'angiographie vasculaire a infrarouge
US6759566B1 (en) 1995-11-18 2004-07-06 Bristol-Myers Squibb Company Bandaging system
US5703225A (en) 1995-12-13 1997-12-30 Kimberly-Clark Worldwide, Inc. Sulfonated cellulose having improved absorbent properties
US20020099318A1 (en) 1997-05-16 2002-07-25 Susan Suehr Multi-layer compression bandage
WO1999058090A1 (fr) 1998-05-14 1999-11-18 Ethicon, Inc. Bande de contention multicouche
EP1718257A1 (fr) 2004-02-13 2006-11-08 Bristol-Myers Squibb Company Pansement pour plaies a couches multiples
US7753894B2 (en) 2004-04-27 2010-07-13 Smith & Nephew Plc Wound cleansing apparatus with stress
US20060142560A1 (en) 2004-12-29 2006-06-29 Glasser Wolfgang G Sulfoalkylated cellulose
WO2006110527A2 (fr) 2005-04-08 2006-10-19 3M Innovative Properties Company Systeme de bande de contention
US8235955B2 (en) 2005-04-27 2012-08-07 Smith & Nephew Plc Wound treatment apparatus and method
US20090234206A1 (en) * 2007-11-27 2009-09-17 Sanna Gaspard Medical device for diagnosing pressure ulcers
US20160114074A1 (en) 2008-11-27 2016-04-28 Speciality Fibres And Materials Ltd. Absorbent material
WO2010061225A2 (fr) 2008-11-27 2010-06-03 Speciality Fibres And Materials Limited Matériaux absorbants
EP2498829A1 (fr) 2009-11-10 2012-09-19 ConvaTec Technologies Inc. Composant pour pansement des plaies
US20110282309A1 (en) 2010-04-27 2011-11-17 Smith & Nephew Plc Wound dressing and method of use
WO2013007973A2 (fr) 2011-07-14 2013-01-17 Smith & Nephew Plc Pansement et méthode de traitement
WO2013175306A2 (fr) 2012-05-23 2013-11-28 Smith & Nephew Plc Appareils et procédés pour une thérapie de plaie par pression négative
US20150190286A1 (en) 2012-08-01 2015-07-09 Smith & Nephew Plc Wound dressing and method of treatment
WO2015085240A1 (fr) * 2013-12-05 2015-06-11 Veriskin Llc Dispositif de surveillance d'une perfusion cutanée
WO2016174048A1 (fr) 2015-04-27 2016-11-03 Smith & Nephew Plc Appareils à pression réduite
US20160339158A1 (en) 2015-05-18 2016-11-24 Smith & Nephew Plc Fluidic connector for negative pressure wound therapy
EP3424417A1 (fr) * 2016-03-04 2019-01-09 NS Materials Inc. Capteur de débit sanguin et dispositif de mesure de débit sanguin
WO2017195038A1 (fr) 2016-05-13 2017-11-16 Smith & Nephew Plc Appareil de surveillance et de thérapie de plaie activé par un capteur
WO2018162728A2 (fr) * 2017-03-09 2018-09-13 Smith & Nephew Plc Dispositif, appareil et procédé de détermination de pression de perfusion cutanée
US20190350470A1 (en) * 2018-05-21 2019-11-21 ARC Devices Ltd. Apparatus in Electronic Medical Records Systems that Determine and Communicate Multi-Vital-Signs from Electromagnetic Radiation of a Subject

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025044554A1 (fr) * 2023-08-31 2025-03-06 北京他山科技有限公司 Module de mesure de paramètres cutanés séparable

Also Published As

Publication number Publication date
GB202003586D0 (en) 2020-04-29

Similar Documents

Publication Publication Date Title
US12593998B2 (en) Device, apparatus and method of determining skin perfusion pressure
US12290352B2 (en) Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
US12424307B2 (en) Wound analysis device and method
US20250009290A1 (en) Sensor enabled wound therapy dressings and systems implementing cybersecurity
US20240412840A1 (en) Negative pressure wound therapy system using eulerian video magnification
JP7354098B2 (ja) センサ対応型創傷療法被覆材およびシステムのためのセンサ位置決めおよび光学検知
JP2021502845A (ja) 統合センサ対応型創傷モニタリングおよび／または治療被覆材ならびにシステム
WO2019020550A2 (fr) Encapsulation biocompatible et libération des contraintes des composants pour pansements de traitement de plaies à pression négative activés par capteur
WO2021180947A1 (fr) Dispositif, appareil et procédé de détermination de pression de perfusion cutanée

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21713332

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21713332

Country of ref document: EP

Kind code of ref document: A1